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Abstract 
CD8+ T cell differentiation is a complex process that requires integration of 
signals from the TCR, co-stimulatory molecules and cytokines. Ligation of the 
peptide-MHC complex with the cognate TCR initiates a downstream signaling 
cascade of which the IL-2 inducible T-cell kinase (ITK) is a key component. Loss 
of ITK results in a measured reduction in T cell activation. Consequently, Itk 
deficient mice have defects in thymic selection, CD8+ T cell expansion and 
differentiation in response to virus infections, and generate a unique population 
of innate-like CD8+ T cells. The mechanisms that translate TCR and ITK-derived 
signals into distinct gene transcription programs that regulate CD8+ T cell 
differentiation are not defined. Our microarray screen identified IRF4 as a 
potential transcription factor mediating the differentiation of innate-like T cells, 
and antiviral CD8+ T cell in response to acute and chronic LCMV infections. 
 
Innate-like CD8+ T cells are characterized by their high expression of 
CD44, CD122, CXCR3, and the transcription factor Eomesodermin (Eomes). 
One component of this altered development is a non-CD8+ T cell-intrinsic role for 
IL-4. We show that IRF4 expression is induced upon TCR signaling and is 
dependent on ITK activity. In contrast to WT cells, activation of IRF4-deficient 
CD8+ T cells leads to rapid and robust expression of Eomes, which is further 
enhanced by IL-4 stimulation. These data indicate that ITK signaling promotes 
IRF4 up-regulation following CD8+ T cell activation and that this signaling 
 xii 
pathway normally suppresses Eomes expression, thereby regulating the 
differentiation pathway of CD8+ T cells. 
 
ITK deficient mice also have reduced expansion of CD8+ T cells in 
response to acute LCMV infections. We show that IRF4 is transiently up-
regulated to differing levels in murine CD8+ T cells, based on the strength of TCR 
signaling. In turn, IRF4 controls the magnitude of the CD8+ T cell response to 
acute virus infection in a dose-dependent manner. Furthermore, the expression 
of key transcription factors such as T cell factor 1 and Eomesodermin are highly 
sensitive to graded levels of IRF4. In contrast, T-bet expression is less 
dependent on IRF4 levels and is influenced by the nature of the infection. These 
data indicate that IRF4 is a key component that translates the strength of TCR 
signaling into a graded response of virus-specific CD8+ T cells. 
 
The data from these studies indicated a pivotal role of IRF4 in regulating 
the expression of T-bet and Eomes. During persistent LCMV infections, CD8+ T 
cells differentiate into T-bethi and Eomeshi subsets, both of which are required for 
efficient viral control. We show that TCR signal strength regulates the relative 
expression of T-bet and Eomes in antigen-specific CD8+ T cells by modulating 
levels of IRF4. Reduced IRF4 expression results in skewing of this ratio in favor 
of Eomes, leading to lower proportions and numbers of T-bet+ Eomes- precursors 
and poor control of LCMV Clone 13 infection. Altering this ratio in favor of T-bet 
 xiii 
restores the differentiation of T-bet+ Eomes- precursors and the protective 
balance of T-bet to Eomes required for efficient viral control. These data highlight 
a critical role for IRF4 in regulating protective anti-viral CD8+ T cell responses by 
ensuring a balanced ratio of T-bet to Eomes, leading to the ultimate control of 
this chronic viral infection.  
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CHAPTER I: INTRODUCTION 
 
The immune system is extremely complex and has evolved to protect the 
host from infection. A successful immune response eliminates the pathogen with 
minimal pathology to the host. The immune system is broadly divided into two 
branches, the innate and the adaptive immune system. The innate immune 
system is the first line of defense against infections and comprises cells such as 
macrophages, dendritic cells, mast cells, basophils and eosinophils etc. Though 
originally thought to be non-specific, the role of innate immune cells in response 
to specific pathogen challenges has gained increasing attention. The cells of the 
innate immune system respond to infection through specific germline-encoded 
receptors called the pattern recognition receptors (PRR) that recognize pathogen 
associated molecular patterns (PAMP) on pathogens, for example, a PRR Toll 
like receptor 4 recognizes bacterial lipopolysaccharide. The response of the 
innate immune cells is fast and serves to limit the spread of infection. Further, 
these cells also prime the adaptive immune system by presenting antigenic 
peptides to adaptive immune cells, however they do not form any immunological 
memory.  
 
The cells of the adaptive immune system, T and B lymphocytes, are highly 
specialized cells and recognize antigens through surface expressed T cell and B 
cell receptors (TCR and BCR). These receptors arise from the rearrangement of 
germline-encoded genes and thus are highly diverse and specific for the target 
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pathogen. This endows an individual with the ability to respond to a large number 
of pathogens during its lifetime. Cells of the adaptive immune system serve as a 
second line of defense against infections. Unlike the innate immune cells, the 
response of adaptive immune cells is usually slow and may take up to a few 
days. Fortunately, upon antigen clearance, a small population of the responding 
cells survives that form immunological memory. These memory cells prevent 
reinfection of the host by mounting a faster and bigger response than the primary 
infection. 
 
 T cells develop from early thymic progenitors (ETP) that arise in the bone 
marrow and seed the thymus. In the thymus, ETP’s undergo sequential 
progression from CD4- CD8- double negative (DN) cells, through CD4+ CD8+ 
double positive (DP) cells, to mature CD4+ or CD8+ single positive (SP) cells. 
The most immature ETPs retain αβ and γδ T cell, NK cell, dendritic cell and 
myeloid potential. This non-αβ T lineage potential is not lost until thymocytes 
rearrange their TCRβ chain that pairs with a surrogate a chain to form a pre-TCR 
complex. Assembly of the pre-TCR complex on cell surface arrests further β 
chain rearrangement and causes proliferation and maturation of thymocytes to 
the double positive stage. At this stage, DP thymocytes rearrange TCRα chain to 
form functional TCRs and undergo selection and lineage commitment. TCRs that 
weakly recognize self-peptide presented by self Major Histocompatability 
Complex (MHC) undergo positive selection. In contrast, thymocytes with strong 
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self-reactive receptors are deleted by negative selection. These processes, 
called central tolerance ensure that the mature T cell pool is self-MHC restricted 
and self-tolerant. During positive selection, CD4 and CD8 co-receptors also bind 
to invariant sites on MHC molecules. Co-receptor binding is necessary for 
positive selection and ensures that thymocytes that recognize MHC class II 
molecules develop into CD8+ T cells while those recognizing MHC class I 
molecules become CD4+ T cells in a process known as lineage commitment 
(Ciofani and Zúñiga-Pflücker, 2007).  
 
Mature CD4+ and CD8+ T cells then circulate in the lymphatic system and 
migrate to secondary lymphoid organs in search of cognate antigen. Antigen 
encounter results in T cell activation. Optimal T cell activation requires three 
signals; signal 1 through the TCR, signal 2 through co-stimulation and signal 3 
from cytokines. Interaction of the TCR with cognate peptide-MHC complex 
(Signal 1) results in a series of signal transduction events collectively called the 
TCR signaling pathway. 
 
TCR signaling pathway 
The TCR complex consists of disulfide linked TCR αβ heterodimer, CD3 
ε,δ and γ chains and 2 ζ  chains. All chains have intracellular immunoreceptor 
tyrosine-based activation motifs (ITAM) that are essential for receptor signaling. 
Association of the TCR with its appropriate peptide-MHC complex on antigen 
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presenting cells results in activation of Src kinase lymphocyte-specific protein 
tyrosine kinase (Lck). Lck phosphorylates tyrosine residues in the ITAMs of the 
CD3 and ζ  chains. Zeta-chain-associated protein kinase 70 (Zap70) binds to the 
phosphorylated ITAMs where it is phosphorylated and activated by Lck. Zap70 in 
turn recruits and phosphorylates Linker for activation of T cells (LAT) and SRC 
homology 2 (SH2)-domain-containing leukocyte protein of 76 kDa (SLP-76) to 
the signaling complex. Phospholipase Cγ (PLCγ) docks onto the LAT-SLP76 
complex where it is phosphorylated by the Inducible T cell kinase (ITK). ITK is a 
key protein that regulates proximal TCR signaling and T cell differentiation. Its 
role will be discussed in detail later. Once activated, PLCγ hydrolyzes 
phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two secondary 
messengers, inositol trisphosphate (IP3) and diacylglycerol (DAG) (Smith-Garvin 
et al., 2009).  
 
IP3 causes release of Ca2+ from intracellular stores, leading to the opening 
of Ca2+-release-activated Ca2+ channels (CRAC) on the plasma membrane. This 
leads to a prolonged phase of Ca2+ influx that ultimately activates transcription 
factors such as nuclear factor of activated T cells (NFAT). DAG activates the 
protein kinase C (PKC)/RasGRP pathway that leads to the activation of the 
mitogen-activated protein kinase (MAPK) pathway leading to phosphorylation of 
extracellular signal-realted kinase (ERK). Activated ERK initiates transcription of 
the Fos gene. Fos then binds to the constitutively expressed Jun protein leading 
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to the formation of the transcriptional regulator AP-1. A third pathway is induced 
by the combined actions of DAG and Ca2+. This pathway activates of PKCθ 
resulting in release of nuclear factor of kappa light polypeptide gene enhancer in 
B-cells (NFκB) from its inhibitor IκB. In T cells, activation of NFAT, AP-1 and 
NFκB results in expression of genes such as interleukin (IL) -2 that are required 
for T cell proliferation and differentiation into effector cells (Smith-Garvin et al., 
2009).  
 
Inducible T cell kinase (ITK) 
 ITK is a non-receptor tyrosine kinase belonging to the family of Tec 
kinases that also includes members Btk, Rlk and Tec. It is the most predominant 
Tec kinase in T cells and was independently discovered by three groups in the 
1990’s and is also known as Emt (expressed in mast cells and T lymphocytes) 
and Tsk (T cell-specific kinase) (Gibson et al., 1993; Heyeck and Berg, 1993; 
Siliciano et al., 1992; Tanaka et al., 1993; Yamada et al., 1993). ITK contains a 
C-terminus kinase domain, followed by a SH-2 and SH-3 domains, a proline rich 
domain, a Zn2+ binding Btk homology domain and the N terminal pleckstrin 
homology (PH) domain (Andreotti et al., 2010).   
 
 ITK is predominantly cytosolic in resting T lymphocytes. Recruitment of 
ITK to the proximal TCR signaling complex is mediated by activation of 
Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) that phosphorylates PIP2 
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generating PIP3. PIP3 accumulates in the plasma membrane where it is bound by 
the PH domain of ITK, leading to accumulation of ITK in the plasma membrane. 
Here ITK interacts with the LAT-SLP76 complex via its SH-2 and SH-3 domains 
and is phosphorylated and activated by Lck. Activated ITK then undergoes cis-
autophosphorylation. ITK then phosphorylates PLCγ leading to production of 
secondary messengers IP3 and DAG and downstream T cell activation (Andreotti 
et al., 2010).  
 
Biochemical effects of Itk deficiency in T cells 
 The role of ITK in TCR signaling in thymocytes and in primary and 
secondary activation of peripheral T cells has been well characterized. Based on 
the central location of ITK in the proximal TCR signaling complex, one might 
speculate that the loss of ITK would result in complete ablation of TCR signaling. 
Contrary to this, loss of ITK results in a measured decrease in TCR signaling due 
to reduced phosphorylation and activation of PLCγ resulting in a concomitant 
decrease in the levels of IP3 and DAG. As a result, ITK knockout cells have 
reduced Ca2+ flux as well as a decrease in the phosphorylation of downstream 
kinases ERK1, ERK2 and JNK (Atherly et al., 2006a; Liu et al., 1998; Miller and 
Berg, 2002; Schaeffer et al., 2000; 1999). Hence, IL-2 production and 
proliferation of Itk deficient cells is compromised but not abolished (Liao and 
Littman, 1995; Liu et al., 1998; Miller and Berg, 2002; Schaeffer et al., 1999). 
These data indicate that unlike Lck and Zap70 that function in a digital manner to 
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regulate TCR activation, ITK works as a rheostat modulating the strength of TCR 
signaling (Andreotti et al., 2010; Smith-Garvin et al., 2009). Indeed, one study 
examining the effects of kinase-dead mutant of Lck and ITK on TCR activation 
found that depending on the levels of kinase-dead Lck expressed in the cell, cells 
either did not flux Ca2+ or fully fluxed Ca2+, while cells expressing inactive ITK 
had uniformly reduced Ca2+ flux per cell (Donnadieu et al., 2001).  
 
 As a result of the unique role of ITK in regulating TCR signal strength, Itk 
deficient mice have altered thymic selection (Liao and Littman, 1995; Lucas et 
al., 2002; Schaeffer et al., 2000) and develop a unique population of innate-like T 
cells (Atherly et al., 2006b; Broussard et al., 2006; Dubois et al., 2006). These 
mice are also defective in mounting an anti-viral CD8 T cell response (Atherly et 
al., 2006a; Bachmann et al., 1997). 
 
ITK and thymic selection 
 The paradox of thymic selection can be explained together by the “altered 
peptide” and the “affinity model” (Moran and Hogquist, 2012). The affinity model 
of thymic selection suggests that the strength of TCR signaling sensed by 
thymocytes influences the outcome of positive and negative selection. Hence 
TCRs that recognize self-peptide MHC complexes with signals of lower threshold 
are positively selected, while stronger signals lead to negative selection and 
death by apoptosis (Moran and Hogquist, 2012). Based on this model, it can be 
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hypothesized that loss of ITK would result in reduced strength of TCR signaling 
leading to lower positive selection.  
 
Indeed, data from three independent studies examining the role of ITK in 
positive selection of CD4+ and CD8+ T cells confirmed this to be the case: first, 
the expression of CD5, a marker that positively correlates with the strength of 
TCR signaling was expressed at lower levels on Itk deficient double positive and 
single positive thymocytes (Schaeffer et al., 2000). Second, the proportions and 
numbers of polyclonal mature single positive CD4+ and CD8+ T cells were 
reduced in thymii of Itk deficient mice (Liao and Littman, 1995; Schaeffer et al., 
2000). This trend was also observed in three different lines of CD4+ TCR 
transgenic mice- 2B4, 5C.C7 and AND TCR transgenic mice that are specific for 
the moth cytochrome c peptide bound to I-Ek/I-Ab. Of these, 2B4 and 5C.C7 TCR 
transgenic CD4+ T cells have lower avidity than the AND TCR for the selecting 
ligand-I-Ek complex. As a result, the effect of ITK deficiency was more 
predominant on 2B4 and 5C.C7 TCR transgenic CD4+ T cells than on the AND 
TCR. Furthermore, the effect of ITK deficiency was also validated on the strength 
and density of the selecting ligand using the AND TCR transgenic CD4+ T mice. 
The AND TCR has higher avidity for I-Ek than I-Ab. Based on these observations, 
it would be expected that loss of ITK would have minimal effect on positive 
selection of AND TCR transgenic CD4+ T cells in ANDk/k mice followed by ANDk/b 
mice while the selection in ANDb/b would be severely affected. Indeed, lowest 
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numbers of AND TCR transgenic CD4+ T cell developed on the ANDb/b 
background followed by ANDk/b mice while the development of CD4+ T cells was 
least affected in ANDk/k mice (Lucas et al., 2002).   
 
The effect of ITK deficiency on selection of CD8+ T cells was examined 
using HY TCR transgenic mice. The HY antigen is encoded by the Y 
chromosome, hence HY TCR transgenic CD8+ T cells undergo negative 
selection in male mice while they are positively selected in the female mice. The 
numbers of HY TCR transgenic T cells were lower in the thymii of Itk deficient 
female mice relative to WT mice, indicating reduced positive selection (Liao and 
Littman, 1995; Schaeffer et al., 2000). The data on negative selection, however, 
is unclear. Liao et. al. found no significant difference in the negative selection and 
deletion of HY TRC transgenic CD8+ cells in male mice while Schaeffer et. al. 
found an increase in the proportion and numbers of DP thymocytes and CD8+ 
single thymocytes in these mice. Further, a majority of the mature CD8+ T cells in 
the periphery of these mice were HY TCR transgenic (Liao and Littman, 1995; 
Schaeffer et al., 2000).  
 
 Together these data indicate that subtle defects in TCR signaling such as 
those observed in the absence of ITK result in defects in positive and negative 
selection in the thymus. Additional evidence for the role of ITK in these 
processes comes from studies using mice harboring the Y145F mutation in 
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SLP76. Y145F mutant SLP76 does not activate ITK and hence these mice also 
show defects in positive and negative selection, similar to those observed in Itk 
deficient mice (Jordan et al., 2008). 
 
ITK and the development of innate-like T cells 
 In mice lacking Itk, a unique population of mature non-conventional CD8+ 
T cells develops called the innate-like CD8+ T cells. Even in the absence of any 
prior antigen exposure, these cells express markers associated with activated or 
memory T cells such as high expression of hyaluronic acid receptor CD44, IL-
2/IL-15 receptor β chain (CD122), NK1.1, C-X-C Chemokine Receptor Type 3 
(CXCR3) and IL-4 receptor α chain (CD124). Further, innate-like T cells are able 
to produce IFNγ and IL-4 upon stimulation with phorbol 12-myristate 13-acetone 
(PMA) and Ionomycin directly ex-vivo (Atherly et al., 2006b; Broussard et al., 
2006; Dubois et al., 2006). Time-course analysis experiments indicated that 
innate-like T cells develop in the thymus and do not home to the thymus after 
differentiation in the periphery. Further, innate-like T cells can be seen in the 
thymus as early as neonatal day 4 (Atherly et al., 2006b). Fetal thymic organ 
cultures of WT and Itk deficient E15.5 fetal thymii indicated that these cells arose 
intra-thymically and could be observed by D8 post culture (Broussard et al., 
2006). Unlike conventional CD8+ T cells that are selected on thymic epithelial 
cells, innate-like T cells in Itk deficient mice are selected on hematopoietically 
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derived cells in the thymus and are selected on both MHC class Ia and Ib 
proteins (Broussard et al., 2006). Innate-like T cells also require IL-15 and IL-4 
for development (Atherly et al., 2006b; Dubois et al., 2006; Weinreich et al., 
2010) and express the transcription factor Eomesodermin (Eomes). Besides Itk 
deficient mice, innate-like CD8+ T cells are also observed in mice with defects in 
TCR signaling such as Y145F SLP76 mutant mice, Itk/Rlk double deficient mice, 
and in mice lacking transcription factors that are activated downstream of the 
TCR signaling such as CREB binding protein (CBP), Inhibitor of DNA binding 3 
(Id3) and Kruppel-like factor 2 (Klf2) (Broussard et al., 2006; Fukuyama et al., 
2009; Jordan et al., 2008; Verykokakis et al., 2010; Weinreich et al., 2009).  
 
 The signals required for the development of innate-like T cells in Itk 
knockout mice are not well established. Three independent studies established 
the non-CD8+ T cell-intrinsic role for IL-4 in the development of these cells 
(Figure 1.1). Weinreich et. al., generated mixed-bone marrow chimeras with an 
excess of Itk deficient bone marrow mixed in with WT bone marrow. Analysis of 
mature CD8+ T cells in these mice indicated that in the presence of Itk deficient 
cells, WT cells differentiated into Eomeshi , CD44hi, CD122hi, IL-4 receptor a 
(CD124) high, CXCR3hi innate-like CD8+ T cells. This conversion was dependent 
on the high levels of environmental IL-4 produced by the Promyelocytic 
leukaemia zinc finger (PLZF) expressing CD4+ cells in Itk knockout mice. In 
support of these findings, the bystander effect of IL-4 on CD8+ T cell             
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Figure 1.1: Non-CD8+ T cell-intrinsic role for IL-4 in the development of 
innate-like CD8+ T cells: This model depicts the current understanding of the 
development of innate-like cells. Mice deficient for Itk, Klf2, Id3, and knock-in 
mice harboring Y145F SLP-76 mutation have an expanded population of thymic 
CD4+ PLZF+ cells that produce high levels of IL-4. This exogenous IL-4 acts on 
developing conventional CD8+ T cells and induces Eomes expression. Eomes in 
turn up-regulates the expression of CD122, CXCR3 and IFNγ leading to the 
differentiation of innate-like T cells in these mice. 
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differentiation could be abolished by a compound deficiency of CD124 or PLZF 
and Itk (Weinreich et al., 2010). Studies in mice lacking Id3 indicated a similar 
effect of PLZF+ γδ NKT cells in regulating differentiation of innate-like T cells 
through bystander IL-4 production. Similar to Weinreich et. al., analysis of mixed 
bone marrow chimeras with a majority of Id3 deficient cells and a minority of WT 
cells indicated a conversion of WT CD8+ T cells into innate-like cells in the 
thymus. Further, this effect was mediated by PLZF induced IL-4, as loss of either 
protein in Id3 deficient mice rescued development of conventional CD8+ T cells 
in these mice (Verykokakis et al., 2010). A third study examined the development 
of innate-like T cells in Y145F SLP76 mutant mice. Similar to the previous two 
studies, in mixed bone marrow chimera experiments, Y145F SLP76 cells could 
convert WT cells into innate-like T cells. This phenotype was found to be 
dependent on PLZF+ γδ cells. Further, blocking of IL-4 signaling using anti-IL-4 
antibodies could partially rescue the phenotype (Gordon et al., 2011). In 
conclusion, these data suggested that exogenous IL-4 acts on bystander 
conventional CD8+ T cells in mice deficient for Itk, Id3, Y145F SLP76 mutant etc. 
leading to Eomes up-regulation, resulting in expression of CD122 and CXCR3 
leading to innate-like CD8+ T cell differentiation (Figure 1.1). 
 
 Although the data described above provide compelling evidence to 
support a role of IL-4 in the development of innate-like T cells, these studies do 
not rule out a possible role of TCR signal strength in this process. Two pieces of 
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evidence exists in support for a role of TCR signal strength: first, in Itk knockout 
mice that expressed a hypersensitive allele of Erk2-the sevenmaker mutant 
(Erksem), there was a partial rescue of the conventional CD8+ T cell 
development. Thus, CD8+ SP T cells in these mice had lower expression of 
CD44, CD122 and IFNγ (Broussard et al., 2006). Second, the studies evaluated 
the role of IL-4 in conversion of bystander polyclonal WT CD8+ T cells into 
innate-like CD8+ T cells. Under these experimental conditions, it is not possible to 
control for TCR affinity, and thus it is likely that only the cells expressing the low 
affinity TCR’s were converted to an innate-like phenotype. Indeed, bone marrow 
chimera experiments examining the role of exogenous IL-4 in the conversion of 
WT CD8+ T cells expressing the high affinity OT I TCR indicated that the 
efficiency of conversion of OT I CD8+ T cells to an innate-like phenotype was 
much lower than that observed for polyclonal WT cells (Weinreich et al., 2010). 
Further, the degree of conversion of OT I cells was much poorer relative to the 
frequency of innate-like CD8+ T cells found in Itk knockout mice (Atherly et al., 
2006b; Broussard et al., 2006). 
 
 To determine the role of TCR signal strength in the generation of innate-
like CD8+ T cells, we performed a microarray experiment and identified the 
transcription factor Interferon regulatory factor 4 (IRF4) as a potential candidate 
regulating this process. Chapter III of this thesis will discuss the role of TCR 
signaling, ITK and IRF4 in the differentiation of innate-like T cells.  
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ITK and anti-viral CD8+ T immune response 
 The ability to protect the host from infection is the hallmark feature of an 
effective immune response. Infection with intracellular pathogens such as viruses 
like Lymphocytic choriomeningitis virus (LCMV) or bacteria like Listeria 
monocytogenes (LM), results in activation of CD8+ T cells amongst other cell 
types. Activated CD8+ T Cells then undergo multiple rounds of cell division to 
generate a large population of effector cytotoxic T lymphocytes (CTL) CTL 
produce cytokines like IFNγ, tumor necrosis factor α (TNF α) and IL-2 along with 
cytotoxic molecules perforin and granzyme B that induce apoptosis of infected 
cells. Following pathogen clearance, the majority of the effector CD8+ T cells die 
and a small but stable population of memory cells capable of self-renewal, high 
proliferation and rapid effector functions survives (Figure 1.2) (Kaech and Cui, 
2012). The dynamics of CD8+ T cell responses to infection with LCMV are 
discussed in detail later in this chapter. 
 
 In CD8+ T cells, loss of ITK results in impaired TCR signaling in-vitro 
characterized by lower PLCγ phosphorylation and Ca2+ flux and reduced 
phosphorylation of ERK1 and ERK2. Further, in-vitro differentiated CD8+ T cells 
exhibit reduced proliferative capacity and IFNγ and TNFα production. 
Correspondingly, infection of Itk deficient mice with LCMV results in reduced 
expansion of CD8+ T cells at the peak of effector CD8+ T cell response due to a 
cell-intrinsic defect in the proliferation of these cells. There is also a concomitant 
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Figure 1.2: Kinetics of anti-viral CD8+ T cell response in acute LCMV 
infection: After infection of naïve C57BL6/J mice with LCMV Armstrong, virus 
titers in spleen rise by day 3-4 post infection and decline thereafter. The 
decrease in viral titers is concomitant with CD8+ T cell activation and expansion. 
The numbers of CD8+ T cells peak at day 8-9 post infection. The magnitude of 
CD8+ T cell expansion is dependent on the strength of TCR signaling and is 
regulated by signaling molecules like ITK and SLP76 and the affinity of the TCR 
for cognate antigen, antigen dose and duration of antigen exposure. Following 
viral clearance, CD8+ T cells undergo attrition via apoptosis and a small 
population of memory cells survives that mediate rapid effector functions upon 
re-infection.  
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decrease in the numbers of IFNγ  producing cells as well as the expression of 
IFNγ on a per cell basis. Further, Itk deficient memory T cells are less poly-
functional with respect to IFNγ and TNFα expression (Atherly et al., 2006a; 
Bachmann et al., 1997). Furthermore, CD8+ T cells from Itk knockout mice also 
show reduced LCMV-specific cytotoxic responses in-vitro (Bachmann et al., 
1997). Interestingly, despite these functional defects in CD8+ T cells 
differentiation, Itk deficient mice exhibit no delay in viral clearance (Atherly et al., 
2006a; Bachmann et al., 1997). A similar defect in CD8+ T cell signaling was also 
observed in T cells expressing the Y145F mutant SLP-76 or mice hemizygous for 
the Y145F mutant SLP-76 allele. These mice too had a reduction in the numbers 
of IFNγ, IFNγ/TNFα, and IFNγ/IL-2 producing cells. Together, these data indicate 
that reduced strength of TCR signaling such as that achieved by loss of Itk result 
in reduced expansion of anti-viral CD8+ T cell responses (Figure 1.2).  
 
 The role of TCR signal strength in CD8+ T cell responses is a well-
researched topic. Considerable evidence suggests that the magnitude of the 
CD8+ T cell response is proportional to the affinity of the TCR for the cognate 
ligand, antigen load and duration of antigen exposure. In an elegant study by 
Zehn et. al., the role of TCR affinity in CD8+ T cell expansion was determined by 
examining the response of OT I TCR transgenic T cells to LM expressing 
different affinity variants of the  ovalbumin (Ova) peptide. This study showed that 
there was a dramatic difference in the expansion of OT I cells in response to 
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peptides of differing affinities. Stimulation with weaker affinity ligands resulted in 
decreased proliferation. As a result, these cells reached peak expansion earlier 
and started contracting faster. In contrast, T cells stimulated with the higher 
affinity ligands underwent more rounds of division leading to a larger proliferative 
burst. At the termination of the response, irrespective of the strength of the 
stimulating ligand, a small pool of memory cells survived that expanded to 
comparable levels after re-challenge. These data indicated that proliferation of 
CD8+ T cells in response to re-infection is dictated by the strength of the recall 
stimulus and not by prior antigen exposure (Zehn et al., 2009).   
 
 Antigen load and duration of antigen exposure also affect expansion of T 
cells. Mercado et al. examined the magnitude of the CD8+ T cells response to 
infection with an ampicillin sensitive strain of LM in the presence or absence of 
antibiotic treatment. Antibiotic treatment rapidly eliminates bacteria thus reducing 
antigen load. Examination of CD8+ T cell responses indicated that although 
antibiotic treatment had no effect on initial proliferation of CD8+ T cells, the peak 
expansion of CD8+ T cell was significantly lower upon antibiotic treatment 
compared to the controls. Administration of antibiotics at later time points during 
infection did not dramatically affect the magnitude of the response indicating that 
strength of TCR stimulation at the time of CD8+ T cell priming is the major factor 
determining CD8+ T cell expansion (Mercado et al., 2000). A later study by Joshi 
et. al. also confirmed these observations and showed that reducing antigen load 
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mainly affected the expansion of the short-lived effector T cell population without 
substantially affecting the numbers of memory cells formed (Joshi et al., 2007).  
 
However the decrease in CD8+ T cell expansion induced by antibiotic 
treatment could be an effect of the reduced antigen load or the decrease in 
associated inflammation. To delineate the role of antigen abundance under 
constant inflammatory conditions, Joshi el al. examined the CD8+ T cell response 
to recombinant vaccinia virus expressing different amounts of LCMV GP33-41 
epitope. Here, the frequency and magnitude of the effector CD8+ T cell response 
was proportional to the antigen abundance (Joshi et al., 2007). Prlic et.al. 
examined the effect of duration of antigen exposure on the expansion of CD8+ T 
cells under constant inflammatory conditions. Here mice were immunized 
simultaneously with LM and diphtheria toxin sensitive dendritic cells pulsed with 
ova peptide and the response of OT I TCR transgenic cells was examined. 
Administration of diphtheria toxin resulted in ablation of the antigen presenting 
cells thus decreasing the duration of antigen exposure only. Early depletion of 
dendritic cells (1, 12 and 24h post immunization) resulted in lower expansion of 
CD8+ T cells relative to mice that received diphtheria toxin at later time points 
(48h). A closer examination of the CD8+ T cell proliferation indicated that OT I 
cells underwent fewer rounds of cell-division upon early administration of 
antibiotic treatment (Prlic et al., 2006).  
 
 23 
 Together the data described above indicate that reduction in TCR signal 
strength either by lowering TCR affinity, antigen dose or duration of antigen 
exposure or by loss of ITK expression or mutations in SLP76 result in diminished 
magnitude of the CD8+ T cell response (Figure 1.2) (Atherly et al., 2006a; 
Bachmann et al., 1997; Mercado et al., 2000; Prlic et al., 2006; Zehn et al., 
2009). However, the molecular mechanisms that regulate this process are not 
completely understood. The data described in chapter IV of this thesis will 
discuss the role of TCR signal strength and IRF4 in the regulation of CD8+ T cell 
effector responses. 
 
Why choose IRF4? 
 To determine how signals through the TCR via ITK regulate the 
differentiation of CD8+ T cells at the molecular level, we performed a microarray 
experiment and found that IRF4 was poorly expressed in Itk deficient cells. At the 
time when these studies were performed, it was well established that the levels 
of IRF4 were regulated by the strength of BCR signaling. Further, the levels of 
IRF4 regulated distinct programs of gene expression that differentiated B cells 
into two antagonistic lineages. Lower levels of IRF4 promoted the germinal 
center B cell fate by up-regulating the expression of activation-induced 
deaminase (AID), a cytidine deaminase and essential for somatic hypermutation 
(SHM) and class switch recombination (CSR). On the other hand, higher IRF4 
expression resulted in lower levels of AID with a concomitant increase in B 
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lymphocyte induced maturation protein 1 (Blimp-1) expression. Blimp-1 regulates 
the expression of genes such as X-box binding protein 1 (Xbp1) that are involved 
in increasing endoplasmic reticulum and secretory apparatus of the B cells thus 
promoting plasma cell differentiation. Based on these data a regulatory network 
was proposed where lower strength of BCR signaling would induce lower levels 
of IRF4 leading to stable expression of AID that would induce SHM to generate 
BCRs with higher affinity. Signals through the higher affinity BCR would increase 
intracellular IRF4 levels leading to suppression of AID expression and increase 
Blimp1 expression for plasma cell differentiation (Klein et al., 2006; Sciammas et 
al., 2011; 2006).  
  
 Based on these data we hypothesized that variations in TCR signal 
strength would lead to up-regulation of different levels of IRF4. Higher levels of 
IRF4 would promote the development of conventional CD8+ T cells while lower 
levels would regulate the differentiation of innate-like T cells. In the context of 
viral infections, we speculated that levels of IRF4 would regulate the peak 
expansion of CD8+ T cells. 
 
Interferon Regulatory Factors 
Interferon Regulatory Factors (IRF) were originally discovered as 
transcription factors that were induced following treatment with type I interferons. 
As of today, there are ten members, IRF1 through IRF10. Of these, IRF1 through 
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IRF9 are expressed in mice and humans, while IRF10 is expressed in chickens. 
IRF proteins can act as transcriptional activators or repressors, and play critical 
roles in the development and differentiation of multiple innate and adaptive 
immune responses. All members of this family share a common N-terminal DNA 
binding domain (DBD) consisting of 5 tryptophan residues that bind to interferon 
stimulatory response elements (ISRE). Except for IRF6, all IRF proteins also 
share a C-terminal IRF-association domain that is required for homo and hetero-
dimerization between different IRF family members and other transcription 
factors. Besides these, IRF1 through 5, IRF8 and IRF9 also contain a nuclear 
localization signal (Lohoff and Mak, 2005).  The work described in this thesis will 
focus on the role of one IRF family member, IRF4 in the differentiation of innate-
like CD8+ T cells as well as effector CD8+ T cells in response to acute and 
chronic viral infections. 
 
Discovery of IRF4 
Irf4 (also known as PIP, LSIRF and ICSAT) was discovered independently 
by multiple groups. Matsuyama T. et.al. cloned LSIRF (Lymphoid Specific 
Interferon Regulatory Factor) by screening a murine cDNA library using 
degenerate primers that amplified within the conserved DBD of IRF family 
members. Unlike other IRF proteins, LSIRF was neither ubiquitously expressed 
nor induced in response to type I IFN stimulation.  Instead, the expression of 
LSIRF was restricted to lymphoid cells, and up-regulated in response to anti CD3 
 26 
stimulation of the T cell receptor (TCR) or anti IgM stimulation of the B cell 
receptor (BCR) (Matsuyama et al., 1995). Eisenbeis et al. discovered a novel 
PU.1 interaction partner (PIP) that formed an activating complex with PU.1 on the 
immunoglobulin light chain λ gene enhancer El2-4 (Eisenbeis et al., 1995). The 
expression of PIP was also restricted to B and T cells. A later study showed that 
PIP is NF-EM5, a B cell restricted factor that bound to Ek3 DNA in a PU.1 
dependent manner (Brass et al., 1996). A third study by Yamagata T et al. 
reported cloning of the human homolog of LSIRF/PIP called ICSAT (IFN 
consensus sequence-binding protein in adult T cell leukemia cells lines or 
activated T cells) while attempting to isolate a factor that bound to the 5’ proximal 
promoter of the human Il5 gene. This protein, however, recognized a sequence 
adjacent to the Il5 promoter (Yamagata et al., 1996). These studies also showed 
that IRF4 bound to ISRE and repressed IRF1 or IFN-stimulated gene expression 
(Brass et al., 1996; Matsuyama et al., 1995; Yamagata et al., 1996).  
 
Structure of IRF4 
IRF4 is a 51kDa protein consisting of 450 amino acids. The IRF4 protein 
contains a hydrophilic N terminal DBD (residues 1-134) and C terminal regulatory 
domain (residues 170-450) separated by a flexible linker region (Brass et al., 
1996; 1999). The N terminal DBD is highly conserved amongst different IRF 
members and contains 5 tryptophan residues separated by 10-18 amino acids 
forming a helix-turn-helix motif (Matsuyama et al., 1995). A high degree of 
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homology exists between IRF4 and IRF8 or ICSBP (IFN-consensus-sequence-
binding protein), with approximately 83% homology in the N terminus DBD and 
51% homology in the C-terminus domain (Eisenbeis et al., 1995; Matsuyama et 
al., 1995; Yamagata et al., 1996).  
 
The C terminal regulatory domain of IRF4 consists of an activation domain 
and an auto-inhibition domain that regulates DNA binding and ternary complex 
formation. Residues 401-408 of the auto-inhibition domain mask the DBD 
through direct hydrophobic interactions. This inhibition of DNA binding is 
alleviated by the interaction of IRF4 with a partner such as PU.1. The residues 
397-403 of IRF4 help stabilize the interaction of Arg398 and Lys399 of IRF4 with 
pSer148 of DNA-bound PU.1 (Brass et al., 1996; 1999). This interaction of IRF4 
with PU.1-DNA complex results in a conformation change in IRF4 that rotates the 
regulatory domain around the linker region, thus unmasking the IRF4 DBD and 
allowing for the formation of IRF4/PU.1/DNA ternary complex (Brass et al., 1996; 
1999). Once bound to the DNA, IRF4 can enhance PU.1 stimulated gene 
transcription due to the presence of the activation domain. Although IRF4 and 
IRF8 share high degree of homology, IRF8 lacks this activation domain; hence it 
cannot stimulate PU.1 transcriptional activity (Brass et al., 1996). Together, these 
data explain previous observations that despite the presence of a DBD and 
activation domain, IRF4 by itself neither binds to lB domain of the El2-4 
enhancer, nor enhances transcription, however, the presence of phosphorylated 
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DNA bound PU.1 results in formation of IRF4/PU.1/DNA ternary complex and 
enhancement of PU.1 mediated transcription (Brass et al., 1996; 1999). IRF4 and 
PU.1, additionally, also interact through their DBD’s albeit at 800-fold lower 
affinity than that observed for the full-length IRF4 for PU.1-DNA complex (Brass 
et al., 1999). 
 
Crystal structure of IRF4/PU.1/DNA ternary complex indicates that the 
DBD of IRF4 and PU.1 contain a “winged” helix-turn-helix motif comprising three 
α helices that are flanked on one side by four-stranded β sheet that bind to 
opposite faces of the DNA in the major groove. The PU.1 recognition helix (α3) 
orients itself perpendicular to the DNA sugar-phosphate backbone while the IRF4 
recognition helix (α3) is parallel to the DNA axis. The binding of these two 
proteins creates two opposing bends in the DNA resulting in no net distortion of 
the DNA backbone. The proximity of these contacts increases the cooperative 
binding of PU.1 and IRF4 as distortions created in the DNA by the binding of one 
transcription factor help configure the DNA for the binding of the other protein. 
These distortions also reduce the overall length of DNA by ~5.1Å relative to B-
DNA. This allows Asp117 of IRF4 DBD to interact with Arg222 and Lys223 of 
PU.1 DBD and residues Leu116 and Val11 of IRF4 to interact with Arg222 of 
PU.1 across the minor groove. Mutation of any of these residues results in 
reduced recruitment of IRF4 to the DNA indicating the importance of these 
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residues in cooperative binding of IRF4 and PU.1 to the DNA and formation of 
the ternary complex (Escalante et al., 2002).  
 
Transcriptional activity of IRF4 
The IRF family members are recruited to DNA as homo- or heterodimers.  
The N-terminus DBD of the IRF family of transcription factors binds to the 5’-
GAAA-3’ sequences contained within the canonical ISRE that contains two IRF 
motifs separated by 2 base pairs (A/GNGAAANNGAAACT) (Huber and Lohoff, 
2014). Three distinct modes of IRF4 binding to its target sequences have been 
characterized. These include the co-binding of IRF4 and Ets family proteins PU.1 
and SPI-B heterodimers to Ets-IRF4 composite element (EICE), AP1-IRF4 
heterodimers to AP-1-IRF4 composite elements (AICE) and the recruitment of 
IRF4 homodimers to the ISRE’s (Brass et al., 1996; 1999; Glasmacher et al., 
2012; Li et al., 2012; Tussiwand et al., 2012). The nature of the IRF4 
homo/heterodimers and hence its transcriptional activity is regulated by the 
immune cell type.  
 
In B cells, binding of IRF4 to all three motifs is observed, though two thirds 
of the total sites are co-bound by IRF4 and PU.1 (Ochiai et al., 2013). Occupancy 
of EICE sites by IRF4 is observed early during B cell differentiation due to the 
high affinity of the IRF4-PU.1/SPI-B complexes to EICE’s. ISRE’s are bound later 
during B cell activation when the levels of IRF4 peak due to the lower affinity of 
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IRF4 homodimers for the ISRE elements. This temporal regulation of IRF4 levels 
allows for dynamic control of B cell fate into plasma cells or germinal center B 
cells (Ochiai et al., 2013). In dendritic cells that express both AP-1 family of 
transcription factors and Ets family members PU.1 and SPI-B, IRF4 is recruited 
to both AICE and EICE motifs (Tussiwand et al., 2012). 
 
T cells express low levels of PU.1 and SPI-B. In these cells, the 
predominant IRF4 binding partners are AP-1 transcription factors such as JUN 
(JUNB, JUND, c-Jun) and basic leucine zipper transcription factor ATF-like 
(BATF). Two types of AICE’s have been described with either 0 or 4bp spacing 
between the AP-1 (5’-TGA[G/C]TCA-3’) and IRF4 binding sites (5’-GAAA-3’). 
This results in 3 different types of AICE’s: TGA[C/G]TAAGAAA, 
GAAATGA[C/G]TAA and TTTCNNNNTGA[C/G]TAG (Glasmacher et al., 2012; Li 
et al., 2012). Mutational analysis revealed that both sites are important for the 
assembly of IRF4/JUN/BATF complexes on DNA. Further the orientation and 
spacing of the IRF4 site with respect to the AP-1 site is critical for the formation 
of the quaternary complex (Glasmacher et al., 2012). There also exists functional 
cooperativity in the binding of IRF4 and BATF-JUN complexes to DNA. The 
presence of BATF-JUN heterodimers serves to recruit IRF4 to the DNA. 
Reciprocally, IRF4 helps recruit BATF-JUN heterodimers to low affinity AP-1 
sites. As a result, loss of either IRF4 or BATF results in reduced recruitment of 
BATF or IRF4, respectively, to target sequences in-vivo (Glasmacher et al., 
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2012; Li et al., 2012). Further cooperativity and specificity of the BATF-JUN and 
IRF4 interaction is mediated by the physical interaction of residues H55, L56, 
K63, E77 of BATF leucine zipper domain with IRF4 (Glasmacher et al., 2012; 
Tussiwand et al., 2012). This data is substantiated by the fact that FOS, an AP-1 
family member does not form ternary complexes with IRF4. However, a chimeric 
protein containing FOS DBD and BATF leucine zipper domain is actively 
recruited to AICE probes along with IRF4 (Tussiwand et al., 2012). In Th17 cells, 
binding of IRF4 and BATF to AICE motifs is associated with increase in DNA 
accessibility thus facilitating subsequent recruitment of other transcription factors 
like STAT3, RORγt, c-Maf etc. (Ciofani et al., 2012).  
 
IRF4 regulates Th cell differentiation 
Naïve CD4+ T cells can differentiate into distinct populations of helper 
cells characterized by the expression of specific transcription factors and effector 
cytokines. These include the Th1, Th2, Th9, Th17 and Tfh populations.  
 
Th1 cells differentiation is regulated by the cytokines IL-12 and IFNγ and 
transcription factors T-bet and STAT4. Th1 cells produce IFNγ and are required 
for clearance of intracellular pathogens. IL-4, STAT6 and GATA3 induce the 
differentiation of Th2 cells that make IL-4, IL-5 and IL-13 and are important for 
immunity against helminth infections (Zhu et al., 2010). The role of IRF4 in CD4+ 
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Th1 and Th2 cell differentiation has been characterized in detail, however 
conflicting results were observed. Irf4 deficient mice are unable to clear 
Leishmania major infection that requires a robust Th1 response and a 
suppression of Th2 response that promotes chronic infection (Lohoff et al., 
2002). This defect in parasite clearance was due to a cell-intrinsic inability of Irf4 
knockout T cells to produce IFNγ post infection as well as increased apoptosis of 
Irf4 deficient T cells in draining lymph nodes as the Irf4 deficient mice failed to 
generate a Th2 response (Lohoff et al., 2002; 2004). Similar to in-vivo activation, 
Irf4 deficient CD4+ T cells are also unable to differentiate into IFNγ or IL-4 
producing Th1 or Th2 cells respectively under in-vitro skewing conditions. 
Instead, under Th2 skewing conditions, Irf4 deficient CD4+ T cells showed 
significant IFNγ production. Though the cause of IFNγ expression is unclear, the 
authors attributed the defect in Th2 skewing to reduced GATA3 expression in Irf4 
deficient CD4+ T cells in the presence of IL-4, as overexpression of GATA3 in Irf4 
deficient CD4+ T cells rescued the phenotype (Lohoff et al., 2002). 
 
In contrast to the data described above, Rengarajan J. et al. found no 
defect in Th1 polarization or increase in IFNγ expression under Th2 skewing 
conditions by Irf4 deficient CD4+ T cells. The authors, however, did report a 
defect in production of Th2 cytokines, IL-4, IL-5 and IL-13 by Irf4 deficient CD4+ T 
cells (Rengarajan et al., 2002). Mechanistically, this study showed that IRF4 
physically interacted with NFATc2 (NFAT1), and synergized with NFATc2 and c-
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Maf to enhance transcriptional activation of the IL-4 promoter, thus promoting 
Th2 polarization. IRF4 can also enhance IL-4 transcription by binding to the Il4 
enhancer Il4 VA (Rengarajan et al., 2002).  
 
Besides IL-4, NFATc2 and IRF4 also synergistically regulate IL-10 
expression in Th2 cells. The conserved non-coding sequence 9 (CNS9) of the IL-
10 promoter contains clustered NFATc2 and IRF4 binding sites. IRF4 and 
NFATc2 preferentially bind to these sites in Th2 cells relative to Th1 cells, and 
mutations in the binding sites results in dramatically reduced CNS9 enhancer 
activity (Lee et al., 2009). The authors ascribed the Th2 biased IL-10 
transcription to higher nuclear levels of IRF4 in Th2 cells compared to Th1 cells 
as the nuclear and cytoplasmic levels of NFATc2 and the levels of IRF4 in 
cytoplasmic extracts of Th1 and Th2 cells were similar. Besides CNS9, IRF4 also 
binds to the promoter and CNS3 of the Il10 gene in Th2 cells (Lee et al., 2009; 
2011). 
 
Within the Th2 population, the high expression of IRF4 segregates with IL-
10hi Th2 cells. As expected, ectopic expression of IRF4 in total Th2 or IL-10low 
Th2 cells results in increased IL-10 and IL-4 expression with a concomitant 
decrease in IL-9 expression. A similar increase in IL-10 expression is also 
observed upon overexpression of IRF4 in Th1 cells (Ahyi et al., 2009). 
Interestingly, this study showed that transcription factor PU.1, which represses 
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Th2 cytokine production (Chang et al., 2005), physically interacted with IRF4 in 
Th2 cells and in PU.1 deficient T cells there was an increase in the binding of 
IRF4 to the Il10p and Il10 CNS3 (Ahyi et al., 2009).  
 
Besides intrinsically regulating Th2 differentiation, IRF4 also regulates Th2 
cell polarization by regulating dendritic cell (DC) function. IRF4 is essential for the 
development of PDL2+ CD301b+ bone marrow derived dendritic cells (BMDCs) 
in-vitro as well as homing of these cells to skin draining lymph nodes. In mice 
that lacked PDL2+ CD301b+ DC in draining lymph nodes, subcutaneous 
immunization with protease allergens ovalbumin and papain or subcutaneous 
infection with Nippostrongylus brasiliensis resulted in lower percentages of IL-4, 
IL-5 and IL-13 producing CD4+ T cells (Gao et al., 2013). Another study also 
showed Irf4 deficient CD11c+ dendritic cells failed to generate a robust Th2 
response to house dust mite (HDM) challenge in-vivo and in-vitro.  Here, IRF4 
was found to directly activate the expression Th2 skewing cytokines IL-10 and IL-
33 in CD11c+ BMDCs in-vitro and exogenous addition of IL-10 and IL-33 to Irf4 
deficient CD11c+ DC cultures was shown to rescue IL-4 production by Th2 cells 
(Williams et al., 2013). IRF4 orchestrates the function of regulatory T cells (Treg) 
in suppressing spontaneous Th2 responses (Zheng et al., 2009).   
 
IRF4 also regulates the differentiation of Th9 subset of CD4+ T cells. Th9 
cell differentiation is induced by cytokines IL-4 and TGFβ and transcription factor 
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GATA3. Th9 cells produce IL-9 and promote allergic inflammation in mice and 
humans (Huber and Lohoff, 2014). In Th9 cells expression of IRF4 is induced by 
STAT6 downstream of IL-4 signaling (Goswami et al., 2012).  Irf4 deficient CD4+ 
T cells are unable to differentiate into IL-9 producing Th9 cells in-vitro. Further, 
highest expression of IL-9 segregated with cells expressing highest levels of 
IRF4. Although these experiments were performed with germline knockout mice 
that have altered T cell differentiation in the periphery, similar results were 
obtained when IRF4 was silenced in naïve CD4+ T cells. The relevance of these 
findings is underscored by the fact that Irf4 knockout mice were resistant to 
asthma due to the inability of these cells to differentiate into Th9 cells in-vivo. 
Mechanistically, IRF4 regulates Th9 differentiation by directly binding to the Il9 
promoter and regulating its transcription (Staudt et al., 2010). Another detailed 
study showed that IRF4 and Smad2 and Smad3 physically interacted in Th9 cells 
and co localized in the nucleus. Further, these proteins cooperatively bound to 
CNS 2, CNS1 and CNS 0 of the Il9 gene to promote Th9 differentiation, and loss 
of either protein reduced the recruitment of the other to the Il9 CNS DNA (Tamiya 
et al., 2013). Similar to the Smad 2/3 proteins, BATF, an AP-1 family protein and 
a binding partner of IRF4 also promoted Th9 cell differentiation by cooperatively 
recruiting IRF4 to the AICE site at -185 position of the Il9 promoter (Jabeen et al., 
2013). Th9 differentiation is also enhanced by PU.1, another binding partner of 
IRF4.  PU.1 bound to CNS1 and CNS2 regions of the Il9 promoter and induced 
permissive chromatin modifications such as acetylation of histone H3 at these 
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loci. Since IRF4 also binds to these regions, it is interesting to speculate that 
IRF4-PU.1 heterodimers bind to EICE elements in these regions (Chang et al., 
2010).  
 
IRF4 regulates the differentiation of Th17 cells that require cytokines IL-6, 
IL-21 and TGFβ and transcription factors Retinoic acid receptor related orphan 
receptor γ (RORγt) and STAT3. Th17 cells produce pro-inflammatory cytokines 
IL-17A, IL-17F, IL-21 and IL-22 and are important for clearance of mucosal 
infections as well as for generation of autoimmunity (Zhu et al., 2010). IRF4 
controls the differentiation of Th17 cells in-vitro and in-vivo by regulating the 
expression of key Th17 genes such RORγt, Retinoic acid receptor related orphan 
receptor α (RORα), Il17, Il21 and Il23 receptor (Il23r) (Biswas et al., 2010; 
Brüstle et al., 2007; Chen et al., 2008; Huber et al., 2008; Mudter et al., 2011). 
Loss of IRF4 also results in increased expression of Foxp3, a transcription factor 
that antagonizes RORγt function and promotes Treg development (Brüstle et al., 
2007; Huber et al., 2008). As a result, Irf4 deficient mice are resistant to mouse 
models of autoimmunity such as experimental autoimmune encephalitis (EAE) 
and oxazolone and trinitrobenzene sulphonic acid induced colitis (Brüstle et al., 
2007; Mudter et al., 2011; 2008). This resistance to EAE is intrinsic to Irf4 
deficient CD4+ T cells as transfer of WT CD4+ T cells into of Irf4 knockout mice 
results in disease susceptibility (Brüstle et al., 2007). Similarly, transfer of Irf4 
deficient CD4+CD45RBhi cells does not lead to mucosal inflammation in Rag2 
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deficient mice whereas transfer of WT cells leads to severe colitis. In this 
scenario, Irf4 knockout CD4+ CD45RBhi cells also expressed lower levels of IL-6, 
a key Th17 inducing cytokine that regulates IL-21 expression, which in a STAT3 
dependent manner stabilizes Th17 cell differentiation. The importance of all 
these observations is underscored by the fact that humans with inflammatory 
bowel disease have increased expression of IRF4 in their mucosal T cells 
(Mudter et al., 2008).  
 
In Th17 cells, IRF4 expression is regulated by the synergistic effect of IL-1 
and IL-6 signaling. Thus Il1 receptor 1 (Il11r1) deficient T cells are unable to up-
regulate IRF4 expression and differentiate to Th17 cells in-vitro and in-vivo and 
are also resistant to EAE (Chung et al., 2009). In contrast to Irf4 deficiency, 
increased IRF4 activity results in spontaneous rheumatoid arthritis-like joint 
disease and large vessel vasculitis, as observed in mice that lack IRF4-Binding 
Protein (IBP) (Chen et al., 2008). IBP controls IRF4 activity by sequestering it 
and thus preventing it from binding to Il17 and Il21 promoters. As a result, IBP 
knockout CD4+ T cells have increased IL-17, IL-21 and RORγt expression. 
Besides directly regulating IRF4 function, IBP also regulates IRF4 activity by 
regulating the activity of Rho-associated, coiled-coil-containing protein kinase 2 
(ROCK2). Though ROCK2 is expressed in Th0, Th1, Th2 and Th17 cells, active 
ROCK2 is also only observed in Th17 cells. Loss of IBP resulted in enhanced 
ROCK2 activation that phosphorylated IRF4 on S446 and S447 and increased 
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recruitment of IRF4 to IL-17A, IL-21 and RORγt promoters. This phenomenon 
could be reversed by addition of ROCK2 inhibitors to IBP deficient T cells or by 
mutating S446 and S447 sites of IRF4 (Biswas et al., 2010).  
 
 On a transcriptional level, IRF4 regulates the expression of key Th17 
specific genes such as Il17a, Il21 and Il23r by binding to the AICE motifs in the 
promoters of these genes in conjunction with BATF (Garber et al., 2012; Li et al., 
2014). Co-binding of IRF4 and BATF to AICE motifs leads to increased DNA 
accessibility thus facilitating subsequent recruitment of other transcription factors 
like STAT3, RORγt, c-Maf etc (Ciofani et al., 2012). As a result of the 
cooperativity between IRF4 and BATF, BATF deficient cells are unable to 
upregulate the expression of IL-17, IL-21, RORγt and RORα required for Th17 
cell differentiation and are thus resistant to EAE. Further, similar to what has 
been observed with Irf4 knockout T cells, overexpression of RORγt in BATF 
knockout cells was unable to fully rescue the differentiation of Th17 cells (Brüstle 
et al., 2007; Schraml et al., 2009).  
 
IRF4 and BATF also regulate the differentiation of follicular helper T cells 
(Tfh). Tfh cells are characterized by the expression of CXC chemokine receptor 5 
(CXCR5), Programmed Death-1 (PD-1) and inducible costimulator (ICOS), 
require cytokines IL-6 and IL-21 and transcription factor Bcl6 for differentiation, 
and are important for the generation of germinal center B cell responses for 
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antibody production (Huber and Lohoff, 2014). Irf4 deficient CD4+ T cells are 
unable to differentiate into Tfh cells in response to immunization with keyhole 
limpet hemocyanin or upon infection with Leishmania major (Bollig et al., 2012; 
Kwon et al., 2009). Though these experiments were performed with Irf4 germline 
knockout mice, the cell intrinsic defect of these CD4+ T cells was shown by 
transfer of WT CD4+ T cells into Irf4 deficient mice that differentiated into Tfh 
cells with the same frequency as the cells transferred into WT host (Bollig et al., 
2012). The defect in Tfh cell differentiation of Irf4 deficient CD4+ T cells manifests 
at multiple levels. First, Irf4 deficient cells express lower levels of a key 
transcription factor B-cell lymphoma 6 (Bcl6), a direct target of IRF4 in B cells, 
that is required for Tfh differentiation (Bollig et al., 2012; Ochiai et al., 2013). 
Second, IRF4 has also been shown to directly interact with Bcl6 in the ramos cell 
line (Gupta et al., 1999). It is likely that this interaction also influences 
transcriptional activity of IRF4 and Bcl6. Third, IRF4 regulates expression and 
responsiveness to IL-21 in Th17 cells (Huber et al., 2008). It is interesting to 
speculate that IRF4 performs similar functions in Tfh cells where IL-21 is a critical 
mediator of Tfh differentiation, Fourth, IRF4 synergizes with STAT3 downstream 
of IL-21 signaling to regulate gene expression (Kwon et al., 2009). Finally, the 
cooperativity of IRF4 and BATF regulates the expression of key transcription 
factors such as Bcl6 and c-Maf that harbor AP-1 sites in their promoters. As a 
result, BATF deficient CD4+ T cells have severe defects in Tfh differentiation and 
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this defect can only be partially rescued by overexpression of Bcl6 and c-Maf (Ise 
et al., 2011).  
 
Besides regulating the differentiation of effector Th cell lineages, IRF4 also 
controls the differentiation and function of regulatory T cells (Treg). Treg cells are 
a subset of CD4+ T cells characterized by the expression of lineage specific 
transcription factor forkhead box P3 (Foxp3) and IL-2 Receptor α (CD25) that are 
essential for maintaining tissue homeostasis and preventing autoimmunity. 
Selective ablation of IRF4 in Treg cells (using Irf4fl/fl Foxp3 Cre mice) results in 
autoimmune lymphoproliferative disease characterized by increased immune cell 
infiltration of the pancreas, lung, stomach etc. This phenotype was driven by 
higher numbers of CD4+ and CD8+ T cells in the lymph nodes, greater 
expression of Th2 cytokines IL-4, IL-5, IL-10 and IL-13 by the CD4+ T cells, 
increase in germinal center formation, plasma cell differentiation and IL-4 
mediated isotype switching to IgG1 and IgE in Irf4fl/fl Foxp3 Cre mice. Importantly, 
this phenotype was not due to complete absence of Treg cells in Irf4fl/fl Foxp3 Cre 
mice or reduced expression of Foxp3 or cytotoxic T-lymphocyte-associated 
protein 4 (CTLA4) that is a negative co-stimulatory molecule.  On the contrary, 
the numbers of Treg cells in the lymph nodes of these mice were higher relative 
to the WT mice, likely due to increased T cell activation. Further investigation 
indicated that IRF4 positively regulates the expression of ICOS and IL-10 that are 
required for optimal Treg mediated suppression of T cell responses. 
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Furthermore, IRF4 and Foxp3 physically interacted in these cells and also 
directly bound to the Icos promoter. One key feature of this study was that the 
phenotype of mice lacking IRF4 in Treg was different than mice that lacked Treg 
cells completely (Foxp3-/-). In the latter case a spontaneous increase in 
differentiation of CD4+ T cell to Th1 and Th2 phenotypes was observed with 
concomitant increase in isotype switching to IgG2a in addition to IgG1 and IgE. 
These data indicate that IRF4 only regulates a subset of genes involved in Treg 
function and in particular those required for suppression of Th2 function. In depth 
analysis of IRF4 dependent gene data sets in Treg and effector Th2 cells 
indicated that besides Icos, IRF4 also regulates the expression of Maf, 
chemokine receptor 8 (CCR8) and IL-1 receptor 1  (Il1r1) in these two subsets. 
Based on this evidence the authors suggested that interaction of IRF4 with 
Foxp3 allows Treg cells to induce a unique transcriptional module that promotes 
Treg effector differentiation to effectively control the corresponding type of Th cell 
response (Zheng et al., 2009). 
 
IRF4 also controls effector Treg cell function by regulating the expression 
of transcription factor B lymphocyte induced maturation protein 1 (Blimp-1) 
(Cretney et al., 2011). This study showed that IRF4 and Blimp-1 regulate the 
expression of IL-10, ICOS and Chemokine receptor 6 (CCR6). In particular, IRF4 
directly bound to the CNS3, CNS9, promoter and intron 1 of Il10 gene and intron 
1 of Ccr6 gene while Blimp1 directly bound to the intron 1 of Il10 gene.  Further, 
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the authors showed that IRF4 is not only important in Treg cell function during 
Th2 responses, but also during Th1 immune responses such as those induced 
by viral infections (Cretney et al., 2011). 
 
IRF4 and CD8+ T cell differentiation 
In contrast to the in depth literature on the role of IRF4 in Th cell 
differentiation, little information exists as to its function in CD8+ T cell 
differentiation. Like Th9 cells, there exists a subset of CD8+ T cells that produce 
IL-9 called Tc9 cells. Due to the poor expression of Eomes and T-bet these cells 
are poorly cytotoxic but can mediate anti-tumor responses in an IL-9 dependent 
manner (Lu et al., 2014). Further, although Tc9 cells do not cause airway 
inflammation by themselves, they can synergize with Th2 cells to exacerbate the 
inflammation (Visekruna et al., 2013). The importance of these observations is 
underscored by the fact that high proportions of CD8+ IL-9+ cells are observed in 
peripheral blood of humans with atopic dermatitis. Like Th9 cells, Tc9 cells also 
express STAT6, IRF4, and its binding partner PU.1 and loss of STAT6 or IRF4 
results in defects in IL-9 production (Lu et al., 2014; Visekruna et al., 2013).   
 
 IRF4 regulates the differentiation of IL-17 producing Tc17 cells that are 
enriched in the cerebrospinal fluid from patient with early stage multiple sclerosis 
(Huber et al., 2013). Similar to Th17 cells, IRF4 deficiency results in poor 
expression of RORγt, RORα, IL-17 and IL-23R in Tc17 cells with a concomitant 
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increase in IL-17 suppressing transcription factors Eomes and Foxp3 (Huber et 
al., 2013). As a result, immunization of Irf4 deficient mice with myelin 
oligodendrocyte glycoprotein (MOG37–50) results in complete protection of the 
host from EAE. However this resistance to disease induction is due to a 
combined defect in Irf4 deficient CD4+ and CD8+ T cells that reciprocally 
cooperate to promote EAE. Although WT CD8+ T cells can differentiate into Tc17 
cells in Irf4 knockout hosts, they fail to migrate to the CNS. This defect results 
because Irf4 deficient CD4+ T cells are unable to up-regulate the expression of 
CCR6 and promote the migration of Tc17 cells into the CNS. In turn, Irf4 deficient 
CD8+ T cells failed to present cell bound IL-17A to CD4+ T cells to promote their 
pathogenicity (Huber et al., 2013).  
 
 Relatively little is known about the role of IRF4 in CD8+ T cell responses to 
acute and chronic infections. In response to LCMV armstrong infection, Irf4 
deficient mice showed a reduced CD8+ T cell response as evidenced by the 
absence of footpad swelling and cytotoxic activity (Mittrücker et al., 1997). 
However, the role of IRF4 and in particular, the impact of different levels of IRF4 
on this process has not been characterized in detail. Further, However, the 
molecular mechanism linking TCR signaling to anti-viral CD8+ T cell response is 
unclear. Chapters IV and V of this thesis, shall explore the role of IRF4 in 
regulating CD8+ T cell differentiation to acute and chronic infections.  
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LCMV Armstrong and LCMV Clone 13 
LCMV is an old world Arena virus and was originally isolated from a 
monkey in St. Louis, Missouri. It is an enveloped virus with an ambisense RNA 
genome. The long (L) segment of the genome encodes an RNA-dependent RNA 
polymerase and a zinc-finger binding Z protein. The short (S) segment encodes 
the glycoprotein precursor (GP) and nucleoprotein (NP). The glycoprotein 
precursor is cleaved in to the GP1 and GP2 subunits. Mouse is the natural host 
of LCMV, but it also capable of infecting humans.  LCMV Armstrong replicates in 
lymphoid tissues and causes acute infection in adult mice (Matloubian et al., 
1993; Welsh and Seedhom, 2008).  
 
In contrast, LCMV-variant Clone 13 (LCMV Clone 13) causes persistent 
infection in mice. It was originally isolated from adult carrier mice that were 
infected with LCMV Armstrong at birth (Ahmed et al., 1984). LCMV Clone 13 
differs from the parental Armstrong strain by 5 nucleotides, but only two of the 5 
mutations result in amino acid changes. Of these the K1079Q mutation in the 
RNA dependent RNA polymerase increases viral replication in macrophages 
(Matloubian et al., 1993; 1990). The second mutation F260L in the viral GP1 
protein increases the affinity of the ligand GP1 for its receptor α-dystroglycan that 
is expressed on a variety of cell types in liver, lung etc (Ahmed et al., 1991; Kunz 
et al., 2001; Matloubian et al., 1990; Salvato et al., 1991). Thus, these mutations 
allow LCMV Clone 13 to replicate in lymphoid as well as non-lymphoid tissues 
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leading to high viral load and T cell exhaustion. a-dystroglycan is also highly 
expressed on dendritic cells and fibroblastic reticular cells (FRC) (Mueller et al., 
2007). Infection of the CD11c+ and DEC-205+ dendritic cells by LCMV Clone 13 
results in lower expression of MHC I and MHC II proteins and co-stimulatory 
molecules like CD80 and CD86, leading to defective priming of the CD8+ T cell 
response (Sevilla et al., 2000; 2004).  
 
The LCMV infection model has been widely used for understanding 
immune responses to acute and chronic infections. The strength of the system 
results from many features of the virus. First and most importantly, LCMV causes 
natural infection in mice, which are the most widely used model system because 
they represent human immunology fairly well. This allows us to study pathogen-
host interaction in a natural in-vivo environment. Second, as LCMV is non-
cytolytic, it allows us to directly understand the effect of infection on host immune 
response and tissue homeostasis because any tissue pathology that may occur 
during the course of infection is a direct consequence of the host immune 
response. Third, persistent strains of LMCV have broad tropism and hence can 
be used to understand alterations in cell function and tissue homeostasis in the 
presence of continuously expressed foreign genes in multiple cell types. Finally, 
LCMV has a fairly small genome and can be easily manipulated by reverse 
genetics. This allows us to generate a large number of LCMV variants that can 
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be used to study various biological phenomena like viral persistence, immune 
suppression, effector and memory cell generation etc. (Oldstone, 2013).  
 
Immune responses to LCMV Armstrong 
 Infection with LMCV Armstrong generates a strong type I IFN response. 
Type I IFN response is important for early viral control and for the generation of a 
protective cytotoxic T cell response (Müller et al., 1994; van den Broek et al., 
1995).  In C57BL6/J mice, the viral load usually peaks around day 3 or 4 post 
infection and is cleared by day 8 post infection (Ahmed et al., 1984). The 
decrease in virus titers is accompanied by a concomitant increase in the 
numbers of virus-specific CD8+ T cells that peak by day 8-9 post infection. CD8+ 
T cells are indispensable for viral clearance because mice deficient for β2-
microglobulin become persistently infected with LCMV (Matloubian et al., 1994). 
The CD4+ T cell response is slower and peaks by day 9-11. CD4+ T cell 
responses are not required for control of LCMV, however, CD4+ T cell help in the 
form of IL-2 during primary infection is important for the differentiation of memory 
CD8+ T cells which are then capable of maximum re-expansion during recall 
responses (Williams et al., 2006). At the termination of the response, a majority 
of the CD8+ T cells die by apoptosis, and a small pool of memory cells survives. 
These cells are capable of self-renewal as well as rapid expansion upon re-
infection.  
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The phenotype of the anti-viral CD8+ T cells in LCMV infection is well 
characterized. Based on the expression of IL-7 receptor α (IL-7Rα or CD127) 
and killer cell lectin-like receptor subfamily G, member 1 (KLRG1), CD8+ T cells 
can be classified as short-lived effector cells (SLEC) which are KLRG1hi 
CD127low or memory precursor effector cells (MPEC) which are KLRG1low 
CD127hi (Joshi et al., 2007). At the peak of anti-viral responses, the SLECs 
dominate the response. Thereafter, their numbers decline dramatically. In 
contrast, the magnitude of contraction of MPEC is much lower and the numbers 
of MPECs remain fairly stable 30 days post infection. Consequently, MPECs tend 
to predominate at later time points (Joshi et al., 2007; Kaech et al., 2003). The 
inherent stability of the MPEC population is due higher expression of pro-survival 
molecules such as Bcl-2 and Bcl-XL and their ability to undergo homeostatic 
proliferation. In contrast, SLECs have higher levels of cleaved caspase 3, lower 
survival and self-renewal potential and thus are terminally differentiated. Further, 
upon secondary challenge, the MPEC population has greater proliferative and 
protective response, which are the hallmarks of immunological memory (Kaech 
et al., 2003). 
 
 On the basis of homing potentials, memory CD8+ T cells can also be 
classified as central memory T cells (TCM) and effector memory cells (TEM) 
(Sallusto et al., 1999). TCM cells have high expression of L-selectin (CD62L) and 
C-C chemokine receptor type 7 (CCR7) and usually home to secondary lymphoid 
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organs such as spleen and lymph nodes. These cells have high proliferative and 
migratory potential and can convert to TEM cells upon re-stimulation. The TEM 
cells are CD62Llow CCR7low and home to different non-lymphoid tissues such as 
liver, lung, lamnia propria etc. Though these cells have lower proliferative and 
migratory potential, they are constitutively cytotoxic and produce high levels of 
IFNγ (Masopust et al., 2001; Sallusto et al., 1999).   
 
 Many transcription factors are required for the generation of CD8+ T Cell 
effector and memory responses (Figure 1.3). For example, T-bet, Blimp1, ID2 
and STAT4 promote the differentiation of terminal effectors while Eomes, TCF1, 
BCL-6, ID3, FOXO1 and STAT3 induce memory cell development (Banerjee et 
al., 2010; Cannarile et al., 2006; Cui et al., 2011; Hess Michelini et al., 2013; Ichii 
et al., 2002; Intlekofer et al., 2008; 2005; Jeannet et al., 2010; Joshi et al., 2007; 
Kallies et al., 2009; Rao et al., 2012; 2010; Rutishauser et al., 2009; Shin et al., 
2013; Zhou et al., 2010). Chapter IV and V of this thesis will focus on the role of 
three transcription factors- T-bet, Eomes and TCF1 that are discussed in detail 
below. The role of another transcription factor Blimp-1 is also discussed, as it is a 
direct target of IRF4 in B cells and is a critical for anti-viral CD8+ T cell 
responses. 
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Figure 1.3: CD8+ T cell effector and memory differentiation is regulated by 
multiple transcription factors: Activated CD8+ T cells express numerous 
transcription factors. Antigen specific CD8+ T cells expressing higher levels of T-
bet, Blimp-1, Id2 and STAT4 differentiate into terminal effectors. Memory 
differentiation on the other hand is enhanced by increased expression of TCF1, 
Eomes, BCL-6, Id3, FOXO1 and STAT3.     
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T-bet and Eomes 
 T-bet and Eomes are T-box transcription factors that have partially 
redundant functions in the effector CD8+ T cell responses. Despite this  
redundancy, these proteins regulate differentiation of mutually exclusive 
populations of effector or memory cells. The expression of T-bet is induced by 
TCR signaling and IL-12 and maximum levels of T-bet transcripts are observed in 
early effector cells (Intlekofer et al., 2005; Takemoto et al., 2006). The expression 
of Eomes, on the other hand, is higher in memory cells relative to effector cells, 
and is induced by IL-2 and IL-4 (Intlekofer et al., 2005; Takemoto et al., 2006). 
Both T-bet and Eomes up-regulate the expression of CD122, IFNγ, granzyme B 
and perforin in CD8+ T cells (Intlekofer et al., 2008; Pearce et al., 2003). Hence 
loss of either protein does not affect CD8+ T mediated target cell cytotoxicity and 
viral clearance post LCMV infection (Banerjee et al., 2010; Intlekofer et al., 2008; 
2007). However, a compound deficiency of both proteins results in aberrant 
CD8+ T Cell differentiation. Tbx21/Eomes double knockouts have reduced in 
IFNγ, granzyme B and perforin expression, CD8+ mediated cell lysis and viral 
clearance. Further, the numbers of virus-specific cells at D8 are severely reduced 
compared to WT mice or mice lacking T-bet or Eomes alone. Furthermore, 
Tbx21/Eomes double knockout virus-specific CD8+ T cells aberrantly 
differentiated into IL-17A producing cells that caused severe weight loss and 
inflammatory disease in these mice. Excessive IL-17A initiated neutrophil 
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infiltration and destruction of numerous organs such as liver, lung, heart etc 
(Intlekofer et al., 2008). 
 
Besides complementing each other, T-bet and Eomes also perform unique 
functions during CD8+ T cell differentiation. T-bet regulates the development of 
TEM and TCM as well as SLEC and MPEC populations. In the absence of T-bet, 
CD8+ T cells express high levels of CD127, CD62L and CD27 and preferentially 
home to peripheral lymph nodes. Further, T-bet deficient memory cells also show 
enhanced expansion, IFNγ expression and protection in recall responses, 
indicating differentiation of these cells into a TCM phenotype (Intlekofer et al., 
2007). Expression of T-bet regulates the terminal differentiation of CD8+ T cells 
by promoting SLEC formation. T-bet induces SLEC differentiation in a dose 
dependent manner. The proportions of SLECs are highest in WT, followed by 
Tbx21 heterozygotes and lowest in Tbx21 knockouts. Since, the SLECs are the 
predominant population of CD8+ T cells at the peak of the infection, loss of T-bet 
also results in reduced anti-viral CD8+ T cell expansion (Joshi et al., 2007).  
 
 In contrast, mice lacking Eomes have no defect in expansion of CD8+ T 
cells after primary challenge with LCMV. However, the Eomes deficient CD8+ T 
cells are unable to expand to the same levels as the WT cells upon re-infection. 
Competitive bone marrow chimera experiments indicated that even though WT 
and Eomes deficient cells expand to the same levels by D8 post infection, Eomes 
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deficient memory cells are outcompeted by the WT memory cells even in the 
absence of re-challenge. This indicated a defect in homeostatic proliferation 
and/or survival of Eomes knockout memory cells. Indeed, Eomes deficient 
memory cells expressed lower levels of CXCR4, a chemokine receptor required 
for homing to bone marrow, a preferred site for homeostatic proliferation and 
CD122, which is required for IL-15 responsiveness (Banerjee et al., 2010; Becker 
et al., 2005). As a result, fewer proportions of proliferating Eomes deficient cells 
were observed. Further, Eomes knockout CD8+ T cells also expressed reduced 
levels of the pro-survival protein Bcl-2 indicating lower survival potential of these 
cells. These data indicated that Eomes is not required for memory cell 
generation, rather it promotes memory cell maintenance (Banerjee et al., 2010).  
 
T cell factor 1 (TCF-1) 
 TCF-1 is a transcription factor downstream of the canonical Wnt signaling 
pathway. TCF-1 is important for normal thymic development as TCF-1 
inactivation results in defects in thymocyte maturation (Verbeek et al., 1995). 
Studies using mice with constitutively active Wnt signaling or TCF-1 deficiency 
have indicated that TCF1 regulates memory CD8+ T cell differentiation as loss of 
TCF1 resulted in impaired expansion of memory cells upon re-challenge 
(Jeannet et al., 2010; Zhao et al., 2010; Zhou et al., 2010). TCF-1 deficient 
memory cells have poor survival as well as homeostatic proliferation due to lower 
expression of Bcl-2, IL-15Rα (IL-15 receptor α) and CD122. Consequently, long-
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term maintenance of these cells is severely compromised. These defects are 
reminiscent of Eomes deficiency. Indeed, careful examination indicated that TCF-
1 directly bound to the regulatory region in the Eomes promoter and induced its 
expression. Further, over-expression of Eomes in TCF-1 knockout cells was 
sufficient to rescue the attrition of TCF-1 deficient memory cells (Zhou et al., 
2010).  
 
Blimp-1 
 Blimp-1 is critical for the differentiation of terminal effector CD8+ T cells 
during acute infections. Blimp-1 is preferentially expressed in SLECs and loss of 
Blimp-1 results in rapid differentiation of CD8+ T cells in to MPECs characterized 
by reduced T-bet and increased TCF-1 and Bcl-6 expression. Blimp-1 deficient 
CD8+ T cells have improved survival and proliferation due to increased 
expression of CD25 and CD27 leading to more numbers of effectors and memory 
cells. However, Blimp-1 knockout CD8+ T cells have lower expression of perforin, 
granzyme B and granzyme K and migration to sites inflammatory sites. Thus 
these cells are poorly cytotoxic and unable to control LCMV or Influenza A 
infections (Kallies et al., 2009; Rutishauser et al., 2009; Shin et al., 2013). 
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Immune responses to LCMV Clone 13 
  Infection with LCMV Clone 13 results in generation of CD8+ and CD4+ T 
cell responses as well as B cell responses, all of which are essential for long-
term viral control (Matloubian et al., 1994; Thomsen et al., 1996). A key feature of 
infection with LCMV Clone 13 is high viral loads that lead to extreme T cell 
dysfunction known as T cell exhaustion (Fuller and Zajac, 2003; Mueller and 
Ahmed, 2009; Zajac et al., 1998). During exhaustion, there is a hierarchal loss of 
CD8+ T functions characterized by loss of effector cytokine production and 
eventual deletion of antigen-specific cells. This process can be divided into 5 
stages. During the first stage, proliferation, cytotoxicity and IL-2 production by 
antigen specific cells is compromised. This is followed by stage two where cells 
lose their ability to express TNFα. By stage three, antigen specific T cells have 
impaired IFNγ expression as well as increased expression of inhibitory molecules 
like PD-1. By stage four, cells lose their ability to make all effector cytokines and 
are highly apoptotic. Stage five is characterized by physical-deletion of these 
cells by apoptosis (Wherry et al., 2003).   
 
Apart from high viral load, CD8+ T cell exhaustion is also regulated by 
level of epitope presentation. Thus even at same viral load, CD8+ T cells specific 
for epitopes such as NP396 and GP34 that are presented at high levels by DCs 
are deleted while T cells specific for GP33 and GP276 that are presented at 
lower levels are functionally impaired (Wherry et al., 2003). Another exogenous 
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factor regulating exhaustion is IL-10. IL-10 is an immunosuppressive cytokine 
that is produced by DCs, CD4+ T cells and B cells during LCMV clone 13 
infections. In mice deficient for IL-10 or those receiving IL-10 blocking antibody 
treatment, there is resurgence in the numbers and functionality of anti-viral CD8+ 
T cells and rapid clearance of virus (Brooks et al., 2006). The expression of 
inhibitory molecules such as PD-1 that dampens TCR signaling also induces T 
cell dysfunction. Indeed, blocking of PD-1 signaling resulted in restoration of 
CD8+ T cell proliferation, cytotoxicity, and cytokine production leading to efficient 
viral control (Barber et al., 2006). 
 
On the surface, CD8+ T cell exhaustion may appear as a mechanism of 
viral immune evasion. However in-depth analysis of this phenomenon has 
indicated that this mechanism is important to maintain a balance between 
immunopathology and protective immunity. This was illustrated in elegant 
experiments by Cornberg et. al. where they infected mice with three different 
doses of LCMV Clone 13. The lowest dose induced a robust CD8+ T cell 
response that lead to rapid virus clearance with minimal pathology. The highest 
dose induced CD8+ T cell exhaustion, high viral loads and mild 
immunopathology. However, medium dose of Clone 13 induced partial loss of 
effector cytokine production and up-regulation of inhibitory T cell receptors like 
PD-1 to intermediate levels. These sub-optimally functioning CD8+ T cells 
induced severe immunopathology leading to high rates of mortality. All the mice 
 57 
that survived this dose exhibited high viral loads and severe necrosis of lung and 
liver. These data indicated that T cell exhaustion may indeed be a beneficial for 
host survival (Cornberg et al., 2013; Waggoner et al., 2012). CD8+ T cell 
differentiation in chronic LCMV infections has been shown to be regulated by 
transcription factors Blimp-1, Tbet and Eomes. 
Blimp-1 
Blimp-1 is highly expressed in exhausted CD8+ T cells and promotes 
expression of inhibitory receptors such as PD-1, LAG-3, CD160 and 2B4. 
However, loss of Blimp-1 expression does not enhance anti-viral CD8+ T cell 
response. Instead, Blimp-1 deficient mice are unable to control LCMV Clone 13 
infections. Interestingly, Blimp-1 haplo-deficient mice controlled infection better 
and expressed reduced levels of PD-1. This enhancement of function over full 
knockouts was due to higher increased cytotoxicity as a consequence of higher 
granzyme B expression. These data indicate that Blimp-1 may act to balance 
CD8+ T cell exhaustion and effector functions (Shin et al., 2009).  
 
T-bet and Eomes 
Unlike Blimp-1, the expression of T-bet is down-regulated in chronic 
LCMV infections. Loss of T-bet resulted in reduced numbers of anti-viral CD8+ T 
cells, lower effector cytokine production, higher expression of inhibitory receptors 
and an inability to control viremia. T-bet directly bound and repressed PD-1 
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expression in anti-viral CD8+ T cells. As a result, overexpression of T-bet 
increased CD8+ T cell numbers and reduced expression of PD-1 (Kao et al., 
2011). A later study by the same group showed that T-bet and Eomes cooperate 
to regulate anti-viral CD8+ T cell responses during chronic infections. Unlike T-
bet, Eomes is highly expressed in exhausted CD8+ T cells and its expression 
correlated with higher expression of Blimp-1, exhaustion markers such as Tim3, 
PD-1, LAG-3, CD160 and 2B4, indicating higher functional exhaustion of virus-
specific cells. However, Eomeshi cells had higher proliferative rate and higher 
cytotoxicity while the T-bethi cells were poorly cytotoxic and did not proliferative 
as robustly.  The authors traced lineage relationships between these populations 
and showed there exists a precursor progeny relationship where in antigen-
specific T-bethi cells give rise to terminally differentiated Eomeshi cells, and 
persistent antigen is required for this conversion. Despite diverse functionality, 
both subsets were essential for viral control and loss of T-bet or Eomes resulted 
in higher viremia. Most importantly, these subsets are found in humans with HCV 
infections. Greater frequency of T-bethi cells accrued in patients with resolved 
HCV infections, while patients that were chronically infected had larger 
proportions of Eomeshi cells (Paley et al., 2012).  
 
One key question that remains is how are the relative levels of T-bet and 
Eomes regulated in antigen-specific CD8+ T cells? Chapter V of this thesis will 
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discuss the role of IRF4 in regulating this process in the context of LCMV Clone 
13 infections. 
 
Other immune responses in LCMV Clone 13 infection 
Apart from CD8+ T cells, CD4+ T cells are also important for controlling 
LCMV Clone 13 infections. In the absence of CD4+ T cells, mice become life-long 
carriers of infection (Battegay et al., 1994; Matloubian et al., 1994; Thomsen et 
al., 1996; Zajac et al., 1998). Conversely, transfer of CD4+ T cells into 
persistently infected mice enhances CD8+ T cell numbers and functionality and 
decreases viral titers (Aubert et al., 2011). During chronic viral infections, CD4+ T 
cell do not produce the Th1 cytokine IFNγ. Instead, they are redirected into a Tfh 
cell lineage (Fahey et al., 2011). This differentiation is induced by IL-6 and IL-27 
which not only increase virus specific CD4+ T cell survival and numbers but also 
function redundantly to control IL-21 expression by the Tfh cells in-vivo (Harker et 
al., 2013; 2011). IL-21 acts in a cell-intrinsic manner to increases CD8+ T cell 
proliferation leading to their accumulation. IL-21 also induces cytokine expression 
ultimately reducing viral burden (Elsaesser et al., 2009; Fröhlich et al., 2009; Yi et 
al., 2009). Further, Tfh cells promote development of germinal center B cells and 
enhance LCMV-specific antibody production (Fahey et al., 2011; Harker et al., 
2011). Thus CD4+ T cells serve to empower the cytotoxic as well as humoral 
immune responses to LCMV Clone 13 infections. The importance of the data 
described above is underscored by the fact that mice lacking B cells are unable 
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to resolve LCMV clone 13 infections (Bergthaler et al., 2009; Thomsen et al., 
1996). 
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Thesis Objective  
ITK is a key component of the TCR signaling cascade and loss of ITK 
results in reduced Ca2+ flux and DAG production leading to sub-optimal T cell 
activation. As a result, Itk-/- mice have defects in thymic selection, CD8+ T cell 
expansion in response to LCMV infections and develop a unique population of 
innate-like CD8+ T cells. However, the molecular pathways that link the strength 
of TCR signaling to gene transcription programs that mediate these biological 
outcomes are not known. To identify downstream mediators of these processes, 
we performed a microarray experiment using WT and Itk deficient CD8+ 
thymocytes and identified IRF4 as a potential candidate for the following reasons: 
firstly, the microarray data indicated that IRF4 was under-expressed in Itk-/- CD8+ 
cells relative to WT thymocytes, indicating that signals through ITK are required 
for its optimal expression. Secondly, IRF4 is induced by TCR signaling, of which, 
ITK is a key regulator. Thirdly and most importantly, there existed a precedent in 
B cells wherein the strength of BCR signaling up-regulated IRF4 to differing 
levels. IRF4 in turn converted these differences into distinct gene expression 
programs that regulated antagonistic programs of B cell differentiation. Based on 
these data, we hypothesized that the strength of TCR signaling via ITK 
regulates IRF4 expression. Further, IRF4 would in turn mediate the effects 
of TCR signaling in the context of innate-like T cell development and anti-
viral CD8+ T cell responses. These hypotheses have been addressed in this 
thesis in the following three chapters: 
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Chapter III: TCR Signaling via ITK and IRF4 Regulates CD8+ T Cell 
Differentiation: This chapter tests the hypothesis that TCR signaling via ITK 
induces IRF4 expression, and impaired up-regulation of IRF4 in Itk deficient 
CD8+ T cells enhances the differentiation of innate-like T cells in a cell-intrinsic 
manner. 
 
Chapter IV: Graded levels of IRF4 regulate CD8+ T cell differentiation in 
response to virus infections: This chapter tests the hypothesis that affinity and 
dose of stimulating ligand regulate the levels of IRF4 expression, and IRF4 in 
turn converts the differences in TCR signal strength into varying magnitudes of 
CD8+ T cell expansion during acute infections. 
 
Chapter V: IRF4 regulates the ratio of T-bet to Eomesodermin in CD8+ T 
cells responding to persistent LCMV infection: Results from chapter III and IV 
showed that IRF4 regulates the expression of two key transcription factors T-bet 
and Eomes. An optimal ratio of these factors is required for efficient viral control 
during persistent infections, however, how this balance is maintained in not 
known. This chapter tests the hypothesis that IRF4 regulates the balance of T-
bet and Eomes and reduced expression of IRF4 results in impaired viral control. 
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CHAPTER II: Materials and Methods 
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CHAPTER II: MATERIALS AND METHODS 
Mice  
Mice were bred and housed in specific pathogen-free conditions at the 
University of Massachusetts Medical School (UMMS) in accordance with 
institutional animal care and use committee guidelines. Itk−/−, Irf4fl/fl and Eomesfl/fl 
mice have been described previously (Klein et al., 2006; Liu et al., 1998; Zhu et 
al., 2010). CD4-Cre+ transgenic mice were a gift from Joonsoo Kang (UMMS). 
Irf4fl/fl mice were crossed to CD4-Cre+ transgenic mice at UMMS to generate 
Irf4fl/fl CD4-Cre+ mice. OT-I TCR transgenic Rag1−/− mice and P14 TCR 
transgenic TCRα-/- were purchased from Taconic Farms (Germantown, New 
York) and crossed to Irf4fl/fl CD4-Cre+ mice at UMMS. Eomesfl/fl mice were 
purchased from The Jackson Labs (Maine) and crossed to Irf4+/fl CD4-Cre+ at 
UMMS. C57BL/6 mice purchased from The Jackson Labs (Maine) or Taconic 
Farms (Germantown, New York) (Chapter III), Irf4+/+ and Irf4+/+ CD4-Cre+ mice 
(Chapters III, IV and V) were used as WT controls. 
 
Viruses, Infections and adoptive transfers  
LCMV Armstrong (GP33 and F6L variant) and LCMV clone 13 stocks 
were propagated in baby hamster kidney cells (BHK21) at UMMS (Welsh and 
Seedhom, 2008) and were generously provided by Dr. Raymond M. Welsh. Adult 
male mice (6-9 weeks old) were infected with 2X106 PFU LCMV Clone 13 i.v. or 
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5X104 PFU LCMV-Armstrong GP33 and F6L variants i.p. unless otherwise 
specified. PR8-OVAI (kindly provided by Dr. Richard Webby, St. Jude Children’s 
Research Hospital, Memphis, TN and Dr. Susan L. Swain, UMMS) was grown in 
the allantoic cavity of embryonated hen eggs from virus stocks. Lightly 
anesthetized mice were infected with influenza by intranasal (i.n.) inoculation 0.3 
Lethal Dose 50 (LD50) for PR8-OVAI Influenza A.  
 
For adoptive transfers, splenocytes from P14 WT CD45.1+CD45.2+, P14 
Irf4+/fl CD45.2+, OT-I WT CD45.1+, or OT-I Irf4+/fl CD45.2+ mice were stained with 
antibodies to CD8 and Vα2 to determine the proportions of P14 or OT I cells, and 
equal numbers of WT and Irf4+/fl cells were mixed. Total P14 cells (2,000, 20,000, 
or 1,000,0000) were transferred i.v. into WT or CD45.1+ hosts 1d prior to 
infection. Total of 6,6000 OT-I cells were transferred i.v. into CD90.1 hosts and 
infected with 0.3 LD50 of influenza A PR8-OVAI. 
 
Antibodies  
Eomes Alexa Fluor® 488, KLRG1 fluorescein isothiocyanate (FITC), 
FoxP3 FITC, Eomes phycoerythrin (PE), CD107a PE, CD107b PE, CD27 PE, 
CD127 PE-Cy5, CD127 peridinin chlorophyll protein (PerCP) -Cy5.5, Tbet 
PerCP-Cy5.5, IL-2 PerCP-Cy5.5, IFNγ PerCP-Cy5.5, Eomes PerCP-efluor® 710, 
Vα2 PerCP-eFluor® 710, CD45.1 PECy7, CD127 PE-Cy7 KLRG1 PE-Cy7, Tbet 
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PE-Cy7, CD44 eFluor® 450, KLRG1 eFluor® 450, IFNγ eFluor® 450, IRF4 
allophycocyanin (APC), IRF4 Alexa Fluor® 647, Eomes Alexa Fluor® 647, CD44 
Alexa Fluor® 700, CD62L Alexa Fluor® 700, L-selectin (CD62L) APC-eFluor® 
780, TCRβ APC-eFluor® 780, CD90.2 APC-eFluor® 780, CD45.1 APC-eFluor® 
780, were purchased from eBioscience (San Diego, CA). Ki-67 FITC, CD24 
(HSA) FITC, CD69 PE, CD4 V500, CTLA4 PE, CD124 PE, phospho-STAT6 
APC, CD45.2-V500, TCRβ Alexa Fluor® 700 and TNFα APC-cy7 antibodies 
were purchased from BD Pharmingen (San Jose, CA).  CD8 PE-TexasRed, 
Granzyme B PE, Granzyme B APC, LIVE/DEAD® Fixable Violet Dead Cell Stain 
Kit, LIVE/DEAD® Fixable Aqua Dead Cell Stain Kit, goat-anti-rabbit IgG Alexa 
Fluor® 647 and Alexa Fluor® 488 were purchased from Life Technologies 
(Grand Island, NY). Rabbit-anti-mouse TCF1 was purchased from Cell Signaling 
Technology (Danvers, MA).  
 
Tetramers  
H2Db-GP33 monomers were prepared at the University of Massachusetts 
Medical School; LCMV-specific (H2Db-NP396 and H2Db-GP276), influenza A 
PR8-OVAI–specific (H2Kb-OVA257) monomers and CD1d tetramer were 
obtained from the NIH Tetramer Core Facility (Atlanta, GA).  
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Peptides  
LCMV peptides GP33-41 (KAVYNFATC), F6L (KAVYNLATC), NP396-404 
(FQPQNGQFI), GP276-286 (SGVENPGGYCL) and GP61-80 
(GLKGPDIYKGVYQFKSV) were synthesized and HPLC purified by 21st century 
Biochemicals (Marlboro, MA). Peptides were ~90% pure.  
 
Surface and Intracellular staining 
Single cell suspensions from spleens and thymii of mice were prepared, 
RBC lysed and plated in 96 well round bottom plates. Cells were washed with 
FACS buffer (1X PBS supplemented with 2% BSA) and Fc receptors were 
blocked using supernatant from 2.4G2 hybridomas. Cells were stained with 
CD1d, H2Db-NP396 and H2Db-GP276, H2Db-GP33, H2Kb-OVA257 or I-Ab-GP66-
77 tetramers prior to staining with cell-surface antibodies. Intracellular cytokine 
and transcription factor staining were performed using BD cytofix/Cytoperm and 
eBioscience Foxp3/transcription factor staining kits respectively, as per 
manufacturers instructions, unless specified. For Fig 3.1A intracellular staining 
for IRF4 was performed as previously described (Sciammas et al., 2006). 
Intracellular TCF1 staining was performed using rabbit-anti-mouse TCF1, 
followed by staining with goat-anti-rabbit secondary. To compare spleens from 
Irf4−/− (T) and Irf4fl/fl X FoxP3-Cre mice, splenocytes were harvested and RBCs 
were lysed at UMMS and Memorial Sloan–Kettering Cancer Center, respectively; 
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stored at 4°C overnight; and stained the following day. Cells retained >90% 
viability. All samples were analyzed on an LSRII flow cytometer (BD 
Biosciences), and data were analyzed using FlowJo (Tree Star). 
 
Phospho-STAT6 Staining 
Splenocytes were harvested from naive OT-I WT or OT-I Irf4fl/fl CD4-Cre+ 
mice and rested for 30 min at 37°C; for experiments using ITK inhibitor 10n 
(Riether et al., 2009), cells were pre-incubated with dilutions of the inhibitor in 
complete RPMI. After pre-incubation, cells were incubated in the presence or 
absence of IL-4 (10ng/mL) in complete RPMI or diluted into the same 
concentrations of 10n or DMSO for 30 min. Cells were fixed with BD Biosciences 
Cytofix for 15 min on ice, washed, and surface-stained. Cells were then 
permeabilized with BD Sciences Phosphoflow-Perm Buffer III for 30 min on ice, 
washed, stained with α-phospho-STAT6 at room temperature for 1h in the dark, 
and analyzed immediately by flow cytometry. 
 
Media Composition 
 All in-vitro T cell cultures were performed using RPMI-1640 supplemented 
with 10% Fetal Bovine Serum (FBS), 100µg/ml streptomycin, 100U/ml penicillin, 
0.292 mg/ml L-glutamine, 25mM HEPES and 0.001% β-Mercaptoethanol 
(henceforth referred to as complete RPMI). Vero cells were propagated in MEM 
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supplemented with 10% Fetal Bovine Serum (FBS), 100µg/ml streptomycin, 
100U/ml penicillin and 0.292 mg/ml L-glutamine (henceforth referred to as 
complete MEM). Plaque assays were overlaid with EMEM supplemented with 
7.5% FBS, 250U/ml streptomycin, 250U/ml penicillin, 1.46 mg/ml L-glutamine 
(henceforth referred to as complete EMEM).  
 
Cell isolation and culture 
Peripheral CD8+ T cells were isolated using CD8+ magnetic affinity cell 
sorting (MACS; Miltenyi) microbeads. To isolate naive CD4−CD8+ (CD8SP) 
thymocytes, CD4+ cells were depleted using MACS microbeads. Purified T cells 
were cultured at a concentration of 1X106 cells/mL in complete RPMI on wells 
coated with AffiniPure Goat anti-Armenian hamster IgG (H+L) (1µg/mL; Jackson 
ImmunoResearch), followed by anti-CD3 and anti-CD28 (high TCR, 1µg/mL + 
4µg/mL; low TCR, 0.1µg/mL + 0.4µg/mL) (ebioscience). IL-7 and IL-4 were 
purchased from R&D Systems and used at a concentration of 10ng/mL. The ITK 
inhibitor 10n (Riether et al., 2009), was synthesized at the National Institute of 
Health’s Chemical Genomics Center and dissolved in DMSO at 100mM before 
dilution into cell culture media at the indicated working concentrations. For in-
vitro activation of P14 T cells with GP33 or F6L peptides, lymph node cells from 
P14 WT and P14 Irf4+/fl mice were mixed with equal numbers of WT CD45.1 
splenocytes and stimulated with indicated doses of peptides for 24, 48, and 72 h.  
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To assay for cytokine production, cells were stimulated with 10ng/mL 
phorbol 12-myristate 13-acetone and 2µg/mL ionomycin (Sigma-Aldrich) for 4h in 
the presence of 0.7µg/mL Golgi Stop and 1µg/mL Golgi Plug (Becton Dickinson) 
(Chapter III). Splenocytes from infected mice were stimulated with 1µM GP33, 
GP276, or NP396 peptides for 5h in the presence of 1mg/ml Golgi Stop and 
1mg/ml Golgi Plug (Becton Dickinson), and antibodies to CD107a and CD107b 
(Chapter IV). 
 
Immunoblotting 
CD4−CD8+ (CD8SP) thymocytes and CD8+ peripheral T cells isolated from 
WT and Irf4−/− (T) mice were cultured under high TCR stimulation condition for 
20hr. Cell lysates were prepared using RIPA lysis buffer containing 1X protease 
inhibitors (cOmplete Protease Inhibitor Cocktail Tablets, Roche). Immunoblots 
were probed for IRF4 (clone M17, Santa Cruz) and Hsp70 (Clone 3A3, Thermo 
Scientific). 
 
In-vivo IL-4 neutralizing treatment 
WT and Irf4fl/fl CD4-Cre+, hosts were injected intra-peritoneally (i.p.) with 
1mg of αIL-4 neutralizing antibody (clone 11B11; BioXCell) or an equal volume of 
PBS 2-4h before adoptive transfer. Splenocytes were harvested from OT-I WT 
and OT-I Irf4fl/fl CD4-Cre+ mice, and equal numbers of cells from each population 
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were mixed and transferred into WT or Irf4fl/fl CD4-Cre+ hosts via tail vein 
injections. After 44 h, splenic CD8+ T cells in the recipients were analyzed by flow 
cytometry. 
 
Bone Marrow Chimeras 
Bone marrow cells were harvested from the femurs and tibia of 
congenically marked WT or Irf4fl/fl CD4-Cre+ mice. Lineage-specific cells were 
depleted using CD4, CD8, and CD90.1/CD90.2 magnetic affinity cell sorting 
beads. WT and Irf4fl/fl CD4-Cre+ bone marrow cells were mixed in various ratios, 
and 6X106 cells were adoptively transferred into sublethally (600-rad) irradiated 
congenic Rag2−/− (CD45.1+) hosts. 7.5 weeks after reconstitution, splenocytes or 
peripheral blood cells were stained with antibodies to CD8, CD44, CD45.1, 
CD45.2, CD90.1, and CD90.2. 
 
Viral titers 
LCMV Armstrong and LCMV Clone 13 virus titers were determined by 
plaque assays. Spleens, livers and kidneys were harvested at indicated time 
points post-infection (p.i.), homogenized in complete RPMI and stored at -80°C. 
Blood was harvested at indicated time points, and serum was isolated and stored 
at -80°C. To determine viral titers, 10-fold serial dilutions of samples were used 
to infect monolayers of vero cells in 1ml complete MEM for 90min at 37°C. Post-
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incubation, cells were overlaid with 4ml of 1:1 mixture of complete EMEM and 
1% Saekem’s agarose. 4 days later, cells were stained with 2ml of 1:1 mixture of 
complete EMEM and 1% Saekem’s agarose supplemented with neutral red. 
Plaques were counted on day 5 and 6. Viral loads are shown as log10PFU/ml 
(Chapter IV) or PFU/ml  (Chapter V). 
 
LCMV-specific antibody titers 
To quantify LCMV-specific antibody titers, high binding 96 well flat bottom 
ELISA plates (Corning) were coated overnight at room temperature with cell 
lysate from LCMV Clone 13 infected BHK21 cells. Plates were washed three 
times with PBS containing 0.5% Tween 20 and blocked with PBS supplemented 
with 10% FCS and 0.2% Tween 20 for an hour. Three-fold serial dilutions of 
serum samples were prepared in blocking buffer and plated on LCMV-coated 
plates for 90 min. Plates were washed with PBS/0.5% Tween 20 and incubated 
with horseradish peroxidase labeled goat anti-mouse IgG detection antibody 
(Bethyl labs) for 90min. Plates were washed again with PBS containing 0.5% 
Tween 20 and developed using 3,3',5,5'-Tetramethylbenzidine substrate. The 
reaction was quenched after 15mins using 0.18M H2SO4 ELISA stop solution 
(Bethyl Labs) and the optical density (OD) was measured at 450nm using an 
Emax Endpoint ELISA microplate reader (Molecular Devices). LCMV-specific 
antibody titers were determined by end-point titer method and two times the 
mean OD of uninfected control sera was used as the cut-off.  
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Statistical analysis 
All data are represented as mean ± Standard Error of Mean (SEM). 
Statistical significance is indicated by ns p>0.05, *p≤0.05, **p≤0.01, ***p≤0.001, 
and ****p≤0.0001. Statistical significance was determined by Mann-Whitney test 
(Chapter III), unpaired Student t test (Chapter IV) or unpaired Student t test with 
Welch’s correction, Ordinary one-way ANOVA using Turkey’s multiple 
comparison test or Log-rank (Mantel-Cox) test (Chapter V). 
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CHAPTER III: TCR SIGNALING VIA ITK AND IRF4 REGULATES CD8+ T 
CELL DIFFERENTIATION 
Abstract 
CD8+ T-cell development in the thymus generates a predominant 
population of conventional naive cells, along with minor populations of “innate” T 
cells that resemble memory cells. Recent studies analyzing a variety of knock-out 
(KO) or knock-in mice have indicated that impairments in the T-cell receptor 
(TCR) signaling pathway produce increased numbers of innate CD8+ T cells, 
characterized by their high expression of CD44, CD122, CXCR3, and the 
transcription factor, Eomesodermin (Eomes). One component of this altered 
development is a non-CD8+ T cell-intrinsic role for IL-4. To determine whether 
reduced TCR signaling within the CD8+ T cells might also contribute to this 
pathway, we investigated the role of the transcription factor, IFN regulatory factor 
4 (IRF4). IRF4 is up-regulated following TCR stimulation in WT T cells; further, 
this up-regulation is impaired in T cells treated with a small-molecule inhibitor of 
the Tec family tyrosine kinase, IL-2 inducible T-cell kinase (ITK). In contrast to 
WT cells, activation of IRF4-deficient CD8+ T cells leads to rapid and robust 
expression of Eomes, which is further enhanced by IL-4 stimulation. In addition, 
inhibition of ITK together with IL-4 increases Eomes up-regulation. These data 
indicate that ITK signaling promotes IRF4 up-regulation following CD8+ T-cell 
activation and that this signaling pathway normally suppresses Eomes 
expression, thereby regulating the differentiation pathway of CD8+ T cells. 
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Introduction 
The immune system is composed of multiple lineages of T lymphocytes 
that differ in their antigen receptor specificity, their expression of effector 
cytokines, and their trafficking patterns in the body. The majority of circulating 
CD4+ and CD8+ T cells arise as naive lymphocytes, which require activation, 
expansion, and effector cell differentiation before participating in a protective 
immune response to infection. In contrast, a smaller subset of T cells completes 
thymic development as fully differentiated effector cells that are able to respond 
to activation signals rapidly and have transcription factor profiles and trafficking 
patterns of effector and/or memory T cells. This latter group, which includes 
invariant natural killer T (iNKT) cells, γδ T cells, and H2-M3–specific T cells, has 
been termed innate T cells (Berg, 2007). 
  
The intracellular signals that direct developing T cells into conventional 
naive vs. innate cell lineages are not well understood. For CD1d-specific iNKT 
cells, the best studied of the innate T-cell lineages, factors regulating their 
development include the strength of T-cell receptor (TCR) signaling and 
differential use of costimulatory receptors, such as SLAM-family proteins 
(Bendelac et al., 2007). Additional insights into the development of innate T cells 
have come from studies of mice carrying deficiencies in T-cell signaling proteins 
or transcription factors. For example, in mice lacking the Tec family tyrosine 
kinase, IL-2 inducible T-cell kinase (ITK), thymocyte development produces a 
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large population of innate CD8+ T cells instead of the normal subset of naive 
CD4−CD8+ (CD8SP) thymocytes. Specifically, Itk-/- CD8SP thymocytes have the 
hallmarks of antigen-experienced T cells because they are CD122+ CD44hi 
CXCR3+, express high levels of the transcription factor Eomesodermin (Eomes), 
and produce IFNγ within hours of ex-vivo stimulation (Atherly et al., 2006b; 
Broussard et al., 2006; Dubois et al., 2006). A wealth of data indicates that 
alterations in TCR signaling pathways play a key role in promoting this innate T-
cell development, because several lines of mice with defects in TCR signaling 
components, or downstream transcription factors regulated by TCR signaling, 
share this same phenotype; these include mice expressing a mutant version of 
SLP-76, in addition to mice deficient in KLF2, Creb-binding protein (CBP), or Id3 
(Fukuyama et al., 2009; Jordan et al., 2008; Verykokakis et al., 2010; Weinreich 
et al., 2009; 2010). 
 
Recent studies have demonstrated that the development of innate 
memory-like CD8SP thymocytes is a complex process. One component of this 
altered development is a non-CD8+ T cell-intrinsic role for IL-4, which promotes 
the conversion of CD8SP thymocytes into memory-like T cells (Weinreich et al., 
2009; 2010). In addition to the environmental factors promoting this phenotype, 
reduced TCR signaling within the CD8+ T cell may contribute to the altered 
expression of lineage- determining transcription factors, such as Eomes. 
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To identify additional components regulating the memory CD8+ T-cell 
phenotype seen in Itk-/- mice, we performed a gene expression microarray 
experiment and focused on transcription factors that were differentially expressed 
between WT and Itk-/- CD8SP thymocytes. This analysis revealed that IFN 
regulatory factor 4 (IRF4) was expressed more highly in TCR-β+CD8+ cells from 
thymii of WT vs. Itk-/- mice. IRF4 is up-regulated following antigen receptor 
stimulation in B cells and T cells (Eisenbeis et al., 1995; Matsuyama et al., 1995). 
In B cells, the strength of B-cell receptor signaling determines the level of IRF4 
protein produced; in turn, this graded expression of IRF4 regulates memory B-
cell vs. plasma cell lineage development (Klein et al., 2006; Sciammas et al., 
2006). IRF4 is also required for T-cell function and is essential for T helper (Th) 
2, Th9, and Th17 CD4+ lineage development (Ahyi et al., 2009; Brüstle et al., 
2007; Chung et al., 2009; Honma et al., 2008; Huber et al., 2008; Lohoff et al., 
2002; Mittrücker et al., 1997; Staudt et al., 2010; Tominaga et al., 2003). In 
addition to the role of IRF4 in effector CD4+ T-cell differentiation, IRF4 is 
important in Foxp3+ regulatory T cells (Tregs), because Irf4-/- Tregs are unable to 
suppress spontaneous T-cell activation in-vivo (Zheng et al., 2009). However, the 
role of IRF4 in the development and function of CD8+ T cells has not been 
investigated. 
 
To address the role of IRF4 in CD8+ T cells, we examined mice with a 
conditional allele of Irf4 (Irf4fl/fl) (Klein et al., 2006) crossed to CD4-Cre+ 
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transgenic mice, thereby deleting IRF4 in all αβ T cells. Although the innate 
memory-like phenotype seen with CD8SP thymocytes in Itk-/- mice was not seen 
in thymocytes from these conditional IRF4-deficient mice, peripheral CD8+ T cells 
in these mice showed a spontaneous conversion to a memory cell phenotype; 
specifically, Irf4fl/fl CD4-Cre+ [hereafter referred to as Irf4fl/fl] CD8+ T cells were 
CD44hi CXCR3+ CD122+ Eomes+ and produced IFNγ on ex-vivo stimulation. 
Further, as shown previously, impaired Treg function in conditional IRF4-deficient 
mice leads to polyclonal activation of peripheral T cells (Zheng et al., 2009). 
However, unlike IRF4-sufficient CD8+ T cells, IRF4-deficient CD8+ T cells 
activated in this environment up-regulate high levels of Eomes and acquire a 
memory cell phenotype. Furthermore, we show that IRF4 is required to suppress 
Eomes up-regulation following in-vitro activation of naive CD8+ T cells and that 
IL-4 enhances Eomes expression in cells with impaired TCR signaling. Lastly, we 
show that a combination of weak T-cell stimulation due to impaired Treg function, 
plus the absence of IRF4, induces the innate-like phenotype in Irf4fl/fl CD8+ T 
cells in-vivo. Together, these data demonstrate that IRF4 functions as a regulator 
of CD8+ T cell differentiation via suppression of Eomes expression after TCR 
signaling via ITK. 
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Results 
A. IRF4 Is Up-regulated During Positive Selection in the Thymus 
Using gene expression microarray analysis, we identified IRF4 as a gene 
more highly expressed in WT compared with Itk-/- CD8SP thymocytes. These 
data were confirmed using intracellular staining, followed by flow cytometry, to 
assess IRF4 protein levels (Fig. 3.1A). In WT thymocytes, IRF4 expression is 
detected at the CD4+8+ (DP) stage, and is predominantly restricted to the subset 
expressing high levels of CD69, representative of cells undergoing positive 
selection due to TCR signaling. IRF4 is also expressed in the majority of WT 
CD4+8- (CD4SP) thymocytes and, again, shows the highest correlation with 
CD69 expression. A smaller proportion of WT CD8SP thymocytes show 
detectable IRF4 expression. Overall, WT thymocytes had consistently higher 
levels of IRF4 protein expression directly ex-vivo compared with Itk-/- thymocytes, 
but the largest difference was found in the CD8SP subset (Fig. 3.1 A and B). 
These data indicate that IRF4 is transiently up-regulated during thymic 
development as cells undergo positive selection and that ITK is required for 
optimal IRF4 expression. 
 
B. IRF4 Deficient T Cells Show Normal Thymic Development 
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Figure 3.1: IRF4 is up-regulated during thymic selection but is not required 
for normal T-cell development: (A) Thymocytes from WT or Itk-/- mice were 
isolated and surface-stained for CD4, CD8, and CD69, and then for intracellular 
IRF4 protein. Thymocyte subsets (DP, CD4SP, and CD8SP) were gated on, and 
IRF4 vs. CD69 is displayed. Numbers on dot-plots represent the percentage of 
cells expressing IRF4, based on comparison with an isotype control. Data are 
representative of six or more independent experiments. (B) Compilation of the 
percentage of IRF4 expressing cells for each thymocyte subset (n = 15; ***P < 
0.001 based on the Mann-Whitney test). 
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To determine whether IRF4 is a component of the pathway regulating 
CD8+ T cell development or differentiation, we analyzed the thymic and 
peripheral T cells in conditional IRF4 deficient mice. For these experiments, Irf4fl/fl  
mice (Klein et al., 2006) were crossed to CD4-Cre+ transgenic mice [hereafter 
referred to as Irf4fl/fl], thereby initiating Irf4 deletion at the DP stage in the thymus. 
In these mice, deletion of the floxed sequences in the Irf4 locus is accompanied 
by expression of GFP; as shown, 70% of DP thymocytes and nearly 100% of 
CD4SP and CD8SP thymocytes are GFP+ (Fig. 3.2A). To confirm that deletion of 
the Irf4 locus occurred on both alleles of Irf4, CD8SP thymocytes and CD8+ 
peripheral T cells were isolated, stimulated in vitro with αCD3/αCD28 stimulation, 
and analyzed by Western blotting. Although abundant IRF4 protein is detected in 
WT cells, IRF4 is virtually absent in cells from the Irf4fl/fl mice (Fig. 3.2B). These 
data demonstrate that Irf4 is efficiently deleted by the CD8SP stage of thymocyte 
maturation. 
 
Analysis of thymocytes from Irf4fl/fl mice indicated that IRF4 is not required 
for normal T-cell development. Compared with WT thymocytes, Irf4fl/fl thymocytes 
showed normal CD4/CD8 ratios, as has been previously reported for germline 
Irf4-/- mice (Mittrücker et al., 1997) and unlike that seen in the absence of ITK 
(Fig. 3.2C). Additionally, there were no differences in the cell surface phenotype 
of CD8SP cells; thus, expression of CXCR3 and CD124 in Irf4fl/fl CD8SP cells 
appeared identical to that in WT cells (Fig. 3.2C). Irf4fl/fl CD8SP thymocytes also  
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Figure 3.2: IRF4 Deficient T Cells Show Normal Thymic Development: (A) 
Thymocytes from WT (red lines) and Irf4fl/fl (blue lines) mice were analyzed for 
GFP expression in gated CD4+8+ (DP), CD4+ TCRβ+, and CD8+ TCRβ+ cells to 
assess the extent of Cre-mediated deletion at the Irf4 locus. (B) Immunoblot 
analysis of IRF4 protein levels in CD4-CD8+ (CD8SP) thymocytes and CD8+ 
peripheral T cells from WT and Irf4fl/fl mice stimulated for 20 h with αCD3/αCD28. 
Data are representative of two independent experiments. (C) Thymocytes from 
WT, Itk-/-, and Irf4fl/fl mice were stained with antibodies to CD4, CD8, CD44, 
intracellular Eomes, CXCR3, and CD124; stimulated for 4 h with phorbol 12-
myristate 13-acetone (PMA) and ionomycin; and stained for intracellular IL-4 and 
IFNγ. CD4 vs. CD8 profiles are shown (Top) along with gated CD8SP cells 
(Middle and Bottom). 
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did not produce IFNγ following ex-vivo stimulation, consistent with their lack of 
expression of Eomes, a transcription factor found at abundant levels in the Itk−/− 
CD8SP cells (Fig. 3.2C). 
 
More detailed analysis of minor thymocyte populations indicated that Irf4fl/fl 
mice had reduced numbers of CD1d/αgalcer-binding iNKT cells and had no 
expansion of CD4+ IL-4 producing γδ T cells (Fig. 3.3A-D). In addition, the thymus 
of Irf4fl/fl mice lacked the abundant promyelocytic leukemia zinc finger-positive 
population of innate CD4+ T cells seen in Itk−/− mice, and shown to be essential in 
the conversion of Itk−/− CD8SP thymocytes to the innate phenotype (Weinreich et 
al., 2010) (Fig. 3.3E). Surprisingly, although reduced numbers of CD1d/αgalcer-
binding iNKT cells were found in the thymus of Irf4fl/fl mice, spleens and livers of 
these mice did not show a reduction in the proportions of iNKT cells relative to 
WT (Fig. 3.4A). Moreover, splenic Irf4fl/fl CD4+ T cells showed a trend toward 
enhanced IL-4 production compared with WT cells, but this difference was not 
statistically significant (Fig. 3.4B). Together, these data indicate that the Irf4fl/fl 
mice do not contain an obvious IL-4 producing subset that would promote Eomes 
expression in CD8SP thymocytes or T cells. 
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C. IRF4 Deficient Peripheral CD8+ T Cells Acquire a Memory 
Phenotype 
In contrast to thymocytes, peripheral CD8+ T cells in the Irf4fl/fl mice 
showed a spontaneous conversion to an innate/memory phenotype (Kallies et 
al., 2009), with increased proportions of CD44hi CD62Lhi cells relative to WT 
CD8+ T cells (Fig. 3.5A). As has been reported previously for the germline Irf4 
deficient mice (Mittrücker et al., 1997), Irf4fl/fl mice had a slight increase in the 
absolute numbers of cells in their spleens (Fig. 3.5B). Cell surface analysis  
indicated additional differences between Irf4fl/fl and WT T cells. In particular, the 
Irf4fl/fl CD8+ T cells had increased levels of CXCR3, CD44, and CD122 compared 
with WT T cells, similar to those seen on Itk-/- T cells (Fig. 3.5C). These data 
indicate that Irf4fl/fl CD8+ T cells undergo a spontaneous conversion from naive to 
memory-like T cells following their migration into the periphery. 
 
Because Itk-/- CD8+ T cells express high levels of Eomes (Atherly et al., 
2006b), a transcription factor responsible for promoting IFNγ transcription in 
effector and memory T cells (Intlekofer et al., 2005; Pearce et al., 2003), we 
assayed for Eomes expression in splenic Irf4fl/fl T cells. WT CD8+ T cells 
expressed modest amounts of Eomes protein, and this expression was largely 
restricted to the CD44hi subset. The proportions of Eomes+ cells among the 
peripheral CD8+ T cells in Itk-/- and Irf4fl/fl mice were increased dramatically 
compared with WT mice (Fig. 3.5D). We also examined the expression of the  
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Figure 3.3: Characterization of cell subsets in the thymus of Irf4fl/fl mice: (A) 
CD4+8− (CD4SP) thymocytes from WT, Itk-/-, and Irf4fl/fl mice were stimulated with 
PMA and ionomycin for 4 h and analyzed for IL-4 and IFNγ production by 
intracellular staining. Numbers indicate the percentages of cytokine-producing 
CD4SP cells in each quadrant. (B) (Left) Thymocytes from WT, Itk-/-, and Irf4fl/fl 
mice were analyzed for invariant natural killer T (iNKT) cells by staining with 
αTCRβ antibodies and CD1d/αgalcer tetramer. Numbers indicate the percentage 
of iNKT cells in each sample. (Right) Compilation of the data is shown; statistical 
significance was determined by the Mann–Whitney test. (C) Thymocytes from 
WT, Itk-/-, and Irf4fl/fl mice were analyzed for γδ NKT cells by staining with 
antibodies to CD4 vs. TCRδ. Numbers indicate the percentage of γδ T cells in 
each sample. (D) TCRγδ+ thymocytes from WT, Itk-/-, and Irf4fl/fl mice were 
stimulated with PMA and ionomycin for 4 h and analyzed for IL-4 and IFNγ 
production by intracellular staining. Numbers indicate the percentages of 
cytokine-producing γδ T cells in each quadrant. (E) CD4+CD8− single positive 
(CD4SP) thymocytes from WT, Itk-/-, and Irf4fl/fl mice mice were analyzed for 
promyelocytic leukemia zinc finger (PLZF) vs. CD44 staining. Data are 
representative of five independent experiments. 
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Figure 3.4 Irf4fl/fl mice have normal numbers of invariant natural killer T 
(iNKT) cells in liver and spleen: (A) T cells were isolated from spleens (Top) 
and livers (Bottom) of WT, Itk-/-, and Irf4fl/fl mice and were analyzed for iNKT cells 
by staining with antibody to TCRβ and CD1d/αgalcer tetramer. Numbers indicate 
the percentage of iNKT cells in each sample. (Right) Compilations of data 
indicating percentages of CD1d-Tet+ cells are shown. Data are representative of 
three independent experiments with total of n≥6 mice per group. Statistical 
significance was determined by the Mann-Whitney test. (B) Splenic CD4+ T cells 
from WT, Itk-/-, and Irf4fl/fl mice were stimulated with PMA and ionomycin for 4 h 
and analyzed for IL-4 and IFNγ production by intracellular staining. Numbers 
indicate the percentages of cytokine-producing CD4+ cells in each quadrant. 
(Right) Compilation of data is shown. No statistically significant differences were 
seen by the Mann-Whitney test. 
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related transcription factor, Tbet, in splenic Irf4fl/fl T cells. Peripheral WT and 
Irf4fl/fl CD8+ T cell populations contained similar proportions of Tbet+ cells,  
whereas Itk-/- CD8+ T cells had a significant increase in Tbet expression (Fig. 
3.5D). As for Eomes, the expression of Tbet was limited to the CD44hi subset. 
This increased Eomes expression correlated with enhanced IFNγ production 
following ex-vivo stimulation, although the difference between WT and Irf4fl/fl 
CD8+ T cells did not achieve statistical significance (Fig. 3.5D). 
 
D. Loss of Peripheral Tolerance in Irf4fl/fl Mice 
IRF4 has been shown to be required for the function of FoxP3+ Tregs 
(Zheng et al., 2009). Therefore, we considered whether defects in peripheral 
tolerance might account for the spontaneous activation of CD8+ T cells in Irf4fl/fl 
mice. To test this possibility, we generated mixed bone marrow chimeras in 
which Irf4fl/fl bone marrow was mixed with WT bone marrow and then used to 
reconstitute irradiated congenic Rag2-/- (CD45.1+) hosts. When analyzed at 7.5 
wk after reconstitution, we found that CD8+ T cells derived from Irf4fl/fl bone 
marrow retained a naive phenotype as long as they developed in the presence of 
WT cells (Fig. 3.6). These data indicate that the spontaneous activation of Irf4fl/fl 
CD8+ T cells in intact Irf4fl/fl mice is due to impaired peripheral tolerance in Irf4fl/fl 
mice. 
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Figure 3.5 Peripheral IRF4-deficient T cells share the innate phenotype of 
Itk-/- CD8+ T cells: (A) Splenocytes were isolated from WT, Itk-/-, and Irf4fl/fl mice, 
and they were then stained with antibodies to CD4, CD8, CD44, and CD62L. 
CD4 vs. CD8 staining of total splenocytes (Upper) and CD44 vs. CD62L staining 
on gated CD8+ T cells (Lower) are shown. (B) Compilations of the total 
splenocyte numbers, percentages of CD8+ T cells, and absolute numbers of 
CD8+ T cells in the spleens are shown (n = 8). (C) CD8+ splenic T cells from WT, 
Itk-/-, and Irf4fl/fl mice were analyzed for GFP, CXCR3, CD44, and CD122 
expression. (D) CD8+ splenic T cells from WT, WT, Itk-/-, and Irf4fl/fl mice stained 
with antibodies to CD44, Eomes, and Tbet or were stimulated for 4 h with PMA 
and ionomycin, and they were then analyzed for IL-4 vs. IFNγ expression. 
Compilations of the data show the percentages of Eomes+ cells (n = 12), Tbet+ 
cells (n = 6–10), and IFNγ+ cells (n = 10). Statistically significant differences are 
indicated by *(P < 0.05), **(P < 0.001), or ***(P < 0.0001) based on the Mann-
Whitney test. 
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Figure 3.6 IRF4-deficient CD8+ T cells remain naive in mixed bone marrow 
chimeras: Bone marrow chimeras were generated by transferring 100% WT, 
100% Irf4fl/fl, or mixtures of WT plus Irf4fl/fl bone marrow into congenic irradiated 
Rag2-/- recipients. WT plus Irf4fl/fl mixtures ranged from 30:70-70:30, and were all 
pooled for this analysis. The graph shows the percentages of CD8+ CD44hi cells 
in the spleen or peripheral blood at 7.5 wk after reconstitution. WT (mixed) and 
Irf4fl/fl (mixed) indicate the data for each of these populations present in the set of 
chimeras generated from the bone marrow mixture.  
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Figure 3.6 IRF4-deficient CD8+ T cells remain naive in mixed bone marrow 
chimeras  
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Based on these findings, we examined the phenotype of Foxp3+ Tregs in 
the Irf4fl/fl mice. We observed a significant decrease in the proportion of 
CD4+Foxp3+ Tregs in the spleens of Irf4fl/fl mice compared with WT mice (Fig. 
3.7A). In addition, fewer of the Irf4fl/fl FoxP3+CD4+ T cells expressed cytotoxic T 
lymphocyte associated protein 4 (CTLA4) relative to WT FoxP3+ cells, 
suggesting a functional impairment in the Irf4fl/fl Tregs. We also observed 
reduced expression of CTLA4 on Irf4fl/fl CD4+ Foxp3+ Tregs compared with WT 
Tregs. Collectively, these data support the conclusion that peripheral Irf4fl/fl CD8+  
T cells are activated due to a loss of peripheral tolerance resulting from FoxP3+ 
Treg defects, as previously described (Zheng et al., 2009). 
 
These data indicated that a component of the CD8+ T cell phenotype 
observed in Irf4fl/fl mice was not CD8+ T cell-intrinsic. To determine whether loss 
of IRF4 expression in the CD8+ T cells also contributed to their conversion to a 
memory cell phenotype, we compared Irf4fl/fl CD8+ T cells with CD8+ T cells 
present in Irf4fl/fl × Foxp3-Cre+ mice, with the latter being deficient for IRF4 only in 
FoxP3+ Tregs (Zheng et al., 2009). This comparison revealed considerable 
differences between the peripheral CD8+ T cells present in the two lines of mice 
(Fig. 3.7B). Although the activated CD8+ T cells in the Irf4fl/fl mice predominantly 
exhibited a memory phenotype (CD44hi CD62Lhi), activated IRF4-sufficient Irf4fl/fl 
× Foxp3-Cre+ CD8+ T cells had a CD44hi CD62Llow phenotype associated with 
effector cells. Further, a greater proportion of CD8+ T cells from Irf4fl/fl × Foxp3- 
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Figure 3.7 Aberrant FoxP3+ regulatory T cells in Irf4fl/fl mice: (A) CD4+ T cells 
from the spleens of WT and Irf4fl/fl mice were analyzed for intracellular FoxP3 and 
CTLA-4. Numbers on the dot-plots represent the percentages of CD4+ T cells 
that are FoxP3+CTLA-4+. Below are compilations of the percentages of CD4+ T 
cells that are FoxP3+ or FoxP3+CTLA-4+. Data are representative of two 
independent experiments. Statistical significance was determined by the Mann-
Whitney test. (B) Splenic CD8+ T cells from WT, Irf4fl/fl, FoxP3-Cre control, and 
Irf4fl/fl X FoxP3-Cre mice were analyzed for expression of CD44, CD62L, CD69, 
Ki67, and intracellular Eomes. Dot-plots display gated CD8+TCRβ+ cells; 
numbers indicate the percentages of cells in the indicated quadrants or gates. 
(Right) Compilations of data for the four groups of mice are shown. Statistical 
significance was determined by the Mann-Whitney test (*P = 0.02). 
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Cre+ mice vs. those in Irf4fl/fl mice showed evidence of recent activation, as 
indicated by CD69 up-regulation, although there was no statistically significant 
difference in Ki67 staining between any of the groups of mice. Finally, the   
 
transcription factor Eomes was up-regulated in a significantly higher fraction of 
Irf4fl/fl CD8+ T cells compared with those in Irf4fl/fl × Foxp3-Cre+ mice. These data 
indicate that both environmental factors, as well as a CD8+ T cell-intrinsic role for 
IRF4, are contributing to the phenotype of CD8+ T cells in Irf4fl/fl mice. 
 
E. Both Cell-Intrinsic and Cell-Extrinsic Factors Contribute to the 
Presence of Innate/Memory CD8+ T Cells in Irf4fl/fl Mice 
Irf4fl/fl mice exhibit reduced peripheral tolerance and have increased 
numbers of innate/memory CD8+ T cells in their spleens. To determine the 
relative contribution of cell-intrinsic factors vs. factors contributed by the 
environment in Irf4fl/fl mice (i.e., cell-extrinsic factors), we performed adoptive 
transfer experiments. In particular, we addressed a possible role for IL-4 in the 
environment of Irf4fl/fl mice, because previous studies have indicated a key role 
for IL-4 in Eomes up-regulation during the development of innate CD8+ T cells in 
the thymus (Gordon et al., 2011; Min et al., 2011; Verykokakis et al., 2010; 
Weinreich et al., 2009; 2010). For these experiments, a 1:1 mixture of naive 
CD8+ OT-I Rag1-/- and OT-I Rag1-/- Irf4fl/fl (henceforth referred to as OT-I WT and 
OT-I Irf4fl/fl, respectively) splenocytes were transferred into WT or Irf4fl/fl host 
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mice. In addition, cohorts of mice received either PBS or 1 mg of αIL-4 
neutralizing antibody 2-4 h before adoptive transfer. Donor cells were examined 
44 h later for Eomes and CD44 expression. 
 
As shown in Fig. 3.8A and B, OT-I WT cells show little change when 
analyzed after 2 d in a WT host, whereas OT-1 Irf4fl/fl CD8+ T cells had modestly 
increased proportions of CD44hi and Eomes+ cells in this environment. Neither 
group of cells in the WT hosts was affected by the presence of anti-IL-4 antibody. 
In contrast, following 2 d in Irf4fl/fl hosts, both groups of donor cells showed 
increased expression of CD44 and Eomes, with a significantly enhanced effect 
on the OT-I Irf4fl/fl cells. In the Irf4fl/fl environment, IL-4 blocking caused a trend 
toward reduced Eomes up-regulation in both OT-I WT and OT-I Irf4fl/fl cells, as 
assessed by the median fluorescence intensity (MFI) of Eomes staining on the 
entire cell population (Fig. 3.8B); however, these reductions were not statistically 
significant. These data also show that the majority of CD44lo cells, both OT-I WT 
and OT-I Irf4fl/fl donor cells, have up-regulated Eomes in Irf4fl/fl hosts. Because 
αIL-4 treatment did not abolish this effect, an alternative possibility is the 
presence of high levels of type I IFN in the OT-I Irf4fl/fl mice; a strong type I IFN 
response has been shown to induce Eomes up-regulation specifically on CD44lo 
naive CD8+ T cells (Marshall et al., 2010). Overall, these data indicate that the 
dramatic up-regulation of Eomes in Irf4fl/fl CD8+ T cells is the result of both a cell- 
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Figure 3.8 High expression of Eomes by IRF4-deficient CD8+ T cells is 
dependent on both cell-intrinsic and cell-extrinsic factors in Irf4fl/fl mice: 
Splenocytes from OT-I WT and OT-I Irf4fl/fl mice were mixed 1:1 and adoptively 
transferred into WT or Irf4fl/fl hosts and then injected i.p. with 1 mg of αIL-4 
neutralizing antibody or PBS 2-4 h before adoptive transfer. CD8+ T cells were 
analyzed 44 h later with a viability stain, along with antibodies to CD8, Vα2, Vβ5, 
CD45.1, CD45.2, CD44, CD62L, and intracellular Eomes or an isotype control. 
(A) Dot-plots show Eomes vs. CD44 staining on gated live CD8+, Vα2+, and 
Vβ5+ cells distinguished by CD45.1 (WT) vs. CD45.2 (Irf4fl/fl) staining. Numbers 
indicate the percentages of CD44hi Eomes+ cells. Iso Ctr, antibody control for 
Eomes staining; 0 h, cells analyzed directly ex-vivo before adoptive transfer. (B) 
Compilations of data show percentages of CD44hi Eomes+ cells (Left) and raw 
MFI of Eomes staining (Right) on live CD8+, Vα2+, and Vβ5+ cells distinguished 
by CD45.1 (WT) vs. CD45.2 (Irf4fl/fl) staining from three independent experiments 
with two to three host mice per group per experiment. Statistical significance was 
determined by a t test (*P = 0.01; **P = 0.001; ***P < 0.0001). ns, not significant. 
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intrinsic defect caused by the absence of IRF4 plus an environmental factor 
present in the Irf4fl/fl mice. 
F. IRF4 Is Required to Suppress Eomes Expression Following 
CD8+ T Cell Activation 
To address the cell-intrinsic role of IRF4 in CD8+ T cells directly, we 
performed in vitro stimulation assays using naive Irf4fl/fl vs. WT CD8SP 
thymocytes. Cells were stimulated with high vs. low concentrations of CD3/CD28 
antibodies, in the presence or absence of IL-4. We first determined that IL-4 had 
no impact on IRF4 expression in stimulated WT cells (Fig. 3.9A). As shown in 
Fig. 3.9B, strong stimulation of Irf4fl/fl CD8+ thymocytes led to significantly higher 
expression of Eomes compared with that seen following activation of WT CD8+ 
thymocytes (Fig. 3.9B, high TCR). This increase included a greater percentage of 
cells expressing Eomes, as well as a higher expression of Eomes per T cell (Fig. 
3.9C). Under these conditions, addition of exogenous IL-4 had no impact on 
Eomes expression in either WT or Irf4fl/fl CD8+ thymocytes. When cells were 
stimulated with low concentrations of CD3/CD28 antibodies (Fig. 3.9B, low TCR), 
there was a trend toward more Irf4fl/fl CD8+ thymocytes up-regulating Eomes than 
WT cells, although this difference was not statistically significant; however, these 
conditions did lead to a significantly higher per cell expression of Eomes in the 
Irf4fl/fl CD8+ thymocytes. Interestingly, in cells stimulated with low CD3/CD28 
conditions, addition of exogenous IL-4 had no effect on WT cells but resulted in a  
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Figure 3.9 Naive Irf4fl/fl CD8SP thymocytes up-regulate high levels of Eomes 
following TCR stimulation: WT and Irf4fl/fl CD8SP thymocytes were isolated 
and stimulated with 1 µg/mL CD3 plus 4 µg/mL CD28 (“high TCR”) or 0.1 µg/mL 
CD3 plus 0.4 µg/mL CD28 (“low TCR”) antibodies in the presence or absence of 
IL-4 (10ng/mL) for 38 h. Cells were stained with antibodies to CD4, CD8, CD24, 
CD44, and intracellular Eomes or an isotype control. (A) Histograms show IRF4 
expression on gated CD8+ CD24lo CD44hi cells; numbers on the right indicate the 
median florescence intensity of IRF4 for each population. Data are representative 
of four independent experiments. (B) Histograms show Eomes expression 
relative to the isotype control (Iso Ab; gray-filled histograms) on gated CD8+ 
CD24lo CD44hi cells; numbers indicate the percentages of Eomes+ cells. (C) 
Compilations of data indicate percentages of Eomes+ cells (Upper) and relative 
(Rel.) MFIs of Eomes staining (Lower) for n = 4 experiments. Statistical 
significance was determined by the Mann-Whitney test (*P < 0.03). 
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Figure 3.9 Naive Irf4fl/fl CD8SP thymocytes up-regulate high levels of Eomes 
following TCR stimulation 
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dramatic increase in the per cell expression of Eomes in the Irf4fl/fl CD8+ 
thymocytes (Fig. 3.9C). These data indicate that in WT CD8+ thymocytes, IRF4 
normally suppresses Eomes up-regulation on TCR/CD28 stimulation. 
 
Previous studies have indicated that IL-4 is sufficient to up-regulate 
Eomes in CD8+ T cells undergoing positive selection in the thymus (Min et al., 
2011; Weinreich et al., 2010). To address whether IL-4 alone, in the absence of 
any TCR stimulation, is sufficient to induce Eomes expression in mature 
(CD24loTCRβhi) CD8SP thymocytes, we cultured WT and Irf4fl/fl cells with IL-4 in 
the presence vs. the absence of low concentrations of αCD3/αCD28. IL-7 was 
added to all cultures to promote thymocyte survival. As shown in Fig. 3.10A, in 
the absence of overt TCR/CD28 stimulation, IL-4 + IL-7 alone led to a very 
minimal increase in Eomes expression in both WT and Irf4fl/fl mature CD8SP 
thymocytes compared with cells analyzed directly ex-vivo. When combined with 
the low strength of TCR/CD28 signaling, IL-4 + IL-7 promoted a high level of 
Eomes expression in Irf4fl/fl mature CD8SP thymocytes, with only an incremental 
effect on the WT cells. These latter conditions also induced Tbet up-regulation in 
both populations of thymocytes, with only a modest difference between WT and 
Irf4fl/fl cells (Fig. 3.10B). These data indicate that a combination of weak or 
impaired TCR signaling plus IL-4 is required for robust Eomes up-regulation in 
CD8SP thymocytes. 
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Figure 3.10 IRF4-deficient CD4-CD8+ (CD8SP) thymocytes do not up-
regulate Eomesodermin (Eomes) in response to IL-4 alone: WT and Irf4fl/fl 
CD8SP thymocytes were isolated and stimulated with IL-4 (10ng/mL) and IL-7 
(10ng/mL) in the absence (“No TCR”) or presence of low TCR stimulation 
conditions for 38 h. (A) Histograms show Eomes expression on gated CD8+ 
CD24lo TCRβhi cells relative to their direct ex-vivo levels (0 h); numbers on the 
right indicate the median florescence intensity of Eomes for each population. 
Data are representative of three independent experiments. (B) WT and Irf4fl/fl 
CD8SP thymocytes were isolated and stimulated with low TCR conditions in the 
presence vs. absence of IL-4 for 38 h. Histograms show Eomes (Left) and Tbet 
(Right) expression in gated CD8+ CD24lo TCRβhi cells relative to their direct ex-
vivo levels (0 h); numbers on the right indicate the median florescence intensity 
of staining for the indicated transcription factor. Data are representative of three 
independent experiments. 
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G. ITK Inhibition Synergizes with IL-4 to Promote Eomes Up-Regulation 
The data presented thus far suggest that ITK activation downstream of the 
TCR is required for maximal IRF4 up-regulation, and thus for suppression of 
Eomes expression following CD8+ T-cell activation. To test this prediction, we 
stimulated naive OT- I WT CD8+ T cells with high or low concentrations of CD3/ 
CD28 antibodies in the presence of a small-molecule inhibitor of ITK, 10n 
(Riether et al., 2009). As shown in Fig. 3.11A, ITK inhibition reduced the levels of 
IRF4 expressed in each activated T cell, as indicated by the dose-dependent 
decrease in the MFI of IRF4 staining. The ability of 10n to inhibit IRF4 up-
regulation was seen in both high TCR and low TCR stimulation conditions.  
 
Analysis of Eomes expression in these cells revealed that high TCR 
stimulation led to a modest up-regulation of Eomes, which was not enhanced by 
ITK inhibition. However, when exogenous IL-4 was added to these cultures, we 
observed substantial Eomes up-regulation in the presence of high concentrations 
of 10n. This effect was further enhanced following low TCR stimulation, where IL-
4 in combination with 10n led to robust Eomes expression (Fig. 3.11B). 
 
The ability of IL-4 to enhance Eomes up-regulation was not due to an 
unanticipated role for IL-4 in suppressing IRF4 expression, because OT-I WT 
cells stimulated with “high” or “low” TCR stimulation each expressed slightly 
higher amounts of IRF4 in the presence vs. the absence of IL-4 (Fig. 3.12A). We  
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Figure 3.11 Inhibition of ITK synergizes with IL-4 to up-regulate high levels 
of Eomes following TCR stimulation: Naive peripheral CD8+ T cells were 
isolated from OT-I WT mice and were stimulated with 1 µg/mL CD3 plus 4 µg/mL 
CD28 (“high TCR”) or 0.1 µg/mL CD3 plus 0.4 µg/mL CD28 (“low TCR”) 
antibodies in the presence or absence of IL-4 (10ng/mL) for 31 h. Cultures were 
supplemented with the small-molecule ITK inhibitor, 10n, at the indicated 
concentrations or with DMSO alone at the highest concentration used. Cells were 
stained with a viability dye, and antibodies to CD8, CD69, CD44, intracellular 
IRF4, Eomes, or isotype controls. (A) Histograms show IRF4 expression relative 
to the isotype control (Iso Ab). The concentrations of 10n (Left) and the MFI of 
IRF4 staining (Right) are indicated in each histogram. All data are from cells 
stimulated in high TCR (Left) or Low TCR (Right) in the absence of exogenous 
IL-4. (B) Dot-plots show Eomes vs. CD44 staining in cells stimulated with high 
TCR (Upper two rows) or low TCR (Lower two rows) and supplemented with IL-4 
or 10n as indicated. Numbers at the upper left of each dot-plot indicate the MFI of 
Eomes staining. Numbers at the lower right of each dot-plot indicate the 
percentage of Eomes+ cells. Data are representative of four experiments. (C) 
Compilations of data indicate percentages of Eomes+ cells for each condition. 
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Figure 3.12 IL-4 signaling is not affected by the absence of IRF4 or by 10n 
treatment: (A) Naive OT-I WT peripheral CD8+ T cells were isolated and 
stimulated with 1 µg/mL CD3 plus 4 µg/mL CD28 (“high TCR”) or 0.1 µg/mL CD3 
plus 0.4 µg/mL CD28 (“low TCR”) antibodies in the presence or absence of IL-4 
(10ng/mL) for 31 h. Cells were stained with a viability dye, and antibodies to 
CD8, CD69, CD44, and intracellular IRF4 or with an isotype control. Histograms 
show IRF4 expression relative to the isotype control; numbers on the right 
indicate the median florescence intensity of IRF4 staining for each sample. Data 
are representative of four independent experiments. (B) Peripheral naive OT-I 
WT and OT I Irf4fl/fl CD8+ T cells were rested for 30 min and then cultured in the 
presence or absence of IL-4 at 10ng/mL for 30 min at 37°C. (Left) Histograms 
show phospho-STAT6 (pSTAT6) staining in stimulated cells vs. unstimulated 
controls; numbers on the right indicate the median florescence intensities of 
pSTAT6 staining. (Right) Histograms show CD124 staining on unstimulated 
controls; numbers on the right indicate the median fluorescence intensities 
(MFIs) of CD124 staining. Data are representative of three independent 
experiments. (C) Peripheral naive OT-I WT CD8+ T cells were pre-incubated in 
10n (0nM or 300nM) or DMSO alone for 30 min and then cultured in the 
presence or absence of IL-4 at 10ng/mL for 30 min at 37°C; IL-4 was diluted into 
medium containing 10n or DMSO, as for pre-incubation conditions. (Left) 
Histograms show pSTAT6 staining in stimulated cells vs. unstimulated controls; 
numbers on the right indicate the median florescence intensities of pSTAT6 
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staining. (Right) Histograms show CD124 staining on unstimulated controls; 
numbers on the right indicate the MFIs of CD124 staining. Data are 
representative of three independent experiments. 
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also ruled out effects of 10n, or the lack of IRF4, on IL-4 signaling, based on 
analysis of STAT6 phosphorylation in response to IL-4 stimulation (Fig. 3.12B 
and C). Altogether, these findings demonstrate that impaired CD3/CD28 
signaling, either via inhibition of ITK or by eliminating IRF4, synergizes with IL-4  
to promote high expression of Eomes in naive CD8+ T cells. Furthermore, these 
data show a striking similarity to the altered development of innate-like CD8+ T 
cells observed in the thymus of Itk-/- mice. 
 
Discussion 
This study has identified the transcriptional regulator IRF4 as a key 
downstream mediator that converts differences in TCR signal strength into 
distinct programs of gene expression. We show that robust up-regulation of IRF4 
expression in T cells requires the Tec family tyrosine kinase, ITK, and that, in 
turn, IRF4 suppresses the up-regulation of Eomes following TCR stimulation. 
These data suggest a model to account for the enhanced development of innate 
CD8+ T cells seen in Itk-/- mice. During T-cell development in the thymus, IRF4 is 
transiently up-regulated during the maturation of DP thymocytes into CD4SP and 
CD8SP thymocytes, and in the absence of ITK, the up-regulation of IRF4 in 
CD8SP cells is impaired. Together with the excess IL-4 present in the Itk-/- 
environment, a consequence of alterations in other T-cell lineages, this low TCR 
signaling that drives CD8SP maturation leads to high expression of Eomes, and 
thus to conversion of conventional naive cells into innate CD8+ T cells. In turn, 
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high levels of Eomes promote expression of CD122, IFNγ, CXCR3, and other 
genes associated with a CD8+ memory T-cell phenotype (Intlekofer et al., 2008; 
Takemoto et al., 2006; Weinreich et al., 2010). The precise mechanism by which 
IRF4 suppresses Eomes expression is not yet known. IRF4 can function either 
as a transcriptional repressor or as an activator, depending on the cellular 
context and its binding partners (Lohoff and Mak, 2005). One simple scenario is 
that IRF4, together with a co-repressor, binds to the Eomes locus and represses 
transcription of the gene. To date, our efforts to detect IRF4 binding to consensus 
binding sites in the region surrounding the Eomes promoter by ChIP assays have 
been unsuccessful. It may be that IRF4 binds to a distal region of the Eomes 
locus not yet investigated in our assays; alternatively, the regulation of Eomes 
expression by IRF4 may be indirect, mediated by other factors that are the direct 
targets of IRF4. In addition to ITK, several other proteins have been identified as 
playing a role in conventional vs. innate T-cell development in the thymus. These 
include SLP76, Id3, CBP, and Klf2 (Fukuyama et al., 2009; Jordan et al., 2008; 
Verykokakis et al., 2010; Weinreich et al., 2009; 2010). Mice carrying genetic 
alterations in each of these genes share the general properties of enhanced 
innate CD8+ T-cell development accompanied by excess IL-4 production. In the 
case of SLP-76 Y145F knock-in mice, the connection to the pathway described 
herein is clear, because Y145 of SLP-76 is required for ITK recruitment to the 
linker for activation of T cells (LAT)/SLP-76 adapter complex following TCR 
stimulation (Bunnell et al., 2000; Su et al., 1999); thus, our data predict that T 
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cells from SLP-76 Y145F knock-in mice would also be impaired in IRF4 up-
regulation following TCR stimulation. In the case of KLF2, CBP, and Id3, 
potential links to a pathway involving IRF4 are less apparent. CBP, the 
coactivator “Creb-binding protein,” may be required for IRF4 transcriptional 
activation downstream of the TCR and ITK, as it is for other ITK-regulated genes, 
such as Egr2, Egr3, and IL-2 (Fukuyama et al., 2009). Id3, an antagonist of E-
protein transcriptional activators, and the transcription factor Klf2 are highly 
expressed in naive T cells, and are normally down-regulated following CD8+ T-
cell activation and differentiation (Ji et al., 2011; Weinreich et al., 2009; Yang et 
al., 2011); for these two factors, genetic deficiencies in T cells may lead to 
spontaneous up-regulation of CD8+ effector genes, even in the absence of robust 
TCR stimulation. However, it also remains possible that the Klf2 and Id3 
deficiencies promote innate CD8+ T-cell development by a completely CD8+ non-
intrinsic mechanism, acting solely on the CD4+ NKT-like population that 
overproduces IL-4 in these mice.  
 
Peripheral CD8+ T cells in Irf4fl/fl mice spontaneously convert to a memory 
T-cell phenotype, expressing high levels of CD44, CD62L, CXCR3, CD122, and 
Eomes. We show that there are two components to this process. First, Irf4fl/fl 
mice lack functional Foxp3+ regulatory T cells, as has been described for mice 
bearing a specific deletion of Irf4 only in FoxP3+ T cells (Zheng et al., 2009). As a 
result, the majority of peripheral T cells in Irf4fl/fl mice become activated. The 
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outcome of this activation is then determined by whether the conventional T cells 
are IRF4-deficient or -sufficient. In the Irf4fl/fl X FoxP3-Cre mice, where 
conventional T cells can express IRF4, T-cell activation proceeds down a 
pathway resembling effector cell differentiation. A greater proportion of the CD8+ 
T cells in these mice express CD69 and down-regulate CD62L compared with 
those in the Irf4fl/fl mice, which lack IRF4. In contrast, a higher percentage of 
Irf4fl/fl CD8+ T cells express Eomes than in the Irf4fl/fl X FoxP3-Cre mice. These 
data indicate that the memory/innate cell phenotype of Irf4fl/fl CD8+ T cells is due 
to a combination of both cell-extrinsic and cell-intrinsic factors. These in-vivo 
data, together with our findings from in-vitro stimulations of Irf4fl/fl CD8SP 
thymocytes, indicate that IRF4 up-regulation following CD8+ T-cell activation 
functions to suppress Eomes expression. One interesting possibility is that this 
pathway functions early in the response to infection to promote robust effector 
cell generation; following this early response, as antigen is cleared and TCR 
signaling subsides, IRF4 expression would wane, allowing the up-regulation of 
Eomes and the generation of memory T cells. It is also possible that within a 
heterogeneous population of T cells responding to an infection, those with lower 
TCR affinity or with exposure to limiting amounts of antigen would be induced 
directly into a memory lineage based on weak IRF4 up-regulation failing to 
suppress Eomes expression. Evidence from mixed bone marrow chimeras 
indicates that an excess of klf2-/-, Itk-/-, or id3-/- T cells overproducing IL-4 can 
promote the conversion of WT CD8+ T cells into the innate lineage (Verykokakis 
 121 
et al., 2010; Weinreich et al., 2009; 2010). These data indicate that reduced or 
impaired TCR signaling within the developing CD8SP thymocyte is not 
necessarily required for Eomes up-regulation and the expression of 
effector/memory T-cell genes. However, the efficiency of this conversion is 
reduced compared with that seen with intact Itk-/- or klf2-/- mice, as was 
particularly apparent when OT-1 TCR transgenic CD8+ T cells were tracked as 
the WT population (Weinreich et al., 2010). These data suggest that signaling 
differences intrinsic to the CD8+ cells contribute to this phenotype. It is likely that 
among a heterogeneous population of developing CD8SP thymocytes, there are 
differences in the strength of TCR signaling, which, in turn, may lead to varying 
levels of IRF4 up-regulation. As we demonstrate, CD8SP thymocytes that are 
unable to express IRF4 have a dramatically increased tendency to up-regulate 
Eomes, particularly in the presence of high levels of IL-4. Further, impaired TCR 
signaling via pharmacological inhibition of ITK in naive CD8+ T cells leads to 
robust Eomes expression, in conjunction with IL-4. Together, these data 
demonstrate the synergism of low TCR signal strength and IL-4 in promoting the 
innate/ memory pathway of differentiation. In response to infection, innate CD8+ 
T cells appear to provide rapid effector functions that limit the spread of the 
pathogen. This has been most clearly demonstrated in a Listeria monocytogenes 
system, in which innate CD8+ T cells produce high levels of IFNγ as bystander T 
cells, and thereby reduce bacterial titers at the peak of the infection (Dhanji et al., 
2006). Bystander CD8+ T cells have also been shown to up-regulate Eomes and 
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to acquire effector functions during virus infections in a response that was 
dependent on weak TCR interactions and cytokines, in this case, type I IFNs; this 
latter response was particularly striking because it occurred in >70% of the 
bystander T cells (Marshall et al., 2010). These studies demonstrate that the 
appropriate combination of low TCR signaling plus selected cytokines, such as 
IL-4 or type I IFNs, can promote the rapid acquisition of CD8+ T-cell effector 
functions via the up-regulation of Eomes in a sizeable population of naive T cells. 
Thus, this innate CD8+ T-cell response may provide a protective advantage 
similar to that of true innate cells, such as natural killer cells. 
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CHAPTER IV: GRADED LEVELS OF IRF4 REGULATE CD8+ T CELL 
DIFFERENTIATION IN RESPONSE TO VIRUS INFECTIONS 
Abstract:  
In response to acute virus infections, CD8+ T cells differentiate to form a 
large population of short-lived effectors and a stable pool of long-lived memory 
cells. The characteristics of the CD8+ T cell response are influenced by TCR 
affinity, antigen dose, and the inflammatory cytokine milieu dictated by the 
infection.  To address the mechanism by which differences in TCR signal 
strength could regulate CD8+ T cell differentiation, we investigated the 
transcription factor, IRF4.  We show that IRF4 is transiently upregulated to 
differing levels in murine CD8+ T cells, based on the strength of TCR signaling. In 
turn, IRF4 controls the magnitude of the CD8+ T cell response to acute virus 
infection in a dose-dependent manner. Modest differences in IRF4 expression 
dramatically influence the numbers of short-lived effector cells at the peak of the 
infection, but have no impact on the kinetics of the infection or on the rate of T 
cell contraction. Further, the expression of key transcription factors such as TCF1 
and Eomes are highly sensitive to graded levels of IRF4. In contrast, T-bet 
expression is less dependent on IRF4 levels, and is influenced by the nature of 
the infection. These data indicate that IRF4 is a key component that translates 
the strength of TCR signaling into a graded response of virus-specific CD8+ T 
cells. 
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Introduction 
In response to acute infections, CD8+ T cells undergo priming, 
differentiation and expansion to generate robust effector responses that are 
required for antigen clearance (Kaech and Wherry, 2007; Williams and Bevan, 
2007). At the termination of the response, majority of these effector CD8+ T cells 
die by apoptosis, while a small population of efficient memory T cells survives. 
These memory CD8+ T cells are primed for rapid proliferation and effector 
functions upon re-infection. 
 
The magnitude and quality of the CD8+ T cell response to an infection is 
influenced by many factors, including the affinity of TCR-peptide/MHC 
interactions, the antigen load, co-stimulatory molecule expression, and the 
inflammatory cytokine environment. Differences in TCR affinity do not affect the 
initial activation of antigen specific CD8+ T cells, but at later time points, T cells 
with the highest affinity for the antigen dominate the response (Zehn et al., 2009). 
Similarly, antigen load does not influence the numbers of CD8+ T at the early 
expansion phase, but does regulates the size of the overall response at the peak 
of infection (Badovinac et al., 2002; Mercado et al., 2000; Prlic et al., 2006).  To 
date, the molecular mechanisms linking TCR affinity and antigen density to the 
magnitude of the CD8+ T response have not been characterized.  
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CD8+ T cell responses to acute infections are also regulated by variations 
in transcription factor expression. High expression of T-bet and Blimp1 drive the 
differentiation of primed CD8+ T cells into terminal effectors, while T cell factor 1 
(TCF1) and Eomesodermin (Eomes) are important for the generation and 
maintenance of memory cells (Banerjee et al., 2010; Jeannet et al., 2010; Joshi 
et al., 2007; Kallies et al., 2009; Rutishauser et al., 2009; Zhou et al., 2010). 
Though the cytokine milieu influences the transcription factor profile of activated 
CD8+ T cells (Cui et al., 2011; Joshi et al., 2007), how these different molecular 
programs are initially established is not known.  
 
The transcription factor IRF4 is upregulated by BCR and TCR signaling 
(Eisenbeis et al., 1995; Matsuyama et al., 1995).  In B cells, different levels of 
IRF4 regulate differentiation to antibody secreting plasma cells versus germinal 
center cells (Sciammas et al., 2006). In T cells, IRF4 is required for the 
differentiation of helper CD4+ T cell subsets, functional Treg cells, and effector 
and innate like CD8+ T cell (Brüstle et al., 2007; Chung et al., 2009; Cretney et 
al., 2011; Huber et al., 2013; Lohoff et al., 2002; Mittrücker et al., 1997; Nayar et 
al., 2012; Rengarajan et al., 2002; Staudt et al., 2010; Zheng et al., 2009). 
Further, IRF4 was initially found to be required for normal T cell responses to 
acute LCMV infection (Mittrücker et al., 1997). However, the role of IRF4 in CD8+ 
T cell differentiation to acute infections has not been characterized in detail, and 
importantly, the regulation of this process by distinct levels of IRF4 has not been 
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investigated. In this study, we show that variations in antigen dose or in the 
affinity of TCR-peptide/MHC interactions lead to different levels of IRF4 
expression in CD8+ T cells. In turn, these differences regulate the magnitude of 
the CD8+ T cell response to acute virus infection at the peak of the infection 
without having any substantial effect on CD8+ T cell attrition. Eomes and TCF1 
expression are highly sensitive to distinct levels of IRF4, whereas the effects of 
IRF4 on T-bet expression are dependent on the nature of the infection. These 
data indicate that IRF4 is a key factor that links signals from the TCR to the 
transcriptional programming of CD8+ T cells.  
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Results 
A. The strength of TCR signaling regulates the levels and 
duration of transcription factor expression   
The expression of IRF4 is upregulated in naïve T cells by TCR signaling 
(Eisenbeis et al., 1995; Matsuyama et al., 1995). This response is dependent on 
the activation of the Tec kinase ITK (Nayar et al., 2012). To determine if the 
levels of IRF4 were affected by the strength of TCR signaling to stimulation by 
natural ligands, P14 TCR transgenic TCRα-/- (hereafter referred to as P14 WT) 
CD8+ T cells (Pircher et al., 1989) were stimulated in-vitro, and IRF4 levels were 
examined by intracellular staining.  The P14 TCR recognizes the GP33-41 epitope 
(GP33) of LCMV bound to H2-Db.  A single amino acid substitution from 
phenylalanine to leucine at position six generates a lower affinity peptide ligand, 
F6L (Gronski et al., 2004). F6L–H2-Db complexes display approximately 5-fold 
reduction in the equilibrium dissociation constant (KD) for binding to the P14 
TCR, and 100-1,000-fold reduction in functional avidity. 
 
P14 T cells were stimulated with the high affinity GP33 peptide and the 
lower affinity F6L variant.  At 24h, both populations of cells expressed similar 
amounts of IRF4.  However, high IRF4 expression was sustained at 48h and 72h 
post-stimulation in cells stimulated with GP33, whereas cells stimulated with F6L 
showed declining IRF4 as early as 48h post-activation (Fig. 4.1A). Histograms  
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Figure 4.1 Variations in TCR affinity and antigen dose upregulate IRF4, 
Eomes and TCF1 to different levels: P14 WT and P14 Irf4fl/fl cells were 
stimulated in-vitro.  At 0, 24, 48 and 72hr, cells were stained and analyzed for 
IRF4, Eomes, and TCF1 expression.  Histograms show gated live CD8+ CD45.2+ 
CD44hi T cells. Gray histograms show staining on direct ex-vivo CD8+ CD45.2+ 
P14 WT cells. P14 Irf4fl/fl cells stimulated with 1µM GP33 peptide are included as 
negative staining controls for IRF4 expression. Data are representative of 4 
independent experiments. Graphs are compilations of raw median fluorescence 
intensity (MFI) of gated live CD8+ CD45.2+ CD44hi T cells. 
 
(A, C, E)  P14 WT T cells were stimulated with 1µM GP33 or F6L peptide.            
* denotes significant differences in MFI of WT cells stimulated with GP33 versus 
F6L ligands. 
 
(B, D, F)  P14 WT cells were stimulated with the indicated doses of GP33 
peptide. (B) 1µM and 100nM stimulation conditions were significantly different for 
IRF4 expression at 72hr, 10nM stimulation was significantly different from 1µM 
and 100nM at all timepoints. (D) 10nM stimulation was significantly different from 
1µM and 100nM at 24h. (F) 10nM stimulation was significantly different from 1µM 
and 100nM at 72h. 
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showing IRF4 staining on IRF4-deficient P14 T cells (P14 Irf4fl/fl) stimulated with 
the GP33 peptide are included as negative controls.  Alterations in peptide dose 
also impacted IRF4 expression.  As shown, higher doses of GP33 peptide (1µM 
and 100nM) induced strong IRF4 expression at 24h and 48h post-stimulation 
relative to the 10nM stimulation condition (Fig. 4.1B). By 72h, differences in IRF4 
levels were observed between each of the peptide doses, with the highest 
peptide dose leading to the most sustained IRF4 expression (Fig. 4.1B). These 
data indicate that expression of IRF4 is transient, and is regulated by the strength 
of TCR stimulation.  
 
In CD8+ T cells, IRF4 negatively regulates the expression of the 
transcription factor, Eomesodermin (Eomes), that is required for the maintenance 
of memory cells post-infection (Banerjee et al., 2010; Nayar et al., 2012). As 
shown in Fig 4.1C, stimulation with the lower affinity F6L peptide resulted in 
higher Eomes expression, correlating with their reduced IRF4 expression.  
Similar results were seen with diminishing doses of GP33 (Fig. 4.1D).  Eomes 
expression in CD8+ T cells is positively regulated by the transcription factor, 
TCF1 (Zhou et al., 2010).  As shown in Fig. 1E, stimulation with GP33 or F6L 
peptide resulted in similar TCF1 expression 24h post-activation; however, at later 
timepoints, TCF1 remained highest in cells stimulated with the lower affinity F6L 
ligand. A similar pattern was seen with the lowest dose of GP33 (Fig. 4.1F).  
Together, these data demonstrate that varying TCR signal strength, either by 
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changes in TCR-MHC/peptide affinity or dose, leads to distinct expression 
patterns of three key transcription factors in CD8+ T cells. 
 
To determine whether IRF4 regulated the expression of Eomes and/or 
TCF1, we utilized P14 T cells with one or two alleles of Irf4 deleted (P14 TCR 
transgenic TCRα-/- x Irf4+/fl x CD4-Cre and P14 TCR transgenic TCRα-/- x Irf4fl/fl x 
CD4-Cre, referred to as P14 Irf4+/fl and P14 Irf4fl/fl, respectively).  For these 
studies, P14 WT, P14 Irf4+/fl and P14 Irf4fl/fl T cells were stimulated in-vitro with 
GP33.  As expected, WT cells expressed the highest levels of IRF4 while Irf4+/fl 
cells expressed intermediate levels of IRF4 relative to Irf4fl/fl and WT cells 24 and 
48h timepoints (Fig 4.2A); furthermore, this pattern of expression showed a 
striking similarity to that seen following stimulation of WT P14 T cells with the 
lower affinity F6L ligand or with lower doses of GP33 peptide (Compare Fig 4.2A 
with Figs 4.1A and 4.1B).  Eomes expression inversely correlated with IRF4 
levels; P14 Irf4fl/fl cells expressed the highest levels of Eomes, with P14 Irf4+/fl T 
cells expressing intermediate levels of Eomes compared to WT cells (Fig. 4.2B). 
TCF1 expression was elevated in P14 Irf4fl/fl and P14 Irf4+/fl cells at the 72h 
timepoint relative to the WT samples with P14 Irf4+/fl cells expressing the highest 
levels of TCF1 (Fig. 4.2C).  These data indicate that a complete or heterozygous 
deficiency in Irf4 leads to lower expression of IRF4, and in turn, this alteration 
changes the expression patterns of Eomes and TCF1 in stimulated CD8+ T cells. 
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Figure 4.2 Irf4 regulates Eomes and TCF1 expression in a dose-dependent 
manner: (A-C) P14 WT, P14 Irf4+/fl and P14 Irf4fl/fl cells were stimulated with 1µM 
GP33 peptide for the indicated time-points, and cells were stained and analyzed 
for IRF4, Eomes, and TCF1 expression.  Histograms show gated live CD8+ 
CD45.2+ CD44hi T cells. Gray histograms show staining on direct ex-vivo CD8+ 
CD45.2+ P14 WT cells. Data are representative of 4 independent experiments. 
Graphs are compilations of raw median fluorescence intensity (MFI) of gated live 
CD8+ CD45.2+ CD44hi T cells. (A) IRF4 expression was significantly different 
between all genotypes at 24 and 48hr and between P14 WT and P14 Irf4+/fl cells, 
and P14 WT and P14 Irf4fl/fl cells at 72hr. (B) P14 WT and P14 Irf4fl/fl cells were 
significantly different at all timepoints, while P14 Irf4+/fl and P14 Irf4fl/fl cells were 
significantly different at 48 and 72hr. (C) TCF1 expression was significantly 
different between P14 WT and P14 Irf4+/fl cells at 72hr. 
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B. A heterozygous deficiency in Irf4 reduces virus-specific CD8+ 
T cell clonal expansion 
To elucidate the role of graded IRF4 expression during polyclonal CD8+ T 
cell differentiation in-vivo, WT, Irf4+/fl x CD4-Cre and Irf4fl/fl x CD4-Cre (henceforth 
referred to as Irf4+/fl and Irf4fl/fl) mice were infected with LCMV-Armstrong. 
Responses to three LCMV epitopes i.e. H2-Db/GP33-41, H2- Db /NP396-404, H2- Db 
/GP276-396 (hereafter referred to as GP33, NP396 and GP276) were examined 
using MHC-peptide tetramers. At the peak of the response, i.e. day 8 (D8) post-
infection (p.i.), the magnitude of the CD8+ T cell response depended on the gene 
dosage of Irf4. WT CD8+ T cells mounted the most robust response, followed by 
Irf4+/fl, and then Irf4fl/fl cells (Fig. 4.3A, 4.4A and 4.4B).  Enumeration of viral titers 
by plaque assay indicated that all WT (5/5) and Irf4+/fl  (3/3) mice had cleared the 
virus, while only 30% of Irf4fl/fl (3/10) mice had cleared LCMV by D8 p.i.  These 
data indicated that modest reductions in IRF4 expression did not interfere with 
viral clearance, but that a minimal level of IRF4 was required for sterilizing 
immunity to LCMV (Fig. 3B). As our in-vitro studies showed reduced IRF4 
expression levels following activation of WT versus P14 Irf4+/fl T cells, these initial 
infection experiments indicated that even modest differences in the magnitude of 
IRF4 expression had a profound effect on the clonal expansion of virus-specific 
CD8+ T cells. 
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Figure 4.3 Reduced gene dosage of Irf4 limits CD8+ T cell clonal expansion 
at the peak of the response without affecting attrition: Splenocytes from 
LCMV-infected WT, Irf4+/fl and Irf4fl/fl mice were analyzed at D8, 10, 14 and 28 
post-infection. (A) Dot plots show CD44 vs H2Db-GP33 tetramer staining on 
gated live CD8+ T cells. Graphs on right show a compilation of percentages and 
numbers from D8 p.i.  (B) LCMV titers in spleen at D8 post infection. Dotted line 
indicates limit of detection. (C) Dot plots show CD44 vs H2Db-GP33 tetramer 
staining on gated live CD8+ T cells at indicated timepoints p.i..  Graphs show the 
compilation of total numbers of CD44hi GP33-specific T cells (left), proportions of 
CD44hi GP33-specific T cells at each timepoint normalized to the numbers at D8 
(right). The graph below shows the differences in the numbers of CD44hi GP33-
specific T cells between D8 and D28 p.i (i.e., average #D8 - average #D28) for 
each genotype; the number on the graph indicates the fold difference in the 
average numbers of WT cells lost between D8 and D28 relative to the loss of 
Irf4+/fl cells.   Data are from 2 or more independent experiments with at least 6 
mice per group per timepoint. (D) Splenocytes from LCMV-infected WT and Irf4+/fl 
mice at D14 and D28 p.i. were stimulated for 5hr with GP61 peptide and 
analyzed for IFNγ expression. Graphs show a compilation of data indicating the 
numbers of IFNγ-producing cells at D14 (left) and D28 (right) p.i. (E) Graphs 
show the average numbers at D14 and D28 p.i. to indicate the rate of attrition 
(left); bar graph indicates the loss of GP61 specific cells at D14 versus D28 p.i 
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(right); the number on the bar graph indicates the fold difference in the average 
numbers of WT cells lost between D8 and D28 relative to the loss of Irf4+/fl cells. 
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Figure 4.4 Reduced gene dosage of Irf4 limits NP396 and GP276 epitope-
specific CD8+ T cell clonal expansion at the peak of the response without 
affecting attrition: Splenocytes from LCMV-infected WT, Irf4+/fl and Irf4fl/fl mice 
were analyzed at D8, 10, 14 and 28 post-infection. Dot plots show CD44 vs 
H2Db-NP396 (A) or CD44 vs H2Db-GP276 (B) tetramer staining on gated live 
CD8+ T cells on D8 p.i.. Graphs on right show a compilation of percentages and 
numbers from D8 p.i. Dot plots show CD44 vs H2Db-NP396 (C) or CD44 vs 
H2Db-GP276 (D) tetramer staining on gated live CD8+ T cells from the indicated 
timepoints p.i. Graphs show compilations of the total numbers of virus-specific T 
cells (left), the numbers of virus-specific T cells at later timepoints normalized to 
the numbers present at D8 p.i (right). The graph below shows the differences in 
the numbers of CD44hi virus-specific T cells between D8 and D28 p.i (i.e., 
average #D8 - average #D28) for each genotype; the number on the graph 
indicates the fold difference in the average numbers of WT cells lost between D8 
and D28 relative to the loss of Irf4+/fl cells. Data are from 2 or more independent 
experiments with at least 6 mice per group per timepoint. 
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C. Reduced levels of IRF4 do not affect the kinetics of CD8+ T 
expansion or attrition 
The reduced numbers of virus specific Irf4+/fl cells at D8 p.i. could be 
attributed to delayed kinetics of Irf4+/fl CD8+ T cell expansion relative to the WT 
cells. Based on previous data indicating a regulatory T cell defect in Irf4fl/fl mice 
that disrupts normal T cell homeostasis (Nayar et al., 2012; Zheng et al., 2009), 
studies of Irf4fl/fl mice were not included in the subsequent analyses.  Instead, we 
focused on a comparison of WT versus Irf4+/fl T cell responses, to understand the 
effect of partial loss of IRF4 expression on CD8+ T cell differentiation. 
Examination of WT and Irf4+/fl CD8+ T cell populations at later time points 
following LCMV-Armstrong infection indicated that the peak response for both 
WT and Irf4+/fl CD8+ T cells was at D8 p.i; by D10 p.i., both populations had 
started to contract (Fig. 4.3C and 4.4C and 4.4D).  Following antigen clearance, 
the majority of CD8+ T cells undergo attrition by apoptosis, and form a small but 
stable pool of memory cells (Kaech and Wherry, 2007; Williams and Bevan, 
2007). Examination of virus-specific CD8+ T cells at D14 and D28 p.i. confirmed 
that this pattern was observed for both WT and Irf4+/fl CD8+ T cells. However, by 
D28 p.i., the differences in the numbers of WT and the Irf4+/fl cells were quite 
modest, and no longer significant for 1 of the 3 epitopes examined (Fig. 4.3C and 
4.4C and 4.4D). Normalization of virus-specific CD8+ T cell numbers to the peak 
of the response indicated that loss of one allele of Irf4 did not change the kinetics 
of the CD8+ T response, nor did it affect the rate of CD8+ T cell contraction.  
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Thus, in comparison to the numbers of virus-specific T cells present at the peak 
of the response, greater numbers of WT CD8+ T cells were lost between D8 and 
D28 p.i. relative to Irf4+/fl CD8+ T cells (Fig. 4.3C and 4.4C and 4.4D).  Therefore, 
not only did WT cells undergo more robust expansion than the Irf4+/fl CD8+ T 
cells, the WT cells also underwent more extensive contraction. 
 
We also examined the CD4+ T cell response to LCMV-Armstrong in 
infected WT and Irf4+/fl mice.  Similar to our findings for CD8+ T cells, analysis of 
GP61 epitope-specific CD4+ T cells at D14 and D28 p.i. indicated a defect in 
Irf4+/fl CD4+ T cell expansion relative to the WT cells (Fig. 4.3D).  Further, 
consistent with our analysis of the CD8+ T cell response, we found that greater 
numbers of WT GP61-epitope specific CD4+ T cells were lost between D14 and 
D28 p.i. relative to  Irf4+/fl CD4+ T cells (Fig. 4.3E). 
 
To generalize these findings to a distinct infection model, we performed a 
second series of studies examining CD8+ T cell responses to the PR8-OVAI 
strain of Influenza A.  At D8 p.i., both WT and Irf4+/fl mice mounted robust 
OVA257-26(Nayar et al., 2012)4-specific poly-clonal CD8+ T cell responses. As with 
LCMV, Irf4+/fl CD8+ T cells showed a diminished response relative to WT cells.  
This reduction was observed in the draining mediastinal lymph node (DLN) as 
well as in the lungs of infected mice (Fig 4.5A, 4.5B).  By D28 p.i., OVA257-264-
specific CD8+ T cell populations had undergone attrition in the DLN and lungs of   
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Figure 4.5 Irf4 haplo-deficiency results in a reduced CD8+ T cell response to 
Influenza A infection: T cells from Influenza A (PR8-OVAI)-infected WT and 
Irf4+/fl mice were analyzed at D8 and 28 p.i.  Dot plots show CD44 vs H2Kb-OVA 
tetramer staining on gated live CD8+ T cells in mediastinal draining lymph nodes 
(DLN) (A) and lungs (B). Graphs below indicate the absolute numbers of OVA-
specific cells at D8 and 28 p.i. (left) and the loss in numbers of CD44hi OVA-
specific T cells between D8 and D28 p.i (i.e., average #D8 – average #D28; right) 
for each genotype; the number on the graph indicates the fold difference in the 
average numbers of WT cells lost between D8 and D28 relative to the loss of 
Irf4+/fl cells. Data are a compilation of two independent experiments with at least 
5 mice per group per time point. 
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both groups of mice; further, at this timepoint, no significant differences in the 
numbers of cells were observed when comparing WT and Irf4+/fl mice.  
Consistent with this, we found that greater numbers of OVA-specific CD8+ T cell 
were lost between D8 and D28 p.i. in both DLN and lungs of WT relative to Irf4+/fl 
mice following infection with PR8-OVAI. 
 
Together, these data suggest that the effects of reduced IRF4 expression 
are a general feature of CD8+ T cell responses to viral infections, and further, are 
impacting CD4+ T cell responses as well.  We conclude that different amounts of 
IRF4 expression during T cell priming regulate the magnitude of the peak 
antiviral T cell response without affecting the kinetics of the response, or the rate 
of attrition following antigen clearance. 
 
D. Reduced gene dosage of Irf4 regulates effector cytokine 
expression  
To assess CD8+ T cell effector functions following virus infection, 
splenocytes from LCMV-Armstrong infected WT, Irf4+/fl and Irf4fl/fl mice were 
examined at D8 and D28 p.i. for IFNγ, TNFα and IL-2 expression.  As expected, 
the gene dosage of Irf4 strongly correlated with the numbers of IFNγ-producing 
CD8+ T cells (Fig. 4.6 A-C).  No differences in the frequencies of TNFa producing 
CD8+ T cells as a proportion of IFNγ+ CD8+ T cells were observed at D8 p.i. when   
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Figure 4.6 Lower expression of IRF4 impairs production of effector 
cytokines at D28 post-infection: Splenocytes from LCMV-GP33-infected WT, 
Irf4+/fl and Irf4fl/fl mice from D8 and D28 p.i. were stimulated for 5hr with GP33 (A), 
NP396 (B) and GP276 (C) peptide and analyzed for IFNγ, TNFα, IL-2, granzyme 
B, and CD107a+CD107b. Dot-plots show IFNγ versus TNFα staining on gated 
live CD8+ CD44hi T cells, and for D28 p.i., IFNγ + cells were analyzed for TNFα 
versus IL-2 staining.  Graphs show a compilation of numbers of IFNγ + cells from 
D8 and D28 p.i., and % TNFα + IL-2- and % TNFα + IL-2+ on gated IFNγ + cells at 
D28 p.i.  At right, histograms show Granzyme B, CD107a+CD107b, and TNFα 
staining on gated IFNγ + cells; gray histograms show staining on naïve CD8+ T 
cells from uninfected WT mice; the graph shows a compilation of mean 
fluorescence intensities (MFI) of TNFα staining at D28 p.i. normalized to WT 
samples in each experiment. Data are representative of 3 independent 
experiments with at least 5 mice per group per timepoint. 
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comparing WT and Irf4+/fl mice; however, Irf4fl/fl mice showed a substantial 
reduction in the relative proportion of this double cytokine-producing subset.  
Furthermore, at D28 p.i, the median fluorescence intensity (MFI) of 
TNFα staining, and the frequencies of TNFα/IFNγ double-producers and 
IFNγ/TNFα/IL-2 triple-producers were significantly decreased in Irf4+/fl mice 
compared to WT controls.  Analyses of granzyme B expression and 
degranulation as assessed by CD107a and CD107b staining revealed no 
differences between any of the genotypes at either timepoint.  Overall, these data 
indicate that reduced expression of IRF4 leads to an impaired ability of virus-
specific CD8+ T cells to produce cytokines other than IFNγ as the cells transition 
into a long-term memory population.  
 
E. Levels of IRF4 expression selectively impact the short-lived 
CD8+ effector cell population 
In response to acute infections, CD8+ T cells undergo clonal expansion 
and differentiation to short-lived effector cells (SLEC, KLRG1hiCD127lo) and 
memory-precursor effector cells (MPEC, KLRG1loCD127hi).  Examination of 
these populations revealed that reduced IRF4 expression had a more substantial 
impact on the numbers of virus-specific SLEC compared to MPEC for each 
population (Fig. 4.7A, 4.8A and 4.9A).  Specifically, at D8 p.i., Irf4+/fl mice had a 
2.5-4.4 fold reduction in numbers of SLEC versus a 1.4-2.0 fold reduction in 
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Figure 4.7 Differences in IRF4 expression regulate the nature of GP33 
epitope-specific CD8+ T cell differentiation: Splenocytes from LCMV-GP33-
infected WT, Irf4+/fl and Irf4fl/fl mice were analyzed at D8, 10, 14 and 28 p.i. (A) 
Dot plots show KLRG1 versus CD127 staining on CD44hi H2Db-GP33 tetramer-
positive live CD8+ T cells.  Graphs show compilations of the percentages and 
numbers of KLRG1hiCD127lo (SLEC) and KLRG1lo CD127hi (MPEC) populations.  
Numbers on timecourse graphs indicate the relative difference in SLEC or MPEC 
numbers between WT and Irf4+/fl mice at D8 p.i. (B) Dot plots show CD44 versus 
CD62L staining on CD44hi H2Db-GP33 tetramer-positive live CD8+ T cells at D28 
p.i.  Graphs show compilations of the percentages and numbers of CD44hi 
CD62Llo (Tem) and CD44hi CD62Lhi (Tcm) populations.  (C) Histograms show 
TCF1, Eomes, and T-bet staining on CD44hi H2Db-GP33 tetramer-positive live 
CD8+ T cells. Graphs show compilations of MFI of transcription factor staining at 
D8 p.i., normalized to WT samples in each experiment. Data are representative 
of 2 or more independent experiments with n≥6 mice per time point. 
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Figure 4.8 Differences in IRF4 expression regulate the nature of NP396 
epitope-specific CD8+ T cell differentiation: Splenocytes from LCMV-GP33-
infected WT, Irf4+/fl and Irf4fl/fl mice were analyzed at D8, 10, 14 and 28 p.i. for 
NP396 epitope-specific responses. Data are organized as outlined in the legend 
for Figure 4.7. 
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Figure 4.9 Differences in IRF4 expression regulate the nature of GP276 
epitope-specific CD8+ T cell differentiation: Splenocytes from LCMV-GP33-
infected WT, Irf4+/fl and Irf4fl/fl mice were analyzed at D8, 14 and 28 p.i. for 
GP276 epitope-specific responses. Data are organized as outlined in the legend 
for Figure 4.7. 
  

 156 
MPEC numbers over the three epitopes examined.  Furthermore, in spite of the 
increase in MPEC percentages among virus-specific CD8+ T cells in Irf4+/fl mice 
at early times after infection (D8, 10, and 14 p.i.), the absolute numbers of 
MPECs in these mice were decreased.  Since the numbers of SLEC are much 
greater than the numbers of MPEC, these data indicate that diminished SLEC 
populations are largely responsible for the decrease in the total magnitude of the 
CD8+ T cell effector response in Irf4+/fl mice.  Interestingly, by D28 p.i., WT and 
Irf4+/fl mice had comparable numbers of virus-specific CD8+ T cells, and no 
significant differences in the numbers of MPEC were observed for two of the 
three viral epitopes examined.  Consistent with these data, examination of virus-
specific effector (TEM) and central (TCM) memory populations at D28 p.i. showed 
only a modest reduction in the numbers of TEM in Irf4+/fl compared to WT mice, 
and no differences in the numbers of TCM cells between the two genotypes (Fig. 
4.7B, 4.8B and 4.9B).  These data indicate that reduced IRF4 expression is 
regulating the expansion phase of the T cell response, but not impacting the 
generation of long-lived virus-specific CD8+ T cells. 
 
F. Differential role for IRF4 in regulating TCF1, Eomes and T-bet 
expression 
Virus-specific CD8+ T cell differentiation is regulated by the expression of 
transcription factors such as TCF1, Eomes, and T-bet at D8 p.i (Banerjee et al., 
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2010; Intlekofer et al., 2005; Jeannet et al., 2010; Joshi et al., 2007; Zhou et al., 
2010).  Consistent with our in-vitro stimulation data, LCMV-specific Irf4fl/fl cells 
expressed the highest levels of TCF1 and Eomes, Irf4+/fl cells had intermediate 
levels, and WT cells had the lowest levels of both factors. In contrast, the 
expression of T-bet was reduced in Irf4fl/fl cells compared to WT, but no 
differences were observed in T-bet levels when comparing WT and Irf4+/fl cells 
(Fig. 4.7C, 4.8C and 4.9C).  These data indicated that TCF1 and Eomes 
expression were more sensitive to modest changes in IRF4 levels than was T-bet 
expression, indicating an IRF4 dose-dependent variation in the regulation of 
these key transcription factors. At later timepoints post-infection, differences in 
Eomes and TCF1 levels in virus-specific Irf4+/fl versus WT cells were less uniform 
across the three epitope-specific populations, although in general, Irf4+/fl cells 
tended to express higher levels of these factors than WT cells at D10 and 14 p.i; 
however, by D28 p.i., no further differences were observed between Irf4+/fl and 
WT cells. Consistent with the transient nature of IRF4 expression and the data 
presented above, these results confirm that variations in IRF4 expression levels 
have the greatest impact at the peak of the virus-specific CD8+ T cell response, 
and are not generally altering the long-lived population of virus-specific CD8+ T 
cells found at D28 p.i.  
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G. Cell-intrinsic role for IRF4 in regulating the magnitude of the 
CD8+ effector T cell response 
To assess whether the altered virus-specific CD8+ T cell response seen in 
Irf4+/fl versus WT mice was due to differences intrinsic to the CD8+ T cells, we 
performed adoptive transfer experiments.  This approach also allowed us to 
examine whether activation of P14 T cells in-vivo with an LCMV variant 
expressing the lower affinity F6L ligand would phenocopy the results of reducing 
IRF4 expression by a heterozygous deficiency in the Irf4 gene.  We first 
established that activation of P14 WT cells with LCMV expressing the GP33 
epitope results in higher IRF4 expression relative to P14 WT cells activated in 
response to LCMV-F6L infection. One million congenically-marked WT P14 
(CD45.1+ CD45.2+) cells were transferred into naïve WT (CD45.2+) hosts.  One 
day later, mice were infected with 1x105 PFU LCMV-Armstrong expressing either 
the WT GP33 epitope (LCMV-GP33) or the mutant F6L epitope (LCMV-F6L).  
Previous studies showed that the single amino acid substitution in the LCMV-F6L 
virus has no impact on viral replication or viral clearance when compared to 
LCMV-GP33 (Gronski et al., 2004). As expected, at D3 p.i., P14 cells activated 
with LCMV-GP33 expressed higher levels of IRF4 relative to P14 cells activated 
in response to the F6L epitope (Fig 4.10A). These data were consistent with the 
results seen upon in-vitro stimulation of WT P14 cells with the GP33 and F6L 
ligands (Fig 4.1A). 
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Figure 4.10 Cell intrinsic requirement for IRF4 in regulating the magnitude 
of CD8+ T cell responses: (A) 1x106 P14 WT (CD45.1+ CD45.2+) cells were 
transferred into CD45.2+ hosts one day prior to infection with 1x105 PFU LCMV-
GP33 or LCMV-F6L virus.  Histograms show IRF4 staining on gated live CD8+ 
CD44hi P14 cells; the gray histogram represents IRF4 staining on naïve CD8+ 
CD44lo cells.  The graphs below show compilations of MFI for IRF4 staining 
normalized to the LCMV-GP33 infection in each experiment. (B-D) 2,000 or 
20,000 P14 cells comprising a 1:1 mix of P14 WT (CD45.1+CD45.2+) and P14 
Irf4+/fl (CD45.2+) were transferred into CD45.1+ congenic hosts one day prior to 
infection with LCMV-GP33 or LCMV-F6L, and splenocytes were analyzed on D8 
p.i.  Dot-plots show CD45.1 versus CD45.2 staining on input cell mixture (B), or 
on gated live CD8+ CD44hi from mice infected with LCMV-WT (C) or LCMV-F6L 
(D). Graph shows a compilation of percentages of P14 WT and P14 Irf4+/fl 
populations from mice receiving 2,000 P14 cells. Data are representative of ≥3 
independent experiments.  
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  To assess the cell intrinsic role of reduced TCR stimulation, either alone or 
in combination with reduced IRF4 expression, in regulating the CD8+ T cell 
response, congenically-marked WT P14 (CD45.1+ CD45.2+) and Irf4+/fl P14 
(CD45.2+) cells were mixed 1:1 and transferred into naïve WT (CD45.1+) hosts 
(Fig 4.10B).  When analyzed at D8 p.i., we observed a substantially greater 
proportion of WT P14 cells relative to the Irf4+/fl P14 population, indicating 
differential expansion of the two populations (Fig 4.10C and 4.10D). This trend 
was observed when a total of 2,000 or 20,000 P14 cells were transferred as a 1:1 
mixture of the two genotypes.  Strikingly, infection with the LCMV-F6L virus 
reduced the overall expansion of both WT and Irf4+/fl P14 cells, but maintained 
the competitive advantage of the WT over the Irf4+/fl cells (Fig 4.10D).  These 
findings indicate that the decreased expansion of P14 cells in response to LCMV-
F6L relative to LCMV-GP33 is highly correlated with decreased IRF4 expression.  
Thus, these data suggest that variable upregulation of IRF4 in CD8+ T cells is 
responsible for the effect of TCR signal strength on the magnitude of the peak 
effector response, as reported previously (Zehn et al., 2009).   
 
More detailed analyses of the P14 populations were performed with mice 
receiving 20,000 transferred P14 cells prior to infection, as this provided a 
greater number of cells for analysis. Examination of SLEC versus MPEC subsets 
among the P14 populations indicated that the graded magnitude of the response 
seen among the four experimental groups could be largely attributed to       
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Figure 4.11 Irf4 haplo-deficiency selectively impairs terminal effector CD8+ 
T cell numbers and alters transcription factor, CD27 and Bcl2 expression: 
20,000 P14 cells comprising a 1:1 mix of P14 WT (CD45.1+CD45.2+) and P14 
Irf4+/fl (CD45.2+) were transferred into CD45.1+ congenic hosts one day prior to 
infection with LCMV-GP33 or LCMV-F6L, and splenocytes were analyzed on D8 
p.i. (A) Dot plots show KLRG1 versus CD127 staining on gated live CD8+ CD44hi 
P14 populations. Graphs show compilations of percentages and numbers of 
SLEC and MPEC populations for each genotype. (B) The histogram shows TCF1 
expression on gated live CD8+ CD44hi P14 cells. Open histograms, LCMV-WT 
responding cells; shaded histograms, LCMV-F6L responding cells. Colors are as 
indicated in graphs. The graph below shows the compilation of TCF1 MFI 
normalized to WT cells responding to LCMV-WT virus in each experiment. Dot 
plots show CD8 versus TCF1 staining on gated live CD8+ CD44hi P14 cells. The 
graphs at the right show compilations of percentages and absolute numbers of 
CD8+ TCF1+ population for each genotype. (C) Histograms show Eomes, T-bet, 
and CD27 staining on CD8+ CD44hi P14 cells of each genotype, and the graphs 
below show compilations of MFI for each stain normalized to WT cells 
responding to LCMV-WT virus in each experiment. (D) Left histogram shows 
Bcl2 staining on gated live CD8+ CD44hi P14 populations from LCMV-WT 
responding cells (open histograms) and LCMV-F6L responding cells (shaded 
histograms). Colors are as indicated in the graph. The graph below shows the 
compilation of Bcl2 MFI normalized to WT cells responding to LCMV-WT virus in 
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each experiment. Right histogram shows Bcl2 staining on gated live CD8+ CD44hi 
P14 SLEC (open histograms) and MPEC (shaded histograms) populations from 
LCMV GP33 infected mice. Colors are as indicated in graphs. The graph below 
shows the compilation of Bcl2 MFI normalized to WT SLEC samples for each 
experiment. Data are representative of 2-3 independent experiments. 
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differences in the expansion of P14 SLEC (Fig. 4.11A).  This was affected by 
changes in IRF4 expression due to deletion of one Irf4 allele, or by infecting mice 
with an LCMV variant expressing only a lower affinity ligand for the P14 TCR, or 
both.  In contrast, the MPEC populations were largely unaffected by loss of one 
functional Irf4 allele. Regardless of the virus used, Irf4+/fl P14 cells expressed 
higher total levels TCF1 due to the increased proportions of TCF1+ cells among 
the Irf4+/fl P14 populations (Fig. 4.11B). However, similar to our observations 
regarding the MPEC population, the absolute numbers of TCF1+ cells were not 
affected by a heterozygous deficiency in Irf4 (Fig. 4.11B). This is in contrast to a 
recent report showing a ~2-fold decrease in tcf7 mRNA in in-vitro activated Irf4-
deficient OT-I CD8+ T cells (Man et al., 2013). This discrepancy could arise from 
differential priming of CD8+ T cells in-vivo in response to a virus infection versus 
that occurring when T cells are activated in-vitro; alternatively, the differences 
seen might arise from differences in the timepoints examined in our ex-vivo 
analysis versus that used for the in-vitro stimulation studies.  Nonetheless, 
consistent with previous data (Zhou et al., 2010), we found that higher TCF1 
expression in Irf4+/fl P14 cells correlated with enhanced Eomes expression in 
these cells (Fig. 4.11C). In contrast, we observed no differences in the 
expression of T-bet when comparing WT to Irf4+/fl P14 cells (Fig. 4.11C).  
 
The co-stimulatory molecule CD27 is important for survival of CD8+ 
effector and memory cells (Peperzak et al., 2010); interestingly, we found 
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increased expression of CD27 on Irf4+/fl P14 cells than WT P14 cells (Fig. 4.11C). 
This finding is consistent with our observation that, following the peak of the 
antiviral response, Irf4+/fl cells undergo less cell death than their WT counterparts.  
To address this possibility further, we examined Bcl2 expression.  As shown, the 
loss of one allele of Irf4 and/or infection with LCMV-F6L resulted in enhanced 
expression of the pro-survival molecule Bcl2 in P14 cells (Fig. 4.11D). This 
increase could be mainly attributed to higher Bcl2 expression in the Irf4+/fl versus 
the WT P14 MPEC population (Fig. 4.11D). Together, these data are consistent 
with the greater survival potential of Irf4+/fl P14 cells relative to WT, and provide 
an explanation for the reduced numerical attrition of virus-specific Irf4+/fl CD8+ T 
cells observed (Figures 4.3C, 4.4C, 4.4D and 4.5A and 4.5B). Finally, these data 
also indicate that the differences in the clonal expansion and differentiation of 
virus specific effector CD8+ T cells observed upon infection of intact WT and 
Irf4+/fl mice were due to a CD8+ T cell-intrinsic requirement for high levels of 
IRF4; further, these differences mainly arose from the variable expansion of the 
short-lived effector cells.   
  
We next confirmed the cell intrinsic role of IRF4 in CD8+ T cell expansion 
using the Influenza A infection system.  WT and Irf4+/fl OT-I CD8+ T cells were 
mixed 1:1 and transferred into WT hosts, which were then infected with the PR8-
OVAI strain of Influenza A that expresses the epitope recognized by OT-I cells.  
Analysis of OT-I populations at the peak of the response (D8 p.i.) indicated a 
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defect in the ability of Irf4+/fl OT -I cells to clonally expand relative to WT OT-I 
populations in the spleen, draining mediastinal lymph node (DLN) and lung (Fig 
4.12A).  These data are in agreement with the findings from analysis of 
polyclonal OVA-specific CD8+ T cell responses in intact WT and Irf4+/fl mice (Fig 
4.5 A and 4.5B), indicating the CD8+ T cell-intrinsic nature of this effect.  We also 
observed that the expression of TCF1 and Eomes were higher in Irf4+/fl OT-I cells 
compared to WT OT-I cells in the two lymphoid organs examined, whereas little 
difference was observed when comparing the two OT-I populations in the lung 
(Fig 4.12B). Interestingly, unlike our findings with acute LCMV infection, Influenza 
A infection revealed a reduction in T-bet levels in Irf4+/fl OT-I cells compared to 
WT OT-I cells in the spleen and DLN (Fig 4.12B).  The differences in T-bet 
expression seen following Influenza A, but not LCMV, infection might be due to a 
difference in the cytokine milieu between these two virus infections.  Whereas 
high levels of IL-12 are induced during acute Influenza infection, LCMV-
Armstrong infection induces little IL-12 (Monteiro et al., 1998; Orange and Biron, 
1996). As IL-12 is a potent inducer of T-bet expression (Takemoto et al., 2006), 
the presence of IL-12 might reveal a requirement for high levels of IRF4 to 
achieve the maximum expression of T-bet.  In addition, these data confirm the 
critical role of high IRF4 expression in regulating the magnitude of the effector 
CD8+ T cell response in lymphoid organs, but indicate a lesser impact on the 
CD8+ T cells present at the site of infection in a non-lymphoid peripheral tissue.  
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Figure 4.12 IRF4 regulates the numbers and differentiation of CD8+ T cells 
in response to Influenza A infection: 6,000 OT-I cells comprising a 1:1 mix of 
OT-I WT (CD45.1+) and OTI Irf4+/fl (CD45.2+) were transferred into CD90.1 
congenic WT hosts and infected with PR8-OVAI. Spleens, draining mediastinal 
lymph nodes (DLN) and lungs were harvested at D8 p.i.  (A) Dot-plots show 
CD45.1 versus CD45.2 staining on live CD8+ CD44hi CD90.2+ cells.  Graph 
shows the ratios of OT-I WT to OTI Irf4+/fl cells in each organ.  (B) Histograms 
show TCF1, Eomes, and T-bet staining of OT-I WT (red) and OTI Irf4+/fl (blue) 
cells relative to isotype controls (gray histograms).  Graphs show MFI of 
transcription factor staining normalized to WT samples in each experiment.  Data 
are representative of 2 independent experiments. 
  

 170 
H. Differential T cell expansion is driven by variations in the 
levels of IRF4 expressed in competing T cell populations 
The data described above establish a CD8+ T cell-intrinsic requirement for 
IRF4. During polyclonal T cell responses, antigen-specific T cells compete for 
antigen and inflammatory cytokines. To test whether variations in IRF4 
expression levels between competing T cell populations could result in variable T 
cell expansion, we transferred WT P14 T cells into either WT or Irf4+/fl host mice, 
and infected with LCMV-GP33 or LCMV-F6L virus.  Our findings thus far 
predicted that, in the case where WT P14 cells were responding in a host where 
all endogenous T cells are Irf4+/fl, the WT P14 cells should show an enhanced 
response relative to their response in a WT host environment.  In contrast, we 
reasoned that the WT P14 cells should show an impaired response following 
infection with LCMV-F6L in a WT host; however, we predicted that this response 
should improve if the WT P14 cells are transferred into Irf4+/fl hosts, thereby 
providing the WT P14 cells with an advantage based on two functional alleles of 
Irf4. 
 
As shown in Fig 4.13A, the data from these experiments supported our 
predictions.  A single population of WT P14 T cells was transferred into either WT 
or Irf4+/fl hosts, which were then infected with either LCMV-GP33 or LCMV-F6L.  
We found that WT P14 cells contributed more dominantly to the response to 
LCMV-GP33 when the endogenous T cell population was Irf4+/fl cells, in contrast   
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Figure 4.13 Ability to express higher levels of IRF4 provides a competitive 
advantage to antigen-specific CD8+ T cells: (A) 1,000 P14 WT 
(CD45.1+CD45.2+) T cells were transferred into WT or Irf4+/fl hosts (CD45.2+) one 
day prior to infection with LCMV-GP33 or LCMV-F6L, and splenocytes were 
analyzed at D8 p.i. Dot-plots show CD45.1 versus CD45.2 staining on gated live 
CD8+ CD44hi cells. Graphs show a compilation of percentages of P14 WT 
populations. Data are representative of 2 independent experiments with ≥4 mice 
per group. (B) Splenocytes from LCMV-GP33-infected WT mice were analyzed 
at D8, D14 and D28 post-infection (p.i.). Histograms show TCF1 staining of 
CD44hi H2Db-NP396, -GP33 and -GP276 tetramer-positive live CD8+ T cells; 
gray histograms represent isotype control staining. 
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to their contribution when responding in a WT host.  Alternatively, the WT P14 
cells contributed little to the response to LCMV-F6L when present in a WT host, 
but this response could be greatly improved by transferring these cells into an 
Irf4+/fl host, where the endogenous T cell response was handicapped in IRF4 
expression.  These data indicate that the contribution of an individual virus-
specific CD8+ T cell population to the overall response is not simply regulated by 
the levels of IRF4 expressed in those cells, but is also determined by the levels 
of IRF4 expressed in competing T cell populations present in the same individual.   
On the basis of these data, we speculated that the CD8+ T cells forming the most 
robust response to an acute infection would express the highest levels of IRF4, 
thus accounting for the predominance of these populations at the peak of the 
response. In acute LCMV infections, CD8+ T cell responses to GP33 and NP396 
epitopes are immuno-dominant while those to GP276 are sub-dominant (van der 
Most et al., 1998). Since the expression of IRF4 is transient in nature, we were 
unable to detect differences in IRF4 expression in these populations during the 
polyclonal response to LCMV-Armstrong. However, we did observe that the 
magnitude and kinetics of upregulation of TCF1, a target repressed by IRF4, 
were different between the epitope-specific populations. GP276-specific cells 
expressed the highest levels of TCF1, followed by GP33-specific cells, and then 
NP396-specific cells, suggesting lower IRF4 expression in GP276-specific cells 
and the highest expression in NP396-specific cells (Fig 4.13B).  Since TCF1 also 
regulates the differentiation of TEM to TCM (Zhou et al., 2010), these data provide 
 174 
further mechanistic support for the observation that GP276-specific CD8+ T cells 
are the earliest subset to form Tcm in response to LCMV-Armstrong, while 
NP396-specific T cell population are the slowest (Sarkar et al., 2007). These 
results show that variations in IRF4 expression can modulate the relative 
proportions of different virus-specific T cell populations recognizing the same 
epitope, and suggest that differences observed in the expansion of polyclonal T 
cell responses to different epitopes may be driven by differential up-regulation of 
IRF4.  
 
Discussion 
 The adaptive immune system protects us from pathogens by mounting a 
strong primary response, and then retaining protec- tive cells that form 
immunological memory. The recognition of pathogens by CD8+ T cells occurs via 
interactions of the TCR with peptide/MHC complexes. This process not only 
allows for acti- vation of pathogen-specific T cells, but also for the selection of 
high affinity CD8+ T cell clones from the pool of responding T cells (Zheng et al., 
2009). Although even brief Ag exposure is sufficient to in- duce a programmed 
proliferative burst of effector CD8+ T cell (Kaech and Ahmed, 2001; van Stipdonk 
et al., 2001), the ultimate magnitude of the response is nonetheless pro- portional 
to the overall Ag load (Badovinac et al., 2002; Mercado et al., 2000; Prlic et al., 
2006). These findings indicate that TCR signaling contributes to the programming 
of the CD8+ T cell response during the short period of initial Ag exposure. 
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The data presented in this study, along with two recent reports (Man et al., 
2013; Yao et al., 2013), demonstrate that the transcription factor, IRF4, is a 
central component in translating the strength of TCR signaling into the magnitude 
of the CD8+ T cell response to infection. Man et.al. examined the response of 
OT-I CD8+ T cell to infections with Influenza A virus expressing different affinity 
variants of the OVA peptide. This study showed that decreasing the TCR signal 
strength resulted in lower IRF4 expression in OT-I cells both in- vitro and in-vivo, 
and dramatic differences in the numbers of OT-I CD8+ T cells at the peak of the 
response, a phenotype similar to that observed for IRF4-deficient CD8+ T cells 
responding to infection. Yao et.al. also showed that IRF4 expression was 
dependent on the strength of TCR signaling in-vitro, and that loss of IRF4 
expression resulted in a diminished polyclonal CD8+ T cell response at the peak 
of the infection. Consistent with these two studies, we found that upregulation of 
IRF4 in P14 TCR trans- genic CD8+ T cells was also dependent on the affinity 
and the dose of the stimulating peptide. Further, reduced expression of IRF4 was 
also observed following in-vitro stimulation of Irf4 haplodeficient P14 T cells 
compared with WT. Similar to the findings of Man et al. (Man et al., 2013), we 
also found a dose-dependent decrease in CD8+ T cell expansion upon loss of 
one or both alleles of Irf4, a phenomenon that could be phenocopied using an 
LCMV variant expressing a lower affinity ligand for the P14 TCR. Taken together, 
these studies provide strong support for the conclusion that levels of IRF4 are 
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tightly regulated by the strength of TCR sig- naling and, in turn, regulate the 
magnitude of the CD8+ T cell response to infection. 
 
Most importantly, we show that modest variations in the levels of IRF4 
expression, such as those achieved by a heterozygous deficiency in Irf4, are 
sufficient to have a dramatic impact on the peak expansion of virus-specific CD8+ 
T cells. In our studies, reduced IRF4 expression decreased the maximum 
numbers of Ag-specific CD8+ T cells by 2- to 3-fold and, furthermore, had a 
greater impact on the numbers of short-lived effector cells compared with the 
memory precursor effector cells. These data provide a mechanistic explanation 
for previous studies demonstrating that shortening the duration of Ag exposure 
decreases the total CD8+ T cell response and in particular the size of the SLEC 
compartment, without affecting the numbers of MPEC (Badovinac et al., 2002; 
Joshi et al., 2007; Prlic et al., 2006). 
 
Our studies also showed that, following virus clearance and the bulk of the 
T cell attrition, there was virtually no impact on the numbers of Ag-specific T cells 
remaining, regardless of their ability to express high levels of IRF4. This latter 
finding is strikingly similar to the observations of Bevan and colleagues (Zehn et 
al., 2009) in their elegant study examining the response of OT-I T cells to strains 
of Listeria monocytogenes expressing different affinity variants of the OVA 
peptide. In this study, dramatic differences in the peak expansion of OT-I T cells 
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were seen following activation by Listeria strains expressing the different OVA 
variants; however, following bacterial clearance, few differences were found in 
the numbers of long-term surviving OT-I memory T cells. A likely explanation for 
these data are that the higher affinity OVA variants induced higher levels of IRF4 
than did the lower affinity variants, thus accounting for the relative response of 
the OT-I T cells to each bacterial strain. Furthermore, because the expression of 
IRF4 is transient in nature, the effects of different levels of IRF4 are limited to 
CD8+ T cell priming and the peak expansion phase but not thereafter. We also 
found increased expression prosurvival factors, CD27 and Bcl2, in P14 Irf4 
haplosufficient cells, consis- tent with a greater survival potential of these cells 
relative to WT. These data provide a potential mechanism to account for the 
findings of Bevan and colleagues, that ligands representing a broad range of 
TCR affinities generated relatively similar numbers of memory T cells, despite the 
dramatic differences in T cell expansion at the peak of the response (Zehn et al., 
2009). 
 
Inflammatory cytokines produced during an infection also in- crease TCR 
activation by sustaining phosphorylation of ZAP-70 and phospholipase Cγ 
(Richer et al., 2013). Because the activation of phospholipase Cγ, as well as the 
levels of IRF4 expression are Itk dependent (Berg et al., 2005; Nayar et al., 
2012), it is possible that factors such as cytokines also may help sustain IRF4 
expression, which may lead to an overall enhancement in the SLEC response. 
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For instance, IL-12 enhances the expression of T-bet (Takemoto et al., 2006), 
another transcription factor that positively regulates the size of the SLEC 
compartment (Joshi et al., 2007). Because the expression of T-bet was more 
dependent on IRF4 following infection with influenza A than LCMV, it is possible 
that IRF4 also functions to integrate signals from the TCR and cytokines to 
dictate the magnitude of the CD8+ T cell response. 
 
Another transcription factor, Blimp-1, also plays a central role in terminal 
effector cell differentiation. Blimp1-deficient CD8+ T cells have higher expression 
of TCF1 and Eomes transcripts and lower expression of T-bet mRNA (Kallies et 
al., 2009; Rutishauser et al., 2009). Three recent studies found a role for IRF4 in 
Blimp-1 expression in CD8+ T cells (Man et al., 2013; Raczkowski et al., 2013; 
Yao et al., 2013). In our study, we find a dose-dependent effect of IRF4 levels on 
the expression of TCF1 and Eomes in CD8+ T cells responding to infection. 
These observations not only confirm our previous data that IRF4 is a negative 
regulator of Eomes expression (Nayar et al., 2012) but also suggest that 
regulation of Eomes is more complex and possibly involves multiple transcription 
factors functioning in a temporal manner. Taken together, these data indicate 
that IRF4 is a central component of this transcriptional program and that 
themagnitude of IRF4 upregulation during CD8+ T cell priming is a critical 
determinant of the outcome of the response.  
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Our data also provide a potential explanation for observations regarding 
the variable expansion, as well as the varying kinetics, of CD8+ T cell responses 
to different viral epitopes. For instance, polyclonal CD8+ T cells responses to 
LMCV epitopes GP33 and NP396 form the dominant response, whereas those to 
GP276 are subdominant (van der Most et al., 1998), suggesting that IRF4 
expression is higher in the former populations. This possibility would fit with our 
data showing that the response of IRF4-sufficient P14 T cells in an Irf4+/fl host 
following LCMV infection gives the P14 cells a substantial competitive advantage 
over the endogenous response, compared with those same cells responding in a 
WT host. Because of the transient nature of IRF4 expression during T cell 
priming, we were unable to directly test this hypothesis on the polyclonal T cell 
response to LCMV. However, we did observe that the levels of TCF1, a 
downstream target of IRF4, were different between the different epitope-specific 
populations. TCF1 is also important for the conversion of TEM to TCM cells (Zhou 
et al., 2010). Because LCMV GP276–specific cells convert to TCM earlier than 
NP396-specific cells following acute infection (Sarkar et al., 2007), these data are 
consistent with a lower level of IRF4 expression in the GP276- specific subset. In 
further support of this hypothesis, Irf4+/fl CD8+ T cells also convert to TCM more 
rapidly than WT T cells. Thus, differences in the magnitude and/or duration of 
IRF4 expression may be one factor that could account for observed differences 
in the responses of CD8+ T cells to distinct viral epitopes. Overall, our findings, 
along with those of others, demonstrate that variations in the levels of IRF4 
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expressed during T cell priming finetune the size and quality of the pathogen-
specific adaptive immune response. 
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CHAPTER V: IRF4 REGULATES THE RATIO OF T-BET TO EOMESODERMIN 
IN CD8+ T CELLS RESPONDING TO PERSISTENT LCMV INFECTION 
 
Abstract 
 CD8+ T cell exhaustion commonly occurs in chronic infections and 
cancers.  During T cell exhaustion there is a progressive and hierarchical loss of 
effector cytokine production, up-regulation of inhibitory co-stimulatory molecules, 
and eventual deletion of antigen specific cells by apoptosis. A key factor that 
regulates T cell exhaustion is persistent TCR stimulation. Loss of this interaction 
results in restoration of CD8+ T cell effector functions in previously exhausted 
CD8+ T cells. TCR stimulation is also important for the differentiation of Eomeshi 
anti-viral CD8+ effector T cells from T-bethi precursors, both of which are required 
for optimal viral control. However, the molecular mechanisms regulating the 
differentiation of these two cell subsets and the relative ratios required for viral 
clearance have not been described. We show that TCR signal strength regulates 
the relative expression of T-bet and Eomes in antigen-specific CD8+ T cells by 
modulating levels of IRF4. Reduced IRF4 expression results in skewing of this 
ratio in the favor of Eomes, leading to lower proportions and numbers of T-bet+ 
Eomes- precursors and poor control of LCMV Clone 13 infection. Manipulation of 
this ratio in favor of T-bet restores the differentiation of T-bet+ Eomes- precursors 
and the protective balance of T-bet to Eomes required for efficient viral control. 
These data highlight a critical role for IRF4 in regulating protective anti-viral CD8+ 
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T cell responses by ensuring a balanced ratio of T-bet to Eomes, leading to the 
ultimate control of this chronic viral infection.  
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Introduction: 
Acute virus infections are characterized by the formation of robust CD8+ T 
cell effector responses followed by the generation of immunological memory. 
Both CD8+ effector T cells as well as CD8+ memory cells produce a variety of 
cytokines and cytotoxic molecules, and have high proliferative capacity (Kaech 
and Cui, 2012). In contrast, during chronic viral infections, high viral loads cause 
CD8+ T cell exhaustion that is characterized by hierarchal loss of effector 
functions and eventual deletion of antigen-specific cells (Fuller and Zajac, 2003; 
Mueller and Ahmed, 2009; Wherry et al., 2003; Zajac et al., 1998). During 
exhaustion, effector functions such as IL-2 production, proliferation, and 
cytotoxicity are compromised first, followed by a reduction in TNFα production. 
During later stages of exhaustion, cells lose the ability to make IFNγ and up-
regulate high levels of inhibitory receptors such as PD-1 and LAG-3.  Eventually 
the cells become completely dysfunctional and are deleted by apoptosis (Wherry 
et al., 2003). T cell exhaustion was initially thought to be a viral immune evasion 
mechanism, however, recent studies have indicated that it serves to protect the 
host from T cell-mediated immunopathology (Cornberg et al., 2013; Zajac et al., 
1998).  
 
Many factors regulate T cell exhaustion. The expression of the immuno-
suppressive cytokine IL-10 and inhibitory co-receptors like PD-1 enhance T cell 
exhaustion, whereas help from CD4+ T cells aids in the restoration of CD8+ T cell 
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function (Aubert et al., 2011; Barber et al., 2006; Brooks et al., 2006; Matloubian 
et al., 1994). Persistent T cell signaling due to high viral loads and increased 
MHC-I presentation is detrimental as well as beneficial during chronic infection. 
Increased antigen presentation results in reduced numbers and impaired function 
of anti-viral CD8+ T cells; however, loss of this interaction also leads to poor viral 
control (Mueller and Ahmed, 2009). Antigen is also required for the long-term 
maintenance of memory cells during chronic infections, as these cells do not 
undergo homeostatic proliferation in response to IL-7 and IL-15; instead, they 
proliferate in response to antigenic stimulation (Shin et al., 2007; Wherry et al., 
2004).  
 
In the presence of a persistent infection, exhausted CD8+ T cells were 
found as two distinct subsets, one subset expressing high levels of the 
transcription factor, T-bet, and the other subset expressing high levels of the 
related transcription factor, Eomesodermin (Eomes).  Further, Paley, et.al. 
showed that, in response to antigenic stimulation, T-bethi cells give rise to 
Eomeshi cells. T-bethi cells were found to be less exhausted and exhibited higher 
proliferative rates in response to antigen, while the Eomeshi cells were more 
exhausted, but exhibited greater cytotoxic activity than the T-bethi cells.  Both 
subsets were essential for viral control, as loss of either transcription factor 
resulted in viral persistence (Paley et al., 2012). These data indicated that 
optimal expression of T-bet and Eomes, and the presence of both CD8+ T cell 
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subsets, were essential for efficient viral control. However, the pathway that 
regulates the differentiation of antigen-specific T cells into these subsets, and 
whether a specific ratio of the two subsets is critical for viral control, is not known.  
 
IRF4 is a pleiotropic transcription factor that regulates a myriad of 
functions in a wide variety of cell populations (Huber and Lohoff, 2014). Recently, 
we and others have shown that levels of IRF4 in CD8+ T cells are regulated by 
the strength of TCR signaling. Thus, robust expression of IRF4 is important for 
maximal CD8+ T cell expansion in response to acute viral infections (Grusdat et 
al., 2014; Man et al., 2013; Nayar et al., 2014; Yao et al., 2013). When IRF4 
levels are reduced by a haplo-deficiency of the Irf4 gene, the magnitude of the 
CD8+ T cell response is dramatically impaired.  The decreased numbers of virus-
specific T cells are accounted for by a reduction in terminal effector cells (SLEC; 
KLRG1hiCD127lo) without a significant effect on the numbers of memory 
precursor effector cells (MPEC, KLRG1loCD127hi) (Nayar et al., 2014). These 
studies also highlighted a role for IRF4 in the expression of key transcription 
factors T-bet and Eomes, that are important for differentiation and maintenance 
of SLEC and MPEC populations, respectively, during acute infections (Banerjee 
et al., 2010; Joshi et al., 2007; Man et al., 2013; Nayar et al., 2014; Yao et al., 
2013).  
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Here we show that TCR signal strength maintains an optimal balance of T-
bet to Eomes and that this process is regulated by the levels of IRF4 expressed. 
Reduced expression of IRF4 skews this ratio in the favor of Eomes during 
infection with LCMV Clone 13, resulting in reduced differentiation of T-bet+ 
Eomes- precursors and impaired viral control. Reducing Eomes expression in Irf4 
heterozygous mice re-establishes the protective balance of T-bet to Eomes, 
restores differentiation of T-bet+ Eomes- precursors, and ultimately rescues 
defective viral clearance. These data indicate a critical role for IRF4 in regulating 
T cell exhaustion by balancing the relative expression of T-bet and Eomes during 
chronic infection. Overall, these findings demonstrate that reduced differentiation 
of the T-bet+ Eomes- CD8+ T cell population impairs viral clearance, whereas a 
partial reduction in Eomes expression can restore viral control during persistent 
LCMV clone 13 infections. 
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Results 
A. TCR signal strength via IRF4 regulates the ratio of T-bet and 
Eomesodermin in activated CD8+ T cells. 
To understand the role of TCR signal strength in the differentiation of 
CD8+ T cell subsets, we utilized P14 TCR transgenic TCRα-/- cells (hereafter 
referred to as P14 WT), that respond to the GP33-41 epitope (GP33) of 
lymphocytic choriomeningitis virus (LCMV) bound to H2-Db; additionally P14 WT 
cells respond to a lower affinity ‘F6L’ peptide variant of GP33-41, containing a 
single amino acid substitution from phenylalanine to leucine at the sixth position 
of the peptide.  This alteration leads to a 5-fold decrease in the affinity of the P14 
TCR for the F6L-Db complex relative to GP33-41-Db, and as a consequence, a 
100-1000-fold reduction in functional avidity (Gronski et al., 2004). P14 WT T 
cells were stimulated in vitro, and then examined for T-bet and Eomes 
expression by intracellular staining.  At all time points examined, P14 WT T cells 
stimulated with the high affinity GP33 epitope, expressed a higher T-bet to 
Eomes ratio relative to cells stimulated with the lower affinity F6L epitope (Fig 
5.1A).  A similar trend was also observed when P14 cells were stimulated with 
different doses of the GP33 peptide (Fig 5.1B). These data indicate that 
variations in TCR signal strength, such as those achieved by varying the affinity 
of the peptide-MHC for the TCR or by varying the dose of stimulating peptide, 
affect the relative expression levels of these key transcription factors. 
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Figure 5.1: IRF4 regulates the T-bet to Eomesodermin ratio in stimulated 
CD8+ T cells: P14 WT, P14 Irf4+/fl and P14 Irf4fl/fl cells were stimulated in-vitro. At 
24, 48, and 72 h, cells were stained and analyzed for T-bet and Eomes 
expression. P14 WT T cells were stimulated with 1µM GP33 or F6L peptide (A) 
or the indicated doses of GP33 peptide (B). The graphs show compilations of the 
ratios of MFIs for T-bet relative to Eomes, each normalized to the value for 
GP33-stimulated cells (A) or the value for 1µM GP33-stimulated cells (B) at each 
time-point. (C) P14 WT, P14 Irf4+/fl and P14 Irf4fl/fl were stimulated with 1µM 
GP33 peptide. The graph shows compilations of the ratios of MFIs for T-bet 
relative to Eomes, each normalized to the value for WT P14 cells at each time-
point. Data were generated from gated live CD8+CD45.2+CD44hi T cells analyzed 
in four independent experiments.  
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The transcription factor IRF4 is upregulated in CD8+ T cells in a graded 
manner in response to variations in TCR signal strength.  Furthermore, IRF4 is 
known to be a negative regulator of Eomes and a positive regulator of T-bet 
expression in CD8+ T cells (Man et al., 2013; Nayar et al., 2012; 2014; Yao et al., 
2013).  To determine if alterations in IRF4 expression affect the relative up-
regulation of T-bet and Eomes, we compared P14 WT T cells to P14 cells lacking 
one or two functional alleles of Irf4 (Irf4+/fl X CD4-Cre and Irf4fl/fl X CD4-Cre; 
referred to as P14 Irf4+/fl and P14 Irf4fl/fl, respectively). In response to stimulation 
with the GP33 peptide, P14 WT cells expressed the highest T-bet to Eomes ratio, 
while P14 Irf4+/fl cells showed a reduced T-bet to Eomes ratio, and P14 Irf4fl/fl cells 
exhibited the lowest T-bet to Eomes ratio (Fig 5.1C). This pattern was observed 
at all time points examined. These data indicate that the strength of TCR 
signaling via IRF4 regulates the relative expression of T-bet and Eomes in CD8+ 
T cells. 
 
B. Levels of IRF4 regulate CD8+ T cell differentiation into T-bet+ 
Eomes- and T-bet- Eomes+ subsets in response to LCMV Cl13 
infection 
The data described thus far indicated a critical role of IRF4 in maintaining 
the balance of T-bet and Eomes in-vitro. To determine whether the levels of IRF4 
regulate the relative expression of T-bet and Eomes in-vivo, WT, Irf4+/fl X CD4-
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Cre and Irf4fl/fl X CD4-Cre mice (henceforth referred to as Irf4+/fl and Irf4fl/fl, 
respectively) were infected with an exhausting dose of LCMV-Clone 13. Virus 
specific responses to H2-Db/GP33–41, and H2-Db/GP276–286 were examined using 
MHC-peptide tetramers. Consistent with our in-vitro data, we observed that at D8 
post-infection (p.i.), WT CD8+ T cells had the highest T-bet to Eomes ratio, 
followed by Irf4+/fl CD8+ T cells, and then Irf4fl/fl cells (Fig 5.2A). The variations in 
relative T-bet and Eomes expression between WT and Irf4+/fl cells was not due to 
differences in persistent TCR stimulation from antigen, as virus titers in the 
serum were similar between these two genotypes (Fig 5.2B). However, Irf4fl/fl 
mice, that showed the lowest T-bet to Eomes ratio, did have a significantly higher 
viral titer.  
 
Apart from the altered T-bet to Eomes ratio, we observed that Irf4 gene 
dosage also regulated the magnitude of CD8+ T cell expansion. WT mice 
mounted the most robust CD8+ T cell response, followed by Irf4+/fl mice, whereas 
Irf4fl/fl mice had the weakest response  (Fig 5.3C and D).  These data indicate 
that a modest reduction in the levels of IRF4 profoundly impacts CD8+ T cell 
expansion to a persistent infection, similar to that seen for the response to 
LCMV-Armstrong (Man et al., 2013; Nayar et al., 2014).  Further, the reduction in 
CD8+ T cell expansion in Irf4+/fl mice was not a consequence of differences in 
viral load (Fig 5.2B).  In contrast, a complete loss of IRF4 expression severely 
inhibited CD8+ T cell expansion and consequently, rendered the CD8+ T cell 
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Figure 5.2: Irf4 gene dosage regulates T-bet to Eomesodermin ratio, and 
CD8+ T cell clonal expansion in response to LCMV clone 13 infection: 
Splenocytes from LCMV Clone 13-infected WT, Irf4+/fl and Irf4fl/fl mice were 
stained with a viability dye, LCMV-specific H2-Db-GP276 and H2Db-GP33 
tetramers, and antibodies to CD8, T-bet and Eomes and analyzed at D8 p.i.  
 
(A) Graphs show the ratio of MFIs for T-bet relative to Eomes, each normalized 
to the average of WT samples for live CD8+ H2-Db-GP276 (left) and H2Db-GP33 
(right) specific cells. Each data point represents an individual mouse and data 
are a compilation of three independent experiments. 
 
(B) LCMV Clone 13 titers in serum at D12 post-infection. Dotted line indicates 
limit of detection. Each data point represents an individual mouse and data are a 
compilation of four independent experiments.  
 
(C-D) Dot plots show CD8 vs H2-Db-GP276 (C) or CD8 vs H2Db-GP33 (D) 
tetramer staining on live CD8+ T cells. Graphs below show compilations of 
proportions and numbers from D8 post-infection. Each data point represents an 
individual mouse and data are compilations of three independent experiments. 
 
 Significant differences determined by Ordinary one-way ANOVA using Turkey’s 
multiple comparison test.  
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response ineffective at controlling the virus infection (Fig 5.2B and Fig 5.3C and 
D).  
In response to LCMV Clone 13 infection, anti-viral CD8+ T cells 
differentiate into T-bet+ Eomes- precursors that give rise to T-bet- Eomes+ 
progeny in response to antigenic stimulation. Examination of these subsets at D8 
p.i. indicated an IRF4 dose-dependent defect in the differentiation of these 
populations. Irf4+/fl mice exhibited a significant decrease in the numbers and 
proportions of the T-bet+ Eomes- precursors with a concomitant increase in the 
differentiation to T-bet+ Eomes+ cells (Fig 5.3A and B). These double positive 
cells could potentially be an intermediate population that differentiates into T-bet- 
Eomes+ cells later during infection. As the viral titers are not different between 
WT and Irf4+/fl at D12 p.i. (Fig 5.2B), these data indicate an inherent defect in the 
differentiation of CD8+ T cells expressing lower levels of IRF4 (Fig 5.3A and B). 
The differentiation of the Irf4-deficient cells into T-bet+ Eomes- and T-bet+ 
Eomes+ populations was severely compromised, likely accounting for the 
increased viral titers in the Irf4fl/fl mice. These data indicate that IRF4 regulates 
the relative expression of T-bet and Eomes and the differentiation of T-bet+ 
Eomes- precursors into T-bet- Eomes+ progeny early during persistent LCMV 
infection. Further, high levels of IRF4 are required for early viral control. 
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Figure 5.3: IRF4 regulates the differentiation of T-bethi and Eomeshi 
subsets: (A-B) Splenocytes from LCMV Clone 13 infected WT, Irf4+/fl and Irf4fl/fl 
mice were stained with a viability dye, LCMV-specific H2-Db-GP276 and H2Db-
GP33 tetramers, and antibodies to CD8, T-bet and Eomes and analyzed at D8 
p.i. Representative dot plots show T-bet vs Eomes staining on gated CD8+ live 
H2-Db-GP276 (A) and H2Db-GP33 (B) specific cells at D8 p.i. Graphs below 
show compilations of proportions and numbers of T-bet+ Eomes- and T-bet+ 
Eomes+ cells. Each data point represents an individual mouse and data are a 
compilation of three independent experiments; significant differences determined 
by Ordinary one-way ANOVA using Turkey’s multiple comparison test. 
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C. WT levels of IRF4 are essential for optimal control of 
persistent virus infection 
In activated T cells, the expression of IRF4 is regulated by the strength of 
TCR signaling via the mTOR pathway; furthermore, mTOR signaling is 
suppressed during chronic infection by signaling through the inhibitory receptor 
PD-1 (Nayar et al., 2012; Staron et al., 2014; Yao et al., 2013). To test the 
importance of IRF4 expression levels at later timepoints during the persistent 
infection, we examined CD8+ T cell responses to LCMV clone 13 at D22 p.i..  At 
this time point, we observed reduced proportions of virus-specific T cells in the 
spleens of Irf4+/fl mice compared to WT mice.  For GP276-specific cells, a 
reduction in absolute cell numbers was also observed; however, this was not the 
case for the GP33-specific cells  (Fig 5.4A and B). As expected, Irf4fl/fl mice had 
significant reductions in both the proportions and numbers of both subsets of 
virus-specific CD8+ T cells.  Due to the defects in regulatory T cell populations in 
Irf4fl/fl mice and to the limited magnitude of the virus-specific T cell responses, 
further analysis was not carried out on these mice (Nayar et al., 2012; Zheng et 
al., 2009). Instead, we focused on understanding how modest reductions in IRF4 
were impacting the protective response to this persistent virus infection.    
 
Examination of T-bet and Eomes expression in virus-specific CD8+ T cells 
at D22 p.i. with LCMV clone 13 indicated that for both of the LCMV epitopes 
examined, virus-specific Irf4+/fl CD8+ T cells exhibited an altered T-bet to Eomes  
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Figure 5.4: Irf4 gene dosage regulates the proportions of virus-specific 
CD8+ T cells during persistent LCMV clone 13 infection: (A-B) Splenocytes 
from LCMV Clone 13 infected WT, Irf4+/fl and Irf4fl/fl mice were stained with a 
viability dye, LCMV-specific H2-Db-GP276 and H2Db-GP33 tetramers, and 
antibodies to CD8 and analyzed at D22 p.i. Dot plots show CD8 vs H2-Db-GP276 
(A) or CD8 vs H2Db-GP33 (B) tetramer staining on live CD8+ cells. Graphs below 
show compilations of proportions and numbers from D22 post-infection. Each 
data point represents an individual mouse and data are compilations of two 
independent experiments; significant differences determined by Ordinary one-
way ANOVA using Turkey’s multiple comparison test. 
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ratio relative to WT cells (Fig 5.5A and B). This skewed ratio again resulted in 
reduced differentiation of T-bet+ Eomes- populations in WT mice relative to Irf4+/fl 
mice (Fig 5.5C and D).  High viral titers have been implicated in the excessive 
proliferation and eventual depletion of the T-bethi CD8+ T cell population in 
patients with chronic HCV infection (Paley et al., 2012).  However, at day 26 p.i., 
we observed no difference in serum virus titers between Irf4+/fl and WT mice, 
indicating that the altered CD8+ T cell populations were not simply a reflection of 
differences in viral load (Fig 5.5E).  These data indicate that a modest reduction 
in IRF4 expression leads to impaired generation of T-bet+ Eomes- virus-specific 
CD8+ T cells at later timepoints of the persistent infection.  
 
While modest reductions in the levels of IRF4 were inconsequential for 
early control of virus replication through d26 p.i., long-term studies revealed that 
Irf4+/fl mice had a defect in controlling the persistent virus infection.  Relative to 
WT mice, a lower proportion of Irf4+/fl mice controlled LCMV clone 13 infection in 
the kidney, liver and serum when examined more than 100 days p.i. (Fig 5.6A-C). 
In addition, enumeration of viral titers in sera over time indicated that the kinetics 
of viral control were slower for Irf4+/fl mice than WT mice (Fig 5.6D). As expected, 
Irf4fl/fl mice exhibited the highest viral titers and a complete impairment in viral 
control (Fig 5.6 A-D).  
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Figure 5.5: Persistent reduction in virus-specific T-bet+ Eomes- CD8+ T cells 
in LCMV clone 13-infected Irf4+/fl mice: Splenocytes from LCMV Clone 13-
infected WT, Irf4+/fl and Irf4fl/fl mice were stained with a viability dye, LCMV-
specific H2-Db-GP276 and H2Db-GP33 tetramers, and antibodies to CD8, T-bet 
and Eomes and analyzed at D22 p.i.  
 
(A-B) Graphs shows the ratio of MFIs of T-bet relative to Eomes, each 
normalized to the average value for WT samples for live CD8+ H2-Db-GP276 (A) 
and H2Db-GP33 (B) specific cells. Each data point represents an individual 
mouse and data are a compilation of two independent experiments. 
 
(C-D) Dot plots show T-bet vs Eomes staining on live CD8+ H2-Db-GP276 (C) or 
H2Db-GP33 (D) tetramer positive cells. Graphs show a compilation of proportions 
and numbers of T-bet+ Eomes- cells for each population. Each data point 
represents an individual mouse and data are a compilation of two independent 
experiments. 
 
 (E) LCMV Clone 13 titers in serum at D26 post-infection. Dotted line indicates 
limit of detection. Each data point represents an individual mouse and data are a 
compilation of two independent experiments. 
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Significant differences determined by Ordinary one-way ANOVA using Turkey’s 
multiple comparison test. 
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Figure 5.6: High expression of IRF4 is essential for long-term control of 
LCMV Clone 13: Kidney (A), livers (B) and sera (C) were harvested from LCMV 
Clone 13 infected WT, Irf4+/fl and Irf4fl/fl mice between D112-114 post infection 
and virus titers were determined by plaque assay. Dotted line indicates the limit 
of detection. Each data point represents an individual mouse and data are a 
compilation of two independent experiments; significant differences determined 
by Ordinary one-way ANOVA using Turkey’s multiple comparison test. 
 
 (D) Serum was harvested from infected mice at various time point post infection. 
Graph indicates the proportion of mice with viral titers above the limit of detection 
over time. Data are a compilation of two independent experiments; significant 
differences as determined by Log-rank (Mantel-Cox) test.  
 
(E) Anti-LCMV IgG antibody titers in sera at D40 p.i. Each data point represents 
an individual mouse and data are a compilation of three independent 
experiments; significant differences determined by Ordinary one-way ANOVA 
using Turkey’s multiple comparison test. 
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IRF4 is also important for the differentiation of CD4+ Tfh cells that regulate 
plasma cell differentiation. As previous studies have shown that during LCMV 
infection reduced antibody responses lead to virus persistence (Bergthaler et al., 
2009; Thomsen et al., 1996), we considered whether the slower kinetics of virus 
control in Irf4+/fl mice could be accounted for by reduced anti-LCMV antibody 
titers.  Analysis of LCMV-specific IgG antibody titers at D40 p.i. indicated that 
Irf4fl/fl mice were impaired in antibody production, consistent with the requirement 
for IRF4 in Tfh differentiation (Fig 5.6 E). However, we observed no difference in 
antibody titers between WT and Irf4+/fl mice, supporting a CD8+ T cell-intrinsic 
defect in viral control in Irf4+/fl mice. Together these data indicate that high levels 
of IRF4 expression are essential for optimal long-term control of the persistent 
LCMV clone 13 virus infection.  
 
By day 112-114 p.i., Irf4+/fl mice showed no significant differences in their 
numbers of virus-specific CD8+ T cells compared to WT controls, despite the fact 
that fewer of the Irf4+/fl mice were controlling the LCMV clone 13 infection (Fig 5.6 
and 5.7A and B).  Nonetheless, we did observe higher proportions and numbers 
of T-bet+ Eomes- virus-specific CD8+ T cells in WT mice relative to Irf4+/fl mice 
(Fig 5.7C and D).  When the data from the WT mice was segregated according to 
viral titers, we found that WT mice that had not controlled LCMV clone 13 
infection at this time point (boxed data points), appeared as outliers and had 
proportions and numbers of T-bet+ Eomes- virus-specific CD8+ T cells  
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Figure 5.7: The proportions of T-bet+ Eomes- cells correlate with viral 
control at late timepoints of LCMV clone 13 infection: Splenocytes from 
LCMV Clone 13-infected WT, Irf4+/fl and Irf4fl/fl mice were stained with a viability 
dye, LCMV-specific H2-Db-GP276 and H2Db-GP33 tetramers, and antibodies to 
CD8, T-bet and Eomes, and analyzed between D112-114 p.i. Dot plots show 
CD8 vs H2-Db-GP276 (A) or CD8 vs H2Db-GP33 (B) tetramer staining on live 
CD8+ T cells. Graphs below show compilations of proportions and numbers from 
D112-114 post infection.  
 
(C-D) Graphs show compilations of the numbers and proportions of T-bet+ 
Eomes- cells for data in Figures 5A and 5B.  Boxes represent WT mice with viral 
titers above the limit of detection at D112-114. Each data point represents an 
individual mouse and data are a compilation of three independent experiments; 
significant differences determined by Ordinary one-way ANOVA using Turkey’s 
multiple comparison test (A and B) and Unpaired t test with Welch's correction 
(C-D). 
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comparable to Irf4+/fl mice (Fig 5.7C and D).  These findings are consistent with 
the conclusion that persistent antigen is essential for conversion of T-bet+ 
Eomes- cells into T-bet- Eomes+ progeny (Paley et al., 2012).  
 
D. Reducing Eomes expression improves viral control in LCMV 
clone 13-infected Irf4+/fl mice by restoring differentiation of T-bet+ 
precursors 
The data presented above indicated that LCMV clone 13-infected Irf4+/fl 
mice have a lower T-bet to Eomes ratio than WT mice in their virus-specific CD8+ 
T cells at multiple time points post-infection. Since optimal expression of both of 
these factors is essential for viral control, we considered whether manipulation of 
this ratio in favor of T-bet would restore protective CD8+ T cell responses in Irf4+/fl 
mice, leading to improved viral control. To address this, Irf4+/fl mice were crossed 
to Eomes+/fl mice to generate Irf4+/fl Eomes+/fl CD4-Cre mice (henceforth referred 
to as Irf4+/fl Eomes+/fl mice).  These compound heterozygotes were infected with 
LCMV-clone 13, along with WT, Irf4+/fl, and Eomes+/fl mice and analyzed at D77-
82 p.i.. 
 
We first observed higher proportions of GP276-specific T cells in the 
spleens of WT mice relative to the other three genotypes. Analysis of absolute 
cell numbers indicated that WT mice had more GP276-specific CD8+ T cells than 
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did Eomes+/fl or Irf4+/fl Eomes+/fl mice; in addition, Irf4+/fl Eomes+/fl mice had 
significantly fewer cells than did Irf4+/fl mice (Fig 5.8A). In contrast, the 
proportions of GP33-specific CD8+ T cells were similar between all four 
genotypes with only modest differences in the absolute numbers of these virus-
specific CD8+ T cell populations (Fig 5.8B). 
 
Analysis of the levels of T-bet and Eomes in virus-specific CD8+ T cells 
between D77-82 p.i. indicated that the Irf4+/fl and the compound heterozygotes 
had lower T-bet expression relative to WT as would be expected due to the role 
of IRF4 in positively regulating T-bet expression (Fig 5.9A and C- left panels) 
(Man et al., 2013; Nayar et al., 2014; Yao et al., 2013). The expression of Eomes 
was higher in the Irf4+/fl cells relative to Irf4+/fl Eomes+/fl cells, indicating that the 
heterozygous deficiency in Eomes was able to reduce Eomes protein expression 
in Irf4+/fl Eomes+/fl (Fig 5.9A and C, middle panels).  In addition, Irf4+/fl Eomes+/fl 
cells showed normalized ratios of T-bet to Eomes expression levels that were 
comparable to those seen in WT cells (Fig 5.9A and C, right panels). 
Furthermore, the re-establishment of the WT T-bet to Eomes ratio was also 
accompanied by increased proportions of T-bet+ Eomes- virus-specific cells in 
Irf4+/fl Eomes+/fl mice compared to those found in Irf4+/fl mice (Fig 5.9B and D).  
 
To test the functional consequences of the restored T-bet to Eomes ratio 
and increased differentiation of the T-bet+ Eomes- virus-specific CD8+ T cell 
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Figure 5.8: Haplodeficiency of Eomesodermin has a modest effect on the 
magnitude of the virus-specific CD8+ T cell response at D77-82 post-
infection with LCMV clone 13: Splenocytes from LCMV Clone 13-infected WT, 
Irf4+/fl, Eomes+/fl and Irf4+/fl Eomes+/fl mice were stained with a viability dye, 
LCMV-specific H2-Db-GP276 and H2Db-GP33 tetramers, and antibodies to CD8 
and analyzed at D77-82 p.i. (A-B) Dot plots show CD8 vs H2-Db-GP276 (A) or 
CD8 vs H2Db-GP33 (B) tetramer staining on live CD8+ T cells. Graphs below 
show compilations of proportions and numbers of virus-specific CD8+ T cells. 
Each data point represents an individual mouse and data are compilations of 
three independent experiments; significant differences were determined by 
Ordinary one-way ANOVA using Turkey’s multiple comparison test. 
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Figure 5.9: Irf4-Eomes compound haplodeficiency restores the T-bet to 
Eomes ratios in virus-specific CD8+ T cells: Splenocytes from LCMV Clone 13 
infected WT, Irf4+/fl, Eomes+/fl and Irf4+/fl Eomes+/fl mice were stained with a 
viability dye, LCMV-specific H2-Db-GP276 and H2Db-GP33 tetramers, and 
antibodies to CD8, T-bet and Eomes and analyzed between D77-82 p.i. (A and 
C) Graphs show compilation of MFI’s of T-bet (left) and Eomes (middle) 
normalized to average values for WT samples in each experiment, and the 
compilation of ratios of Tbet to Eomes expression (right) for H2-Db-GP276 (A) 
and H2Db-GP33 (C) specific cells. (B and D) Dot plots show T-bet vs Eomes 
staining on live CD8+ H2-Db-GP276 (B) or H2Db-GP33 (D) tetramer positive cells. 
Graph shows the compilation of proportions of T-bet+ Eomes- cells for each virus-
specific subset; significant differences determined by Ordinary one-way ANOVA 
using Turkey’s multiple comparison test. 
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population in Irf4+/fl Eomes+/fl mice, we examined the viral titers in these mice 
between days 77-82 p.i. This analysis showed a significantly higher titer of virus 
in the kidneys of Irf4+/fl mice compared to the other three genotypes analyzed 
(Fig 5.10A). Additionally, in contrast to the Irf4+/fl mice, virus was efficiently 
cleared from livers and sera of WT, Eomes+/fl, and Irf4+/fl Eomes+/fl mice at this 
timepoint (Fig 5.10B and C). Finally, we observed no difference in the kinetics of 
virus clearance when comparing WT to Irf4+/fl Eomes+/fl mice (Fig 5.10D).  These 
data demonstrate that reducing Eomes expression in Irf4+/fl mice restores a 
protective balance of T-bet to Eomes levels, leading to improved protective T cell 
responses to this persistent virus infection. In addition, these data indicate that a 
critical proportion of T-bet+ Eomes- virus-specific CD8+ T cells are necessary for 
controlling LCMV Clone 13.  
 
Discussion 
CD8+ T cell exhaustion is commonly observed during persistent infections 
and cancers (Wherry, 2011). Although a number of cell extrinsic factors such as 
the presence of the immune-suppressive cytokine IL-10, help from CD4+ T cells, 
and high viral loads have been implicated in inducing exhaustion, a clear 
understanding of the CD8+ T cell intrinsic molecular mechanisms is still lacking 
(Aubert et al., 2011; Brooks et al., 2006; Doering et al., 2012; Matloubian et al., 
1994; Mueller and Ahmed, 2009). The role of several transcription factors, such 
as Blimp-1, T-bet and Eomes, have been examined during chronic infection 
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Figure 5.10: Irf4-Eomes compound haplodeficiency restores virus control 
during persistent LCMV clone 13 infection: Kidney (A), livers (B) and sera (C) 
were harvested from LCMV Clone 13 infected WT, Irf4+/fl, Eomes+/fl and Irf+/fl 
Eomes+/fl mice between D77-82 post infection and virus titers were determined 
by plaque assay. Dotted lines indicate the limit of detection. Each data point 
represents an individual mouse and data are compilations of two independent 
experiments. (D) Serum was harvested from infected mice at various time point 
post infection. Graph indicates the proportion of mice with viral titers above the 
limit of detection in serum over time; significant differences as determined by 
Ordinary one-way ANOVA using Turkey’s multiple comparison test (A-C) and  
Log-rank (Mantel-Cox) test (D).  
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 (Kao et al., 2011; Paley et al., 2012; Shin et al., 2009). Blimp-1 is highly 
expressed in exhausted CD8+ T cells and its expression correlates with greater 
expression of exhaustion markers. Yet, Blimp-1 knockouts have a defect in 
controlling LCMV clone 13 infections relative to WT mice, whereas mice haplo-
deficient for Blimp-1 are more proficient at controlling the infection. These data 
indicate that varying the levels of Blimp-1 regulates distinct transcriptional 
modules in exhausted CD8+ T cells, and that levels of Blimp-1 that are too high 
or too low are detrimental to the immune response (Shin et al., 2009). Similarly, 
the expression of T-bet and Eomes segregate into T-bethi and Eomeshi 
populations during persistent infections. Even though both proteins are T-box 
transcription factors and function redundantly early in LCMV Armstrong infection, 
loss of either protein results in impaired control of LCMV clone 13 infections.  
These data indicate that T-bet and Eomes exert unique functions likely due to the 
different gene networks they regulate during LCMV clone 13 infections (Doering 
et al., 2012; Paley et al., 2012). Together these data demonstrate that efficient 
control of LCMV Clone 13 requires an optimal level of each of these transcription 
factors. Interestingly, mice lacking Blimp-1, T-bet, or Eomes have no defect in 
clearing acute LCMV Armstrong infections, yet are impaired in controlling LCMV 
Clone 13 (Banerjee et al., 2010; Intlekofer et al., 2007; Rutishauser et al., 2009). 
Here we find that IRF4 joins this group of transcription factors, as reduced 
expression of IRF4 leads to persistence of LCMV Clone 13 infection, but does 
not affect clearance of LCMV Armstrong (Nayar et al., 2014).   
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Despite the fact that the function of Tbethi and Eomeshi subsets is well 
defined, the factors regulating the differentiation of anti-viral CD8+ T cells into 
these subsets is not known. We explored the role of TCR signaling via IRF4 in 
the relative expression of T-bet and Eomes and the differentiation of T-bet+ 
Eomes- and T-bet- Eomes+ subsets during chronic LCMV infection. We find that 
the balance of these two transcription factors is dependent on the strength of 
TCR signaling and reduction in the affinity or the dose of the stimulating ligand 
resulted in lowering of this ratio. Molecularly, the relative levels of T-bet and 
Eomes were dependent on the magnitude of IRF4 expression, and reduced IRF4 
expression, such as those achieved by haplo-deficiency of Irf4, resulted in 
skewing of this ratio in the favor of Eomes, both in-vitro and in-vivo.  
 
The most severe consequence of the altered T-bet to Eomes ratio was the 
reduced differentiation of T-bet+ Eomes- precursors, and long-term viral 
persistence in Irf4+/fl mice. IRF4 regulates multiple pathways such as 
proliferation, metabolism, and expression of effector cytokines in anti-viral CD8+ 
T cells (Man et al., 2013; Yao et al., 2013). Thus, it is likely that defects in any of 
these pathways could contribute to impaired viral clearance in Irf4+/fl mice rather 
than the lower T-bet to Eomes ratio. To directly test the importance of Eomes, we 
reduced Eomes expression in Irf4+/fl mice by generating Irf4+/fl Eomes+/fl mice. 
These compound heterozygotes had lower Eomes expression relative to Irf4+/fl 
mice, exhibited no alteration in the T-bet to Eomes ratio relative to WT cells, and 
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showed enhanced differentiation of T-bet+ Eomes- cells relative to Irf4+/fl mice. 
Consequently, Irf4+/fl Eomes+/fl mice were indistinguishable from WT mice in 
terms of viral clearance from multiple organs. These data, to the best of our 
knowledge, are the first to test the importance of relative expression of T-bet and 
Eomes in LCMV clone 13 viral control. 
 
Using T-bet and Eomes knockout mice, Paley et. al. showed that both T-
bethi and Eomeshi subsets are important for viral control. However, it is not known 
if reduced differentiation of one population over the other affects viral clearance. 
Our studies show that reduced differentiation of T-bet+ Eomes- population in 
Irf4+/fl mice is detrimental to efficient viral control. Consistent with this 
observation, lower proportions of CD8+ T-bet+ Eomes- cells are observed in lung 
transplant recipients with relapsed CMV infection relative to controllers (Popescu 
et al., 2014). A recent study showed that loss of FoxO1 results in higher levels of 
T-bet and lower levels of Eomes, thus biasing CD8+ T cell differentiation to the T-
bethi subset.  Interestingly, the FoxO1 deficient mice were also defective in viral 
control (Staron et al., 2014). Together these data underscore the importance of 
previous observations that both subsets of CD8+ T cells, the T-bethi and the 
Eomeshi population, play unique and essential functions during anti-viral immune 
responses to LCMV Clone 13 (Paley et al., 2012). Further, these data support 
our conclusion that balanced differentiation of T-bet+ Eomes- and T-bet- Eomes+ 
subsets are important for viral control. 
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Another interesting observation from our data is that excessively high 
levels of Eomes are detrimental to anti-viral CD8+ T cell responses to persistent 
LCMV infections. Though Eomes is necessary for viral control (Paley et al., 
2012), the consequence of high levels of Eomes in this process has never been 
explored. While Eomeshi CD8+ T cells have been shown to have greater 
cytotoxicity in-vitro (Paley et al., 2012), we find that excessively high levels of 
Eomes are detrimental to viral clearance in-vivo. These data draw parallels with 
the role of Blimp-1 in chronic infection, where intermediate levels of Blimp-1 lead 
to most efficient viral control (Shin et al., 2009).  
 
Recently, we and others have shown that the levels of IRF4 regulate the 
magnitude of CD8+ T cell expansion during acute infections. Further, IRF4 
regulates the expression of Eomes and T-bet in anti-viral CD8+ T cells and in in-
vitro activated CD8+ T cells (Man et al., 2013; Nayar et al., 2014; Yao et al., 
2013). Similar to that seen with acute infections, we find here that the levels of 
IRF4 also regulate the magnitude of the CD8+ T cell response to LCMV Clone 13 
at D8 post infection. However, virus-specific CD8+ T cell numbers were only 
modestly different between WT and Irf4+/fl mice at D22 p.i., and not different at all 
at D112-114 p.i. Together, these data are consistent with the findings that CD8+ 
T cells are functionally and transcriptionally similar early after infection with 
LCMV Armstong and LCMV Clone 13, but show a significant divergence in 
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transcription factor networks and the gene targets regulated by these factors at 
later time points (Doering et al., 2012).  
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CHAPTER VI: DISCUSSION 
 
 T cell development and differentiation is a complex process that involves 
integration of signals through the TCR, co-stimulatory molecules and cytokines. 
These extracellular signals are converted into signal transduction cascades that 
lead to activation of various transcription factors. Interplay of these transcription 
factors ultimately dictates cell fate and differentiation by inducing lineage specific 
effector functions. In this thesis we have focused on the role of TCR signal 
strength in the induction of CD8+ T cell differentiation in the context of innate-like 
T cells, and anti-viral CD8+ T cell responses to acute and chronic infection.  
 
 We find that the signals through the TCR via ITK up-regulate the 
expression of the transcription factor IRF4. Further, levels of IRF4 expression are 
dependent on the strength of TCR signaling. Reducing TCR signal strength by 
lowering affinity or dose of stimulating peptide, or via reduction in ITK activity 
leads to lower levels of IRF4 expression (Man et al., 2013; Nayar et al., 2012; 
2014; Yao et al., 2013). These changes in IRF4 expression induce the 
differentiation of activated CD8+ T cells into multiple T cell lineages. 
 
Our data indicate that the differentiation of Eomes+ innate-like T cells is 
regulated by two opposing signals. Signals through the TCR via IRF4 suppress 
up-regulation of Eomes, while IL-4 stimulation and STAT6 promote Eomes 
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expression (Carty et al., 2014; Nayar et al., 2012). The balance of these two 
pathways dictates the net expression of Eomes, and thus differentiation of 
innate-like T cells. However, IL-4 by itself cannot induce high levels of Eomes 
expression; rather signals through the TCR via AKT and mTORC1 synergize with 
IL-4 for maximal Eomes up-regulation (Carty et al., 2014). Hence, TCR signaling 
both induces and suppresses Eomes expression. In further support to these 
data, we observed that Eomes is maximally expressed in activated CD8+ T cells 
by 24hr post stimulation, with stable expression observed up to 48hr. However, 
Irf4 deficient cells not only express significantly higher levels of Eomes relative to 
WT cells, but the expression of Eomes continues to increase in Irf4 deficient cells 
until 48hr post stimulation (Nayar et al., 2012; 2014).  Thus in mice deficient for 
Itk, or Y145F SLP76 mutant mice, signaling via IL-4 and STAT6 predominates, 
resulting in differentiation of innate-like T cells (Figure 6.1).  
 
Recent data using Nur77 GFP reported mice have indicated that innate 
cells such as T-CD4 and iNKT cells perceive high strength of TCR signaling 
during development, and are thus programmed to differentiate into innate cells in 
the thymus (Moran et al., 2011; Qiao et al., 2012).  Since six times more cells 
undergo negative selection than positive selection in WT mice and negative 
selection is compromised in Itk-/- mice (Lucas et al., 2002; Schaeffer et al., 2000), 
and (Stritesky et al., 2013), it can be speculated that the CD8+ T cell repertoire of 
Itk-/- mice is predominated by cells expressing higher affinity TCRs that escaped 
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Figure 6.1: Development of conventional vs. innate CD8+ T cells in the 
thymus: The strength of TCR signaling regulates Eomesodermin expression via 
the Tec family tyrosine kinase ITK and the transcription factor IRF4. Strong TCR 
signaling promotes robust activation of ITK, leading to high levels of expression 
of the transcription factor IRF4. Either in the presence or the absence of IL-4, 
CD8+ T cells stimulated under these conditions express low levels of Eomes. 
During T-cell development in the thymus, this pathway produces conventional T 
cells. In contrast, following weak TCR stimulation, ITK activation is modest and 
cells produce low amounts of IRF4.These conditions, together with IL-4 receptor 
signaling, promote maximal up-regulation of Eomesodermin, leading to the 
development of innate CD8+ T cells. 
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Figure 6.1: Development of conventional vs. innate CD8+ T cells in the 
thymus 
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negative selection. Therefore, it can be speculated that Itk-/- CD8+ T cells are 
naturally inclined to differentiate into innate-like T cells, rather than being 
programmed by a combination of low TCR signal strength and IL-4 signaling. 
However, the expression of CD5, a surface marker that correlates with strength 
of TCR signaling is reduced on DP and CD4 and CD8 SP Itk-/- thymocytes 
relative to WT thymocytes (Lucas et al., 2002; Schaeffer et al., 2000) arguing 
against the notion that CD8 SP Itk-/- thymocytes express high affinity TCRs. 
Further, multiple studies have established the role of IL-4 in the development of 
innate-like T cells in Itk-/- mice (Gordon et al., 2011; Verykokakis et al., 2010; 
Weinreich et al., 2010). Most importantly, these cells are highly enriched in mice 
with defects in TCR signaling such as Y145F SLP76 mutant mice and Itk-/- mice 
(Gordon et al., 2011; Weinreich et al., 2010). These data indicate that the Itk-/- 
innate-like CD8+ T cells are a unique population with signaling requirements 
distinct from those of required for the development of T-CD4 cells and iNKT cells. 
 
Our data indicate that IRF4 is important for suppressing Eomes 
expression, yet innate-like CD8+ T cells do not develop in Irf4fl/fl mice. This 
dichotomy can be explained by the fact that Itk-/- mice have an expansion of IL-4 
producing innate CD4+ PLZF+ T cells (Weinreich et al., 2010), which is not 
observed in Irf4fl/fl mice. It is possible that the absence of exogenous IL-4 
prevents the conversion of conventional CD8+ T cell into innate-like CD8+ T cells 
in Irf4fl/fl mice. We could test this possibility by differentiating WT and Irf4fl/fl CD8+ 
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thymocytes in-vitro using fetal-thymic organ cultures or OP9-DL1 culture system 
in the presence of exogenous IL-4.  
 
Apart from the role of IRF4 in innate-like T cell differentiation, one question 
that remains to be explored is the role of IRF4 in thymic selection. Since 
reduction in TCR signal strength alters positive and negative selection in Itk 
deficient and Y145F SLP76 mutant mice, it is reasonable to hypothesize that 
IRF4 is also participates in these processes.  
 
Besides its role in differentiation of innate-like T cells, Eomes is also 
required for the maintenance of memory cells (Banerjee et al., 2010). Therefore 
we hypothesized that changes in IRF4 would affect lineage commitment of anti-
viral CD8+ T cells into SLEC and MPEC populations. To our surprise, we found 
that the strength of TCR signaling and levels of IRF4 regulated the numbers of 
SLECs, and therefore the magnitude of CD8+ T cell expansion (Nayar et al., 
2014). However, the numbers of MPECs were relatively unaffected indicating 
that low levels of IRF4 were sufficient to induce their differentiation. The reduced 
numbers of SLECs could also be due to the migration of anti-viral Irf4+/fl CD8+ T 
cell to other tissues due to defects in homing. We did not explore this possibility 
in LCMV Armstrong infections. However, our data from Influenza infections 
indicated reduced numbers of OT I Irf4+/fl CD8+ T cells in spleen, lung and 
draining lymph nodes. These data suggest reduced proliferation rather than 
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aberrant migration of cells to other tissues as the likely cause of fewer numbers 
of SLECs in Irf4+/fl mice. 
 
Overall, the data described in chapter IV indicate that distinct levels of 
IRF4 regulate clonal expansion and differentiation of effector cells, and 
development of memory cells. Based on these data we speculate that upon 
antigen encounter, CD8+ T cells would up-regulate IRF4. Amongst these cells, 
those that continue to receive signals through the TCR, co-stimulation, and 
cytokines would express even greater levels of IRF4. Higher IRF4 expression 
would enhance T cell proliferation leading to higher clonal expansion of effector 
cells. On the other hand, cells that up-regulate comparatively lower levels of IRF4 
would differentiate into memory cells (Figure 6.2).  
 
Many models have been put forward to explain the generation of effector 
and memory cells during infection. The separate-precursor model states that 
naïve CD8+ T cells are programmed during thymic development to adopt effector 
or memory fates upon activation in the periphery (Kaech and Cui, 2012). 
However, elegant studies using cellular barcoding as well as transfer of single 
cells have shown that both effector and memory cells can arise from a single 
CD8+ T cell (Buchholz et al., 2013; Gerlach et al., 2013). The decreasing 
potential model suggests that activated CD8+ T cells progressively lose memory 
cell potential upon successive rounds of stimulation. Therefore repetitive 
 233 
Figure 6.2: Differentiation of SLECs and MPECs is regulated by distinct 
levels of IRF4: The expression of IRF4 is up-regulated in CD8+ T cells upon 
interaction with cognate peptide-MHC complex on an APC in the presence of co-
stimulation and cytokines. Within the pool of responding CD8+ T cells, the cells 
that continue to receive these signals up-regulate even higher levels of IRF4 
leading to clonal expansion and differentiation of these cells into SLECs. 
However, cells that up-regulated lower but sufficient levels of IRF4 relative to 
SLECs during the initial stimulus but do not receive further signals differentiate 
into MPECs.    
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stimulation of a CD8+ T cell through the TCR, co-stimulatory molecules, and 
cytokines drives effector T cell differentiation with concomitant loss of memory 
cell potential (Kaech and Cui, 2012). The signal strength model suggests that 
effector cell generation is dependent on the combined strength of TCR signaling, 
co-stimulation and cytokine signaling. Thus higher strength of signaling enhances 
clonal expansion of effector T cells, and selects T cell clones fit to form memory 
cells. However, T cells undergo terminal differentiation when excessively strong 
signals are delivered (Kaech and Cui, 2012). The key difference between the 
signal strength and decreasing potential model is that the former model suggests 
that T cells acquire effector or memory fates early during the response instead of 
progressing through these fates more linearly. The last model, the asymmetric 
cell division model suggests that a single CD8+ T cell gives rise to both the 
effector and memory cell, and that this process occurs following the first cell 
division. According to this model, upon T cell division, the daughter cell proximal 
to the T cell-APC synapse perceives stronger strength of signaling through the 
TCR, co-stimulation, and cytokines and differentiates into effector cells, while the 
distal daughter cells differentiates into a memory cell (Kaech and Cui, 2012). 
Taken together the decreasing potential, signal strength and asymmetric cell 
division models suggest that stronger signal strength drives terminal 
differentiation while a weaker signal preserves memory cell potential. However, 
these models differ with respect to the timing when this decision is made.  
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Our experiments do not test the precise timing at which the levels of IRF4 
become critical for effector and memory cell differentiation. It is possible that 
owing to the proximity to the APC, the proximal daughter cell up-regulates higher 
levels of IRF4 due to greater stimulation through the TCR, co-stimulatory 
molecules, and cytokines compared to the distal cell. Hence levels of IRF4 
expressed after the initial antigen encounter, and prior to the first cell division 
regulate clonal expansion and terminal differentiation of the proximal daughter 
cells as supported by the asymmetric cell division model. It is also likely that 
signal strength perceived after early antigen encounter generates the critical 
levels of IRF4 that are sufficient for T cells to differentiate into effector or memory 
cells as supported by the signal strength model. Further, it is possible that 
successive rounds of T cell stimulation lead to accumulation of increasing levels 
of IRF4 that are required for maximal proliferative burst of activated CD8+ T cells. 
Thus our data support the role of overall signal strength in effector and memory 
cell differentiation, but do not distinguish between decreasing potential, signal 
strength, and asymmetric cell division models. 
 
We also observed that relative to anti-viral WT cells, anti-viral Irf4+/fl CD8+ 
T cells express higher levels of TCF1 and its downstream target Eomes at D8 p.i. 
with LCMV Armstrong, suggesting a linear relationship between these 
transcription factors. Contrary to this, CD8+ T cells stimulated in-vitro with GP33 
and F6L ligands, exhibit maximum differences in Eomes expression earlier than 
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IRF4 expression. Further, P14 Irf4+/fl CD8+ T cell express higher levels of TCF1 
relative to P14 Irf4fl/fl CD8+ T cell in-vitro. This discrepancy in the expression of 
Eomes, IRF4 and TCF1 in-vivo versus in-vitro suggests that the regulation of 
TCF1 and Eomes by IRF4 is a complex process and may involve both direct and 
indirect regulation of these genes, besides being influenced by the binding 
partners IRF4.  
 
Considerable evidence exists regarding the transcriptional nature of IRF4 
in B cells and Th17 cells. Like T cells, the expression of IRF4 is regulated by the 
strength of BCR signaling in B cells (Sciammas et al., 2006). Depending on the 
levels of IRF4 and the co-factors expression in B cells, IRF4 can homodimerize 
or heterodimerize with PU.1 or AP-1. The binding partners of IRF4 dictate the 
nature of the DNA elements such as EICE, AICE or ISRE motifs that are bound 
by IRF4 homo/heterodimers. Further, the affinity of the IRF4 homodimers for 
ISRE is lower than that of IRF4/PU.1 or IRF4/BATF heterodimers for EICE and 
AICE DNA elements (Ochiai et al., 2013). Together these interactions influence 
the genes that are regulated by IRF4. Such a temporal regulation pattern would 
allow differentiation of T cells into unique cell fates depending on the levels of 
IRF4 expressed in the cells (Ochiai et al., 2013). Another feature of IRF4 
transcriptional activity demonstrated in Th17 cells is that IRF4 and BATF 
increase chromatin accessibility post T cell stimulation. This allows lineage 
specific transcription factors such as RORγt, STAT3 etc. to bind to target DNA 
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loci, leading to the assembly of multi-molecular transcriptional machinery that 
regulates the expression of lineage specifying effector functions. 
 
Thus despite modest differences in IRF4 expression between WT cells 
stimulated with GP33 versus F6L peptide at 24hr, it can be speculated that the 
stoichiometry of IRF4 homodimers is significantly different between the two 
stimulation conditions. If expression of Eomes is regulated by the binding of IRF4 
homodimers to the low affinity ISRE elements in the Eomes promoter, then we 
would expect to see significant differences in Eomes expression under these 
conditions. The regulation of TCF1 appears to be a more complex process. P14 
Irf4fl/fl cells have bimodal expression of TCF1 at 72hr. One subset of these cells 
expresses TCF1 to the same level as P14 Irf4+/fl cells, while the other subset 
expresses lower levels of TCF1 similar to the WT cells (hereafter referred to as 
TCF1low cells). As IRF4 regulates multiple facets of T cell differentiation, it is likely 
that other pathways that regulate TCF1 are also affected in P14 Irf4fl/fl cells. As a 
result of the alterations in the differentiation state of the P14 Irf4fl/fl cells, it is likely 
that TCF1low cells may have delays in TCF1 up-regulation. Interestingly, this 
phenomenon is not observed in-vivo in Irf4fl/fl antigen specific cells at D8 p.i. 
Antigen-specific Irf4fl/fl cells express the highest levels of TCF1 followed by Irf4+/fl 
cells. One potential explanation for this discrepancy could be the health of the 
cells. Irf4fl/fl cells have poor survival in-vitro and in-vivo (Man et al., 2013; Yao et 
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al., 2013). Thus it is possible that the TCF1low cells are unfit but escaped viability 
discrimination due to intact plasma membranes. 
 
Apart from the issues discussed above, the data described in chapter IV 
also raise the question that if IRF4 is important for survival of activated CD8+ T 
cells, then why is the survival of MPECs not affected by Irf4 haplo-deficieny?  
 
Eomes is also important for anti-viral CD8+ T cell responses to persistent 
LCMV infections (Paley et al., 2012). Based on our observations that IRF4 
regulates Eomes and T-bet expression, we hypothesized that levels of IRF4 
would be critical for clearance of persistent infections such as LCMV. Indeed we 
found that WT levels of IRF4 were required for efficient viral control. Levels of 
IRF4 regulated the relative expression of T-bet to Eomes, and therefore the 
differentiation of anti-viral CD8+ T cells into T-bet+ precursors. Reduced 
expression of IRF4 resulted in higher Eomes expression, lower proportions of T-
bet+ population, and impaired viral clearance in Irf4+/fl mice. Restoration of T-bet 
to Eomes ratio in Irf4+/fl mice resulted in increased proportions of T-bet+ 
precursors and increased viral clearance. Interestingly the numbers of anti-viral 
CD8+ T cells were lower in Irf4+/fl mice relative to WT mice at D8 post infection, 
but not at D22 post infection. Higher viral loads can induce greater proliferation of 
anti-viral CD8+ T cells. However we observed no difference in virus titers 
between WT and Irf4+/fl mice at D22 p.i. These data raise an important issue: 
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How does IRF4 regulate proliferation in acute versus chronic infections? Further, 
despite the fact that Eomes and T-bet are T-box factors, it unclear as to why do 
these factors function redundantly in early in acute infection but not during 
chronic infections. 
 
It is well established that IRF4 regulates the differentiation of multiple 
CD4+ helper T cells (Huber and Lohoff, 2014). Th cell differentiation is regulated 
by the expression of lineage specific transcription factors. However, the 
expression of IRF4 is not limited to a particular cell type. Then, how does IRF4 
induce multiple differentiation fates in CD4+ and CD8+ T cells? 
 
Again, the answers to the questions can be deduced by extrapolating the 
evidence on IRF4 binding partners in B cells and Th17 cells to CD8+ T cells. It is 
well established that T cell differentiation requires signals through the TCR, co-
stimulation and cytokines. I thus speculate that during T cell differentiation, IRF4 
increases global DNA accessibility. Cytokine induced lineage specific 
transcription factors would then bind to specific loci to regulate the expression of 
effector genes. Specificity of lineage differentiation could also be induced by the 
co-factors that interact with IRF4. For example, IRF4 physically interacts with 
Smad2/3 in Th9 cells, with BATF in Th17 cells and induces expression of STAT3 
dependent genes in Tfh cells (Glasmacher et al., 2012; Kwon et al., 2009; 
Tamiya et al., 2013). It is also likely that IRF4 is expressed at different levels in 
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different Th cell types. For example, STAT6 induces the expression of IRF4, and 
so it is likely that Th2 and Th9 cells express higher levels of IRF4 relative to other 
Th cell types (Goswami et al., 2012). In these cell types, it is possible that high 
levels of IRF4 induce IRF4 homodimers that bind to low affinity ISRE elements in 
target loci.  
 
The role of IRF4 in thymic selection is unclear. The affinity model suggests 
that TCRs with intermediate affinity are selected in the thymus. Those TCRs that 
weakly or fail to recognize the self-peptide-MHC complex and hence are not self 
restricted die by neglect while those that induce strong TCR signals upon 
interaction with self-peptide-MHC complex undergo apoptosis during negative 
selection. We observed that IRF4 is induced in CD69+ DP, CD8+ and CD4+ SP T 
cells indicating that IRF4 is induced during selection (Nayar et al., 2012). Since 
IRF4 is important for survival of activated CD8+ T cells, it is likely that weak 
signals through the TCR induce low levels of IRF4, and these are unable to 
prevent death of cells with low affinity TCRs. Further, I speculate that cells that 
undergo negative selection induce very high levels of IRF4 that are detrimental to 
T cell survival. It is likely that IRF4 forms homodimers in these cells and hence 
may induce genes involved in apoptosis. However, unlike Itk deficient mice, there 
is no defect in the numbers of CD4+ or CD8+ T cells in the thymii of Irf4 deficient 
mice. Hence it was concluded that IRF4 does not regulate T cell development in 
the thymus. However, it is likely that the T cell repertoire in Irf4 deficient mice is 
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different than in WT mice, and higher affinity TCR’s, which would normally be 
deleted by negative selection in WT mice, are preserved in Irf4 deficient mice.  
 
The role of IRF4 in regulating the numbers and survival of SLEC and 
MPEC populations can be explained by speculating that IRF4 is expressed at 
higher levels in SLECs than in MPECs. Thus in SLECs, IRF4 would negatively 
regulate the expression of CDK inhibitors and switch cell metabolism to aerobic 
glycolysis to provide for the energetics demands of rapid proliferation (Man et al., 
2013; Yao et al., 2013). Thus, the levels of IRF4 correlate with the magnitude of 
SLEC expansion. In MPECs reduced expression of IRF4 would allow for higher 
Eomes expression. Eomes regulates the expression of CD122 that is required for 
IL-15 induced homeostatic proliferation and expression of the pro-survival factor 
Bcl2 (Banerjee et al., 2010; Intlekofer et al., 2005; Pearce et al., 2003). 
Therefore, in Irf4 haplo-deficient MPECs, increased expression of Eomes may 
compensate for the requirement of IRF4. In support of this hypothesis, we 
observed higher Bcl2 expression in Irf4 haplo-deficient MPECs relative to WT 
cells (Nayar et al., 2014).  
 
Consistent with the data described above, during chronic LCMV infection 
Eomeshi cells have higher proliferation rates relative to T-bethi cells (Paley et al., 
2012). Thus in mice haplo-deficient for Irf4, higher Eomes expression may induce 
greater proliferation of anti-viral CD8+ T cells leading to similar numbers between 
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WT and Irf4+/fl mice. It is also likely that persistent TCR stimulation induces 
sufficient levels of IRF4 expression for proliferation but not for cytotoxic functions. 
As a result, despite similar numbers of anti-viral CD8+ T cells, Irf4 deficient mice 
have impaired viral control. It is also possible that that IRF4 interacts with 
different binding partners or co-factors during acute versus chronic infection, 
resulting in expression of different sets of genes during those stimulation 
conditions. This is evident in the case of Eomes, which appears to regulate the 
expression of exclusive sets of genes during acute and chronic infections 
(Doering et al., 2012). As a result, it can be speculated that proliferation of Irf4 
deficient cells in chronic infection is only compromised early in the response, 
when the transcriptional profiles of CD8+ T cells and likely the genes regulated by 
IRF4 between acute and chronic infections are similar (Doering et al., 2012). 
However, later in the response the transcriptional profiles of CD8+ T cells from 
acute and chronic infection are significantly different, and it can be speculated 
that IRF4 induced genes that regulate proliferation are also unique.  
 
The T-box transcription factors T-bet and Eomes function redundantly 
early in acute infections (Banerjee et al., 2010; Intlekofer et al., 2005; 2007). As a 
result loss of one protein does not affect generation of anti-viral CD8+ T cell 
responses or impact viral clearance. In contrast, during chronic infections, these 
two transcription factors appear to play exclusive roles and loss of either protein 
impairs viral clearance. This discrepancy can be explained by the fact that T-bet 
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regulates the expression of a common subset of genes during acute and chronic 
infections (Doering et al., 2012). Eomes, on the other hand, regulates genes 
exclusive to acute or chronic infections. These data indicate that the function of 
Eomes during persistent infection is significantly different from its role in acute 
infection. What causes the change in Eomes gene targets between the two types 
of infections is unclear. One speculation might be that similar to IRF4, the binding 
partners or co-factors of Eomes are different in acute and chronic infections. 
These data still do not explain why higher Eomes expression is detrimental to T 
cell mediated cytotoxicity and hence viral clearance in Irf4+/fl mice? A possible 
model is that during infection Eomes and T-bet compete for the T-box binding 
sites on granzyme B and/or perforin gene loci.  However, changes in co-factor 
expression during chronic infection would lead to the assembly of the 
transcription repression complex rather than the activation complex. Thus, it 
would be interesting to see if Eomes can function as a repressor under chronic 
infection conditions. 
 
Finally, I would like to speculate that PD-1 signaling regulates IRF4 
expression. In activated CD8+ T cells, IRF4 is induced downstream of the TCR 
by Akt and mTORC1 pathway. In LCMV Clone 13 infections, PD-1 suppresses 
signaling through Akt and mTORC1 (Staron et al., 2014). Hence it can be 
speculated that reduced Akt phosphorylation would result in lower levels of IRF4 
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expression in anti-viral CD8+ T cells. If true, this would explain why blocking PD-1 
signaling rescues CD8+ proliferation during chronic infections. 
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